Covidence #,Study ID,Title,Reviewer Name,Peer-reviewed or Preprint,Journal,Database/Study ID,Date of Publication (Month and Year),Title of paper,First Author (Last name and Initials),Retrospective/Prospective,Study Design,Does the study primarily compare cancer vs. non-cancer cohorts?,Does the study include inpatients/ outpatients/both/ or non-specific?,Study Country/Countries,Study Regions/Cities,Hospital(s),Study Start Date,Study End Date,Total study size (number of patients),Primary Outcomes of Study,Secondary outcomes of study,outcomes described ,Explicitly included vaccinated patients,Definition of Cancer patient,Comparison group,Comparator group matching strategy,Baseline characteristics:,Cancer Age (measure of centre) e.g. mean/median,Cancer Age (centre),Cancer Age (measure of spread) e.g. IQR/ range/ SD/ SE/ 95% CI/ Variance,Cancer Age (spread),Cancer Sex (% male),Cancer Total number,Control (non-cancer) Age (measure of centre) e.g. mean/median,Control (non-cancer) Age (centre),Control (non-cancer) Age (measure of spread) e.g. IQR/ range/ SD/ SE/ 95% CI/ Variance,Control (non-cancer) Age (spread),Control (non-cancer) Sex (% male),Control (non-cancer) Total number,Which COVID-19 variant does the study identify?,Co-morbidities:,Smoking Number (cancer),Smoking Percentage (cancer),Smoking Number (control),Smoking Percentage (control),Smoking Measure of Association (OR/RR etc),Smoking OR/RR value,Smoking 95% Confidence Interval,Smoking p value,Hypertension Number (cancer),Hypertension Percentage (cancer),Hypertension Number (control),Hypertension Percentage (control),Hypertension Measure of Association (OR/RR etc),Hypertension OR/RR value,Hypertension 95% Confidence Interval,Hypertension p value,Diabetes Mellitus (DM) Number (cancer),Diabetes Mellitus (DM) Percentage (cancer),Diabetes Mellitus (DM) Number (control),Diabetes Mellitus (DM) Percentage (control),Diabetes Mellitus (DM) Measure of Association (OR/RR etc),Diabetes Mellitus (DM) OR/RR value,Diabetes Mellitus (DM) 95% Confidence Interval,Diabetes Mellitus (DM) p value,Cardiovascular Disease (CVD) Number (cancer),Cardiovascular Disease (CVD) Percentage (cancer),Cardiovascular Disease (CVD) Number (control),Cardiovascular Disease (CVD) Percentage (control),Cardiovascular Disease (CVD) Measure of Association (OR/RR etc),Cardiovascular Disease (CVD) OR/RR value,Cardiovascular Disease (CVD) 95% Confidence Interval,Cardiovascular Disease (CVD) p value,Cerebrovascular Disease Number (cancer),Cerebrovascular Disease Percentage (cancer),Cerebrovascular Disease Number (control),Cerebrovascular Disease Percentage (control),Cerebrovascular Disease Measure of Association (OR/RR etc),Cerebrovascular Disease OR/RR value,Cerebrovascular Disease 95% Confidence Interval,Cerebrovascular Disease p value,Chronic Liver Disease Number (cancer),Chronic Liver Disease Percentage (cancer),Chronic Liver Disease Number (control),Chronic Liver Disease Percentage (control),Chronic Liver Disease Measure of Association (OR/RR etc),Chronic Liver Disease OR/RR value,Chronic Liver Disease 95% Confidence Interval,Chronic Liver Disease p value,Chronic Kidney Disease Number (cancer),Chronic Kidney Disease Percentage (cancer),Chronic Kidney Disease Number (control),Chronic Kidney Disease Percentage (control),Chronic Kidney Disease Measure of Association (OR/RR etc),Chronic Kidney Disease OR/RR value,Chronic Kidney Disease 95% Confidence Interval,Chronic Kidney Disease p value,Chronic Lung Disease Number (cancer),Chronic Lung Disease Percentage (cancer),Chronic Lung Disease Number (control),Chronic Lung Disease Percentage (control),Chronic Lung Disease Measure of Association (OR/RR etc),Chronic Lung Disease OR/RR value,Chronic Lung Disease 95% Confidence Interval,Chronic Lung Disease p value,Immunodeficiency/ Immunosuppression Number (cancer),Immunodeficiency/ Immunosuppression Percentage (cancer),Immunodeficiency/ Immunosuppression Number (control),Immunodeficiency/ Immunosuppression Percentage (control),Immunodeficiency/ Immunosuppression Measure of Association (OR/RR etc),Immunodeficiency/ Immunosuppression OR/RR value,Immunodeficiency/ Immunosuppression 95% Confidence Interval,Immunodeficiency/ Immunosuppression p value,Autoimmune Disease Number (cancer),Autoimmune Disease Percentage (cancer),Autoimmune Disease Number (control),Autoimmune Disease Percentage (control),Autoimmune Disease Measure of Association (OR/RR etc),Autoimmune Disease OR/RR value,Autoimmune Disease 95% Confidence Interval,Autoimmune Disease p value,Others: Please Specify Number (cancer),Others: Please Specify Percentage (cancer),Others: Please Specify Number (control),Others: Please Specify Percentage (control),Others: Please Specify Measure of Association (OR/RR etc),Others: Please Specify OR/RR value,Others: Please Specify 95% Confidence Interval,Others: Please Specify p value,Notes Number (cancer),Notes Percentage (cancer),Notes Number (control),Notes Percentage (control),Notes Measure of Association (OR/RR etc),Notes OR/RR value,Notes 95% Confidence Interval,Notes p value,Definition of severity,Definition of ICU admission/Critical,Definition of mortality,Definition of severe disease,Univariate or multivariate analysis?,Multivariate analysis is adjusted by,Primary Cancer Site:,"Thoracic (lung, mesothelioma) Total Number of Patients","Thoracic (lung, mesothelioma) Measure of Association (OR/RR etc.) [mortality]","Thoracic (lung, mesothelioma) value [mortality]","Thoracic (lung, mesothelioma) 95% confidence interval [mortality]","Thoracic (lung, mesothelioma) p value [mortality]","Thoracic (lung, mesothelioma) Cancer: Event/Total [mortality]","Thoracic (lung, mesothelioma) Non-cancer: Event/Total [mortality]","Thoracic (lung, mesothelioma) Measure of Association (OR/RR etc.) [ICU]","Thoracic (lung, mesothelioma) value [ICU]","Thoracic (lung, mesothelioma) 95% confidence interval [ICU]","Thoracic (lung, mesothelioma) p value [ICU]","Thoracic (lung, mesothelioma) Cancer: Event/Total [ICU]","Thoracic (lung, mesothelioma) Non-cancer: Event/Total [ICU]","Thoracic (lung, mesothelioma) Measure of Association (OR/RR etc.) [severe disease]","Thoracic (lung, mesothelioma) value [severe disease]","Thoracic (lung, mesothelioma) 95% confidence interval [severe disease]","Thoracic (lung, mesothelioma) p value [severe disease]","Thoracic (lung, mesothelioma) Cancer: Event/Total [severe disease]","Thoracic (lung, mesothelioma) Non-cancer: Event/Total [severe disease]","Thoracic (lung, mesothelioma) Comment","Thoracic (lung, mesothelioma) Measure of Association (OR/RR etc.) [hospitalisation]","Thoracic (lung, mesothelioma) value [hospitalisation]","Thoracic (lung, mesothelioma) 95% confidence interval [hospitalisation]","Thoracic (lung, mesothelioma) p value [hospitalisation]","Thoracic (lung, mesothelioma) Cancer: Event/Total [hospitalisation]","Thoracic (lung, mesothelioma) Non-cancer: Event/Total [hospitalisation]","Thoracic (lung, mesothelioma) Comment",Breast Total Number of Patients,Breast Measure of Association (OR/RR etc.) [mortality],Breast value [mortality],Breast 95% confidence interval [mortality],Breast p value [mortality],Breast Cancer: Event/Total [mortality],Breast Non-cancer: Event/Total [mortality],Breast Measure of Association (OR/RR etc.) [ICU],Breast value [ICU],Breast 95% confidence interval [ICU],Breast p value [ICU],Breast Cancer: Event/Total [ICU],Breast Non-cancer: Event/Total [ICU],Breast Measure of Association (OR/RR etc.) [severe disease],Breast value [severe disease],Breast 95% confidence interval [severe disease],Breast p value [severe disease],Breast Cancer: Event/Total [severe disease],Breast Non-cancer: Event/Total [severe disease],Breast Comment,Breast Measure of Association (OR/RR etc.) [hospitalisation],Breast value [hospitalisation],Breast 95% confidence interval [hospitalisation],Breast p value [hospitalisation],Breast Cancer: Event/Total [hospitalisation],Breast Non-cancer: Event/Total [hospitalisation],Breast Comment,"Upper GI (gastric, oesophageal) Total Number of Patients","Upper GI (gastric, oesophageal) Measure of Association (OR/RR etc.) [mortality]","Upper GI (gastric, oesophageal) value [mortality]","Upper GI (gastric, oesophageal) 95% confidence interval [mortality]","Upper GI (gastric, oesophageal) p value [mortality]","Upper GI (gastric, oesophageal) Cancer: Event/Total [mortality]","Upper GI (gastric, oesophageal) Non-cancer: Event/Total [mortality]","Upper GI (gastric, oesophageal) Measure of Association (OR/RR etc.) [ICU]","Upper GI (gastric, oesophageal) value [ICU]","Upper GI (gastric, oesophageal) 95% confidence interval [ICU]","Upper GI (gastric, oesophageal) p value [ICU]","Upper GI (gastric, oesophageal) Cancer: Event/Total [ICU]","Upper GI (gastric, oesophageal) Non-cancer: Event/Total [ICU]","Upper GI (gastric, oesophageal) Measure of Association (OR/RR etc.) [severe disease]","Upper GI (gastric, oesophageal) value [severe disease]","Upper GI (gastric, oesophageal) 95% confidence interval [severe disease]","Upper GI (gastric, oesophageal) p value [severe disease]","Upper GI (gastric, oesophageal) Cancer: Event/Total [severe disease]","Upper GI (gastric, oesophageal) Non-cancer: Event/Total [severe disease]","Upper GI (gastric, oesophageal) Comment","Upper GI (gastric, oesophageal) Measure of Association (OR/RR etc.) [hospitalisation]","Upper GI (gastric, oesophageal) value [hospitalisation]","Upper GI (gastric, oesophageal) 95% confidence interval [hospitalisation]","Upper GI (gastric, oesophageal) p value [hospitalisation]","Upper GI (gastric, oesophageal) Cancer: Event/Total [hospitalisation]","Upper GI (gastric, oesophageal) Non-cancer: Event/Total [hospitalisation]","Upper GI (gastric, oesophageal) Comment","Lower GI (colorectal, small bowel) Total Number of Patients","Lower GI (colorectal, small bowel) Measure of Association (OR/RR etc.) [mortality]","Lower GI (colorectal, small bowel) value [mortality]","Lower GI (colorectal, small bowel) 95% confidence interval [mortality]","Lower GI (colorectal, small bowel) p value [mortality]","Lower GI (colorectal, small bowel) Cancer: Event/Total [mortality]","Lower GI (colorectal, small bowel) Non-cancer: Event/Total [mortality]","Lower GI (colorectal, small bowel) Measure of Association (OR/RR etc.) [ICU]","Lower GI (colorectal, small bowel) value [ICU]","Lower GI (colorectal, small bowel) 95% confidence interval [ICU]","Lower GI (colorectal, small bowel) p value [ICU]","Lower GI (colorectal, small bowel) Cancer: Event/Total [ICU]","Lower GI (colorectal, small bowel) Non-cancer: Event/Total [ICU]","Lower GI (colorectal, small bowel) Measure of Association (OR/RR etc.) [severe disease]","Lower GI (colorectal, small bowel) value [severe disease]","Lower GI (colorectal, small bowel) 95% confidence interval [severe disease]","Lower GI (colorectal, small bowel) p value [severe disease]","Lower GI (colorectal, small bowel) Cancer: Event/Total [severe disease]","Lower GI (colorectal, small bowel) Non-cancer: Event/Total [severe disease]","Lower GI (colorectal, small bowel) Comment","Lower GI (colorectal, small bowel) Measure of Association (OR/RR etc.) [hospitalisation]","Lower GI (colorectal, small bowel) value [hospitalisation]","Lower GI (colorectal, small bowel) 95% confidence interval [hospitalisation]","Lower GI (colorectal, small bowel) p value [hospitalisation]","Lower GI (colorectal, small bowel) Cancer: Event/Total [hospitalisation]","Lower GI (colorectal, small bowel) Non-cancer: Event/Total [hospitalisation]","Lower GI (colorectal, small bowel) Comment","Hepatobiliary (liver, pancreas, gall bladder) Total Number of Patients","Hepatobiliary (liver, pancreas, gall bladder) Measure of Association (OR/RR etc.) [mortality]","Hepatobiliary (liver, pancreas, gall bladder) value [mortality]","Hepatobiliary (liver, pancreas, gall bladder) 95% confidence interval [mortality]","Hepatobiliary (liver, pancreas, gall bladder) p value [mortality]","Hepatobiliary (liver, pancreas, gall bladder) Cancer: Event/Total [mortality]","Hepatobiliary (liver, pancreas, gall bladder) Non-cancer: Event/Total [mortality]","Hepatobiliary (liver, pancreas, gall bladder) Measure of Association (OR/RR etc.) [ICU]","Hepatobiliary (liver, pancreas, gall bladder) value [ICU]","Hepatobiliary (liver, pancreas, gall bladder) 95% confidence interval [ICU]","Hepatobiliary (liver, pancreas, gall bladder) p value [ICU]","Hepatobiliary (liver, pancreas, gall bladder) Cancer: Event/Total [ICU]","Hepatobiliary (liver, pancreas, gall bladder) Non-cancer: Event/Total [ICU]","Hepatobiliary (liver, pancreas, gall bladder) Measure of Association (OR/RR etc.) [severe disease]","Hepatobiliary (liver, pancreas, gall bladder) value [severe disease]","Hepatobiliary (liver, pancreas, gall bladder) 95% confidence interval [severe disease]","Hepatobiliary (liver, pancreas, gall bladder) p value [severe disease]","Hepatobiliary (liver, pancreas, gall bladder) Cancer: Event/Total [severe disease]","Hepatobiliary (liver, pancreas, gall bladder) Non-cancer: Event/Total [severe disease]","Hepatobiliary (liver, pancreas, gall bladder) Comment","Hepatobiliary (liver, pancreas, gall bladder) Measure of Association (OR/RR etc.) [hospitalisation]","Hepatobiliary (liver, pancreas, gall bladder) value [hospitalisation]","Hepatobiliary (liver, pancreas, gall bladder) 95% confidence interval [hospitalisation]","Hepatobiliary (liver, pancreas, gall bladder) p value [hospitalisation]","Hepatobiliary (liver, pancreas, gall bladder) Cancer: Event/Total [hospitalisation]","Hepatobiliary (liver, pancreas, gall bladder) Non-cancer: Event/Total [hospitalisation]","Hepatobiliary (liver, pancreas, gall bladder) Comment",Renal Total Number of Patients,Renal Measure of Association (OR/RR etc.) [mortality],Renal value [mortality],Renal 95% confidence interval [mortality],Renal p value [mortality],Renal Cancer: Event/Total [mortality],Renal Non-cancer: Event/Total [mortality],Renal Measure of Association (OR/RR etc.) [ICU],Renal value [ICU],Renal 95% confidence interval [ICU],Renal p value [ICU],Renal Cancer: Event/Total [ICU],Renal Non-cancer: Event/Total [ICU],Renal Measure of Association (OR/RR etc.) [severe disease],Renal value [severe disease],Renal 95% confidence interval [severe disease],Renal p value [severe disease],Renal Cancer: Event/Total [severe disease],Renal Non-cancer: Event/Total [severe disease],Renal Comment,Renal Measure of Association (OR/RR etc.) [hospitalisation],Renal value [hospitalisation],Renal 95% confidence interval [hospitalisation],Renal p value [hospitalisation],Renal Cancer: Event/Total [hospitalisation],Renal Non-cancer: Event/Total [hospitalisation],Renal Comment,"Urology (ureter, bladder, prostate) Total Number of Patients","Urology (ureter, bladder, prostate) Measure of Association (OR/RR etc.) [mortality]","Urology (ureter, bladder, prostate) value [mortality]","Urology (ureter, bladder, prostate) 95% confidence interval [mortality]","Urology (ureter, bladder, prostate) p value [mortality]","Urology (ureter, bladder, prostate) Cancer: Event/Total [mortality]","Urology (ureter, bladder, prostate) Non-cancer: Event/Total [mortality]","Urology (ureter, bladder, prostate) Measure of Association (OR/RR etc.) [ICU]","Urology (ureter, bladder, prostate) value [ICU]","Urology (ureter, bladder, prostate) 95% confidence interval [ICU]","Urology (ureter, bladder, prostate) p value [ICU]","Urology (ureter, bladder, prostate) Cancer: Event/Total [ICU]","Urology (ureter, bladder, prostate) Non-cancer: Event/Total [ICU]","Urology (ureter, bladder, prostate) Measure of Association (OR/RR etc.) [severe disease]","Urology (ureter, bladder, prostate) value [severe disease]","Urology (ureter, bladder, prostate) 95% confidence interval [severe disease]","Urology (ureter, bladder, prostate) p value [severe disease]","Urology (ureter, bladder, prostate) Cancer: Event/Total [severe disease]","Urology (ureter, bladder, prostate) Non-cancer: Event/Total [severe disease]","Urology (ureter, bladder, prostate) Comment","Urology (ureter, bladder, prostate) Measure of Association (OR/RR etc.) [hospitalisation]","Urology (ureter, bladder, prostate) value [hospitalisation]","Urology (ureter, bladder, prostate) 95% confidence interval [hospitalisation]","Urology (ureter, bladder, prostate) p value [hospitalisation]","Urology (ureter, bladder, prostate) Cancer: Event/Total [hospitalisation]","Urology (ureter, bladder, prostate) Non-cancer: Event/Total [hospitalisation]","Urology (ureter, bladder, prostate) Comment","Gynecological (vaginal, uterine, cervical, ovarian, vulval, endometrial, leiomyosarcoma etc) Total Number of Patients","Gynecological (vaginal, uterine, cervical, ovarian, vulval, endometrial, leiomyosarcoma etc) Measure of Association (OR/RR etc.) [mortality]","Gynecological (vaginal, uterine, cervical, ovarian, vulval, endometrial, leiomyosarcoma etc) value [mortality]","Gynecological (vaginal, uterine, cervical, ovarian, vulval, endometrial, leiomyosarcoma etc) 95% confidence interval [mortality]","Gynecological (vaginal, uterine, cervical, ovarian, vulval, endometrial, leiomyosarcoma etc) p value [mortality]","Gynecological (vaginal, uterine, cervical, ovarian, vulval, endometrial, leiomyosarcoma etc) Cancer: Event/Total [mortality]","Gynecological (vaginal, uterine, cervical, ovarian, vulval, endometrial, leiomyosarcoma etc) Non-cancer: Event/Total [mortality]","Gynecological (vaginal, uterine, cervical, ovarian, vulval, endometrial, leiomyosarcoma etc) Measure of Association (OR/RR etc.) [ICU]","Gynecological (vaginal, uterine, cervical, ovarian, vulval, endometrial, leiomyosarcoma etc) value [ICU]","Gynecological (vaginal, uterine, cervical, ovarian, vulval, endometrial, leiomyosarcoma etc) 95% confidence interval [ICU]","Gynecological (vaginal, uterine, cervical, ovarian, vulval, endometrial, leiomyosarcoma etc) p value [ICU]","Gynecological (vaginal, uterine, cervical, ovarian, vulval, endometrial, leiomyosarcoma etc) Cancer: Event/Total [ICU]","Gynecological (vaginal, uterine, cervical, ovarian, vulval, endometrial, leiomyosarcoma etc) Non-cancer: Event/Total [ICU]","Gynecological (vaginal, uterine, cervical, ovarian, vulval, endometrial, leiomyosarcoma etc) Measure of Association (OR/RR etc.) [severe disease]","Gynecological (vaginal, uterine, cervical, ovarian, vulval, endometrial, leiomyosarcoma etc) value [severe disease]","Gynecological (vaginal, uterine, cervical, ovarian, vulval, endometrial, leiomyosarcoma etc) 95% confidence interval [severe disease]","Gynecological (vaginal, uterine, cervical, ovarian, vulval, endometrial, leiomyosarcoma etc) p value [severe disease]","Gynecological (vaginal, uterine, cervical, ovarian, vulval, endometrial, leiomyosarcoma etc) Cancer: Event/Total [severe disease]","Gynecological (vaginal, uterine, cervical, ovarian, vulval, endometrial, leiomyosarcoma etc) Non-cancer: Event/Total [severe disease]","Gynecological (vaginal, uterine, cervical, ovarian, vulval, endometrial, leiomyosarcoma etc) Comment","Gynecological (vaginal, uterine, cervical, ovarian, vulval, endometrial, leiomyosarcoma etc) Measure of Association (OR/RR etc.) [hospitalisation]","Gynecological (vaginal, uterine, cervical, ovarian, vulval, endometrial, leiomyosarcoma etc) value [hospitalisation]","Gynecological (vaginal, uterine, cervical, ovarian, vulval, endometrial, leiomyosarcoma etc) 95% confidence interval [hospitalisation]","Gynecological (vaginal, uterine, cervical, ovarian, vulval, endometrial, leiomyosarcoma etc) p value [hospitalisation]","Gynecological (vaginal, uterine, cervical, ovarian, vulval, endometrial, leiomyosarcoma etc) Cancer: Event/Total [hospitalisation]","Gynecological (vaginal, uterine, cervical, ovarian, vulval, endometrial, leiomyosarcoma etc) Non-cancer: Event/Total [hospitalisation]","Gynecological (vaginal, uterine, cervical, ovarian, vulval, endometrial, leiomyosarcoma etc) Comment",CNS Total Number of Patients,CNS Measure of Association (OR/RR etc.) [mortality],CNS value [mortality],CNS 95% confidence interval [mortality],CNS p value [mortality],CNS Cancer: Event/Total [mortality],CNS Non-cancer: Event/Total [mortality],CNS Measure of Association (OR/RR etc.) [ICU],CNS value [ICU],CNS 95% confidence interval [ICU],CNS p value [ICU],CNS Cancer: Event/Total [ICU],CNS Non-cancer: Event/Total [ICU],CNS Measure of Association (OR/RR etc.) [severe disease],CNS value [severe disease],CNS 95% confidence interval [severe disease],CNS p value [severe disease],CNS Cancer: Event/Total [severe disease],CNS Non-cancer: Event/Total [severe disease],CNS Comment,CNS Measure of Association (OR/RR etc.) [hospitalisation],CNS value [hospitalisation],CNS 95% confidence interval [hospitalisation],CNS p value [hospitalisation],CNS Cancer: Event/Total [hospitalisation],CNS Non-cancer: Event/Total [hospitalisation],CNS Comment,Head and neck Total Number of Patients,Head and neck Measure of Association (OR/RR etc.) [mortality],Head and neck value [mortality],Head and neck 95% confidence interval [mortality],Head and neck p value [mortality],Head and neck Cancer: Event/Total [mortality],Head and neck Non-cancer: Event/Total [mortality],Head and neck Measure of Association (OR/RR etc.) [ICU],Head and neck value [ICU],Head and neck 95% confidence interval [ICU],Head and neck p value [ICU],Head and neck Cancer: Event/Total [ICU],Head and neck Non-cancer: Event/Total [ICU],Head and neck Measure of Association (OR/RR etc.) [severe disease],Head and neck value [severe disease],Head and neck 95% confidence interval [severe disease],Head and neck p value [severe disease],Head and neck Cancer: Event/Total [severe disease],Head and neck Non-cancer: Event/Total [severe disease],Head and neck Comment,Head and neck Measure of Association (OR/RR etc.) [hospitalisation],Head and neck value [hospitalisation],Head and neck 95% confidence interval [hospitalisation],Head and neck p value [hospitalisation],Head and neck Cancer: Event/Total [hospitalisation],Head and neck Non-cancer: Event/Total [hospitalisation],Head and neck Comment,Skin (including melanoma) Total Number of Patients,Skin (including melanoma) Measure of Association (OR/RR etc.) [mortality],Skin (including melanoma) value [mortality],Skin (including melanoma) 95% confidence interval [mortality],Skin (including melanoma) p value [mortality],Skin (including melanoma) Cancer: Event/Total [mortality],Skin (including melanoma) Non-cancer: Event/Total [mortality],Skin (including melanoma) Measure of Association (OR/RR etc.) [ICU],Skin (including melanoma) value [ICU],Skin (including melanoma) 95% confidence interval [ICU],Skin (including melanoma) p value [ICU],Skin (including melanoma) Cancer: Event/Total [ICU],Skin (including melanoma) Non-cancer: Event/Total [ICU],Skin (including melanoma) Measure of Association (OR/RR etc.) [severe disease],Skin (including melanoma) value [severe disease],Skin (including melanoma) 95% confidence interval [severe disease],Skin (including melanoma) p value [severe disease],Skin (including melanoma) Cancer: Event/Total [severe disease],Skin (including melanoma) Non-cancer: Event/Total [severe disease],Skin (including melanoma) Comment,Skin (including melanoma) Measure of Association (OR/RR etc.) [hospitalisation],Skin (including melanoma) value [hospitalisation],Skin (including melanoma) 95% confidence interval [hospitalisation],Skin (including melanoma) p value [hospitalisation],Skin (including melanoma) Cancer: Event/Total [hospitalisation],Skin (including melanoma) Non-cancer: Event/Total [hospitalisation],Skin (including melanoma) Comment,Sarcoma (including Musculo skeletal) Total Number of Patients,Sarcoma (including Musculo skeletal) Measure of Association (OR/RR etc.) [mortality],Sarcoma (including Musculo skeletal) value [mortality],Sarcoma (including Musculo skeletal) 95% confidence interval [mortality],Sarcoma (including Musculo skeletal) p value [mortality],Sarcoma (including Musculo skeletal) Cancer: Event/Total [mortality],Sarcoma (including Musculo skeletal) Non-cancer: Event/Total [mortality],Sarcoma (including Musculo skeletal) Measure of Association (OR/RR etc.) [ICU],Sarcoma (including Musculo skeletal) value [ICU],Sarcoma (including Musculo skeletal) 95% confidence interval [ICU],Sarcoma (including Musculo skeletal) p value [ICU],Sarcoma (including Musculo skeletal) Cancer: Event/Total [ICU],Sarcoma (including Musculo skeletal) Non-cancer: Event/Total [ICU],Sarcoma (including Musculo skeletal) Measure of Association (OR/RR etc.) [severe disease],Sarcoma (including Musculo skeletal) value [severe disease],Sarcoma (including Musculo skeletal) 95% confidence interval [severe disease],Sarcoma (including Musculo skeletal) p value [severe disease],Sarcoma (including Musculo skeletal) Cancer: Event/Total [severe disease],Sarcoma (including Musculo skeletal) Non-cancer: Event/Total [severe disease],Sarcoma (including Musculo skeletal) Comment,Sarcoma (including Musculo skeletal) Measure of Association (OR/RR etc.) [hospitalisation],Sarcoma (including Musculo skeletal) value [hospitalisation],Sarcoma (including Musculo skeletal) 95% confidence interval [hospitalisation],Sarcoma (including Musculo skeletal) p value [hospitalisation],Sarcoma (including Musculo skeletal) Cancer: Event/Total [hospitalisation],Sarcoma (including Musculo skeletal) Non-cancer: Event/Total [hospitalisation],Sarcoma (including Musculo skeletal) Comment,SOLID AGGREGATED [add all solid values] Total Number of Patients,SOLID AGGREGATED [add all solid values] Measure of Association (OR/RR etc.) [mortality],SOLID AGGREGATED [add all solid values] value [mortality],SOLID AGGREGATED [add all solid values] 95% confidence interval [mortality],SOLID AGGREGATED [add all solid values] p value [mortality],SOLID AGGREGATED [add all solid values] Cancer: Event/Total [mortality],SOLID AGGREGATED [add all solid values] Non-cancer: Event/Total [mortality],SOLID AGGREGATED [add all solid values] Measure of Association (OR/RR etc.) [ICU],SOLID AGGREGATED [add all solid values] value [ICU],SOLID AGGREGATED [add all solid values] 95% confidence interval [ICU],SOLID AGGREGATED [add all solid values] p value [ICU],SOLID AGGREGATED [add all solid values] Cancer: Event/Total [ICU],SOLID AGGREGATED [add all solid values] Non-cancer: Event/Total [ICU],SOLID AGGREGATED [add all solid values] Measure of Association (OR/RR etc.) [severe disease],SOLID AGGREGATED [add all solid values] value [severe disease],SOLID AGGREGATED [add all solid values] 95% confidence interval [severe disease],SOLID AGGREGATED [add all solid values] p value [severe disease],SOLID AGGREGATED [add all solid values] Cancer: Event/Total [severe disease],SOLID AGGREGATED [add all solid values] Non-cancer: Event/Total [severe disease],SOLID AGGREGATED [add all solid values] Comment,SOLID AGGREGATED [add all solid values] Measure of Association (OR/RR etc.) [hospitalisation],SOLID AGGREGATED [add all solid values] value [hospitalisation],SOLID AGGREGATED [add all solid values] 95% confidence interval [hospitalisation],SOLID AGGREGATED [add all solid values] p value [hospitalisation],SOLID AGGREGATED [add all solid values] Cancer: Event/Total [hospitalisation],SOLID AGGREGATED [add all solid values] Non-cancer: Event/Total [hospitalisation],SOLID AGGREGATED [add all solid values] Comment,Haematological Total Number of Patients,Haematological Measure of Association (OR/RR etc.) [mortality],Haematological value [mortality],Haematological 95% confidence interval [mortality],Haematological p value [mortality],Haematological Cancer: Event/Total [mortality],Haematological Non-cancer: Event/Total [mortality],Haematological Measure of Association (OR/RR etc.) [ICU],Haematological value [ICU],Haematological 95% confidence interval [ICU],Haematological p value [ICU],Haematological Cancer: Event/Total [ICU],Haematological Non-cancer: Event/Total [ICU],Haematological Measure of Association (OR/RR etc.) [severe disease],Haematological value [severe disease],Haematological 95% confidence interval [severe disease],Haematological p value [severe disease],Haematological Cancer: Event/Total [severe disease],Haematological Non-cancer: Event/Total [severe disease],Haematological Comment,Haematological Measure of Association (OR/RR etc.) [hospitalisation],Haematological value [hospitalisation],Haematological 95% confidence interval [hospitalisation],Haematological p value [hospitalisation],Haematological Cancer: Event/Total [hospitalisation],Haematological Non-cancer: Event/Total [hospitalisation],Haematological Comment,Other Total Number of Patients,Other Measure of Association (OR/RR etc.) [mortality],Other value [mortality],Other 95% confidence interval [mortality],Other p value [mortality],Other Cancer: Event/Total [mortality],Other Non-cancer: Event/Total [mortality],Other Measure of Association (OR/RR etc.) [ICU],Other value [ICU],Other 95% confidence interval [ICU],Other p value [ICU],Other Cancer: Event/Total [ICU],Other Non-cancer: Event/Total [ICU],Other Measure of Association (OR/RR etc.) [severe disease],Other value [severe disease],Other 95% confidence interval [severe disease],Other p value [severe disease],Other Cancer: Event/Total [severe disease],Other Non-cancer: Event/Total [severe disease],Other Comment,Other Measure of Association (OR/RR etc.) [hospitalisation],Other value [hospitalisation],Other 95% confidence interval [hospitalisation],Other p value [hospitalisation],Other Cancer: Event/Total [hospitalisation],Other Non-cancer: Event/Total [hospitalisation],Other Comment,Unspecified Total Number of Patients,Unspecified Measure of Association (OR/RR etc.) [mortality],Unspecified value [mortality],Unspecified 95% confidence interval [mortality],Unspecified p value [mortality],Unspecified Cancer: Event/Total [mortality],Unspecified Non-cancer: Event/Total [mortality],Unspecified Measure of Association (OR/RR etc.) [ICU],Unspecified value [ICU],Unspecified 95% confidence interval [ICU],Unspecified p value [ICU],Unspecified Cancer: Event/Total [ICU],Unspecified Non-cancer: Event/Total [ICU],Unspecified Measure of Association (OR/RR etc.) [severe disease],Unspecified value [severe disease],Unspecified 95% confidence interval [severe disease],Unspecified p value [severe disease],Unspecified Cancer: Event/Total [severe disease],Unspecified Non-cancer: Event/Total [severe disease],Unspecified Comment,Unspecified Measure of Association (OR/RR etc.) [hospitalisation],Unspecified value [hospitalisation],Unspecified 95% confidence interval [hospitalisation],Unspecified p value [hospitalisation],Unspecified Cancer: Event/Total [hospitalisation],Unspecified Non-cancer: Event/Total [hospitalisation],Unspecified Comment,Total (OF ALL CANCERS) Total Number of Patients,Total (OF ALL CANCERS) Measure of Association (OR/RR etc.) [mortality],Total (OF ALL CANCERS) value [mortality],Total (OF ALL CANCERS) 95% confidence interval [mortality],Total (OF ALL CANCERS) p value [mortality],Total (OF ALL CANCERS) Cancer: Event/Total [mortality],Total (OF ALL CANCERS) Non-cancer: Event/Total [mortality],Total (OF ALL CANCERS) Measure of Association (OR/RR etc.) [ICU],Total (OF ALL CANCERS) value [ICU],Total (OF ALL CANCERS) 95% confidence interval [ICU],Total (OF ALL CANCERS) p value [ICU],Total (OF ALL CANCERS) Cancer: Event/Total [ICU],Total (OF ALL CANCERS) Non-cancer: Event/Total [ICU],Total (OF ALL CANCERS) Measure of Association (OR/RR etc.) [severe disease],Total (OF ALL CANCERS) value [severe disease],Total (OF ALL CANCERS) 95% confidence interval [severe disease],Total (OF ALL CANCERS) p value [severe disease],Total (OF ALL CANCERS) Cancer: Event/Total [severe disease],Total (OF ALL CANCERS) Non-cancer: Event/Total [severe disease],Total (OF ALL CANCERS) Comment,Total (OF ALL CANCERS) Measure of Association (OR/RR etc.) [hospitalisation],Total (OF ALL CANCERS) value [hospitalisation],Total (OF ALL CANCERS) 95% confidence interval [hospitalisation],Total (OF ALL CANCERS) p value [hospitalisation],Total (OF ALL CANCERS) Cancer: Event/Total [hospitalisation],Total (OF ALL CANCERS) Non-cancer: Event/Total [hospitalisation],Total (OF ALL CANCERS) Comment,Metastasis status:,M0/Stage I-III: No metastasis Total number of Patients,M0/Stage I-III: No metastasis Measure of Association (OR/RR etc.) [mortality],M0/Stage I-III: No metastasis value [mortality],M0/Stage I-III: No metastasis 95% CI [mortality],M0/Stage I-III: No metastasis p value [mortality],M0/Stage I-III: No metastasis cancer: Event/Total [mortality],M0/Stage I-III: No metastasis Non-cancer: Event/Total [mortality],M0/Stage I-III: No metastasis Measure of Association (OR/RR etc.) [ICU],M0/Stage I-III: No metastasis value [ICU],M0/Stage I-III: No metastasis 95% CI [ICU],M0/Stage I-III: No metastasis p value [ICU],M0/Stage I-III: No metastasis cancer: Event/Total [ICU],M0/Stage I-III: No metastasis Non-cancer: Event/Total [ICU],M0/Stage I-III: No metastasis Measure of Association (OR/RR etc.) [severe],M0/Stage I-III: No metastasis value [severe],M0/Stage I-III: No metastasis 95% CI [severe],M0/Stage I-III: No metastasis p value [severe],M0/Stage I-III: No metastasis cancer: Event/Total [severe],M0/Stage I-III: No metastasis Non-cancer: Event/Total [severe],M0/Stage I-III: No metastasis Comment,M0/Stage I-III: No metastasis Measure of Association (OR/RR etc.) [hospitalisation],M0/Stage I-III: No metastasis value [hospitalisation],M0/Stage I-III: No metastasis 95% confidence interval [hospitalisation],M0/Stage I-III: No metastasis p value [hospitalisation],M0/Stage I-III: No metastasis Cancer: Event/Total [hospitalisation],M0/Stage I-III: No metastasis Non-cancer: Event/Total [hospitalisation],M0/Stage I-III: No metastasis Comment,M1/Stage IV: metastatic disease Total number of Patients,M1/Stage IV: metastatic disease Measure of Association (OR/RR etc.) [mortality],M1/Stage IV: metastatic disease value [mortality],M1/Stage IV: metastatic disease 95% CI [mortality],M1/Stage IV: metastatic disease p value [mortality],M1/Stage IV: metastatic disease cancer: Event/Total [mortality],M1/Stage IV: metastatic disease Non-cancer: Event/Total [mortality],M1/Stage IV: metastatic disease Measure of Association (OR/RR etc.) [ICU],M1/Stage IV: metastatic disease value [ICU],M1/Stage IV: metastatic disease 95% CI [ICU],M1/Stage IV: metastatic disease p value [ICU],M1/Stage IV: metastatic disease cancer: Event/Total [ICU],M1/Stage IV: metastatic disease Non-cancer: Event/Total [ICU],M1/Stage IV: metastatic disease Measure of Association (OR/RR etc.) [severe],M1/Stage IV: metastatic disease value [severe],M1/Stage IV: metastatic disease 95% CI [severe],M1/Stage IV: metastatic disease p value [severe],M1/Stage IV: metastatic disease cancer: Event/Total [severe],M1/Stage IV: metastatic disease Non-cancer: Event/Total [severe],M1/Stage IV: metastatic disease Comment,M1/Stage IV: metastatic disease Measure of Association (OR/RR etc.) [hospitalisation],M1/Stage IV: metastatic disease value [hospitalisation],M1/Stage IV: metastatic disease 95% confidence interval [hospitalisation],M1/Stage IV: metastatic disease p value [hospitalisation],M1/Stage IV: metastatic disease Cancer: Event/Total [hospitalisation],M1/Stage IV: metastatic disease Non-cancer: Event/Total [hospitalisation],M1/Stage IV: metastatic disease Comment,Unknown Total number of Patients,Unknown Measure of Association (OR/RR etc.) [mortality],Unknown value [mortality],Unknown 95% CI [mortality],Unknown p value [mortality],Unknown cancer: Event/Total [mortality],Unknown Non-cancer: Event/Total [mortality],Unknown Measure of Association (OR/RR etc.) [ICU],Unknown value [ICU],Unknown 95% CI [ICU],Unknown p value [ICU],Unknown cancer: Event/Total [ICU],Unknown Non-cancer: Event/Total [ICU],Unknown Measure of Association (OR/RR etc.) [severe],Unknown value [severe],Unknown 95% CI [severe],Unknown p value [severe],Unknown cancer: Event/Total [severe],Unknown Non-cancer: Event/Total [severe],Unknown Comment,Unknown Measure of Association (OR/RR etc.) [hospitalisation],Unknown value [hospitalisation],Unknown 95% confidence interval [hospitalisation],Unknown p value [hospitalisation],Unknown Cancer: Event/Total [hospitalisation],Unknown Non-cancer: Event/Total [hospitalisation],Unknown Comment,Treatment type:,Chemotherapy Total number of patients,Chemotherapy percentage,Chemotherapy measurement of association (OR/RR) [mortality],Chemotherapy value [mortality],Chemotherapy 95% CI [mortality],Chemotherapy p value [mortality],Chemotherapy cancer: Event/Total [mortality],Chemotherapy Non-cancer: Event/Total [mortality],Chemotherapy measurement of association (OR/RR) [ICU],Chemotherapy value [ICU],Chemotherapy 95% CI [ICU],Chemotherapy p value [ICU],Chemotherapy cancer: Event/Total [ICU],Chemotherapy Non-cancer: Event/Total [ICU],Chemotherapy measurement of association (OR/RR) [severe],Chemotherapy value [severe],Chemotherapy 95% CI [severe],Chemotherapy p value [severe],Chemotherapy cancer: Event/Total [severe],Chemotherapy Non-cancer: Event/Total [severe],Chemotherapy Comment [incl. name of targeted/immunotherapy],Chemotherapy Measure of Association (OR/RR etc.) [hospitalisation],Chemotherapy value [hospitalisation],Chemotherapy 95% confidence interval [hospitalisation],Chemotherapy p value [hospitalisation],Chemotherapy Cancer: Event/Total [hospitalisation],Chemotherapy Non-cancer: Event/Total [hospitalisation],Chemotherapy Comment,Hormonal therapy Total number of patients,Hormonal therapy percentage,Hormonal therapy measurement of association (OR/RR) [mortality],Hormonal therapy value [mortality],Hormonal therapy 95% CI [mortality],Hormonal therapy p value [mortality],Hormonal therapy cancer: Event/Total [mortality],Hormonal therapy Non-cancer: Event/Total [mortality],Hormonal therapy measurement of association (OR/RR) [ICU],Hormonal therapy value [ICU],Hormonal therapy 95% CI [ICU],Hormonal therapy p value [ICU],Hormonal therapy cancer: Event/Total [ICU],Hormonal therapy Non-cancer: Event/Total [ICU],Hormonal therapy measurement of association (OR/RR) [severe],Hormonal therapy value [severe],Hormonal therapy 95% CI [severe],Hormonal therapy p value [severe],Hormonal therapy cancer: Event/Total [severe],Hormonal therapy Non-cancer: Event/Total [severe],Hormonal therapy Comment [incl. name of targeted/immunotherapy],Hormonal therapy Measure of Association (OR/RR etc.) [hospitalisation],Hormonal therapy value [hospitalisation],Hormonal therapy 95% confidence interval [hospitalisation],Hormonal therapy p value [hospitalisation],Hormonal therapy Cancer: Event/Total [hospitalisation],Hormonal therapy Non-cancer: Event/Total [hospitalisation],Hormonal therapy Comment,Targeted therapy (RTK inhibitor/mAb against receptors) Total number of patients,Targeted therapy (RTK inhibitor/mAb against receptors) percentage,Targeted therapy (RTK inhibitor/mAb against receptors) measurement of association (OR/RR) [mortality],Targeted therapy (RTK inhibitor/mAb against receptors) value [mortality],Targeted therapy (RTK inhibitor/mAb against receptors) 95% CI [mortality],Targeted therapy (RTK inhibitor/mAb against receptors) p value [mortality],Targeted therapy (RTK inhibitor/mAb against receptors) cancer: Event/Total [mortality],Targeted therapy (RTK inhibitor/mAb against receptors) Non-cancer: Event/Total [mortality],Targeted therapy (RTK inhibitor/mAb against receptors) measurement of association (OR/RR) [ICU],Targeted therapy (RTK inhibitor/mAb against receptors) value [ICU],Targeted therapy (RTK inhibitor/mAb against receptors) 95% CI [ICU],Targeted therapy (RTK inhibitor/mAb against receptors) p value [ICU],Targeted therapy (RTK inhibitor/mAb against receptors) cancer: Event/Total [ICU],Targeted therapy (RTK inhibitor/mAb against receptors) Non-cancer: Event/Total [ICU],Targeted therapy (RTK inhibitor/mAb against receptors) measurement of association (OR/RR) [severe],Targeted therapy (RTK inhibitor/mAb against receptors) value [severe],Targeted therapy (RTK inhibitor/mAb against receptors) 95% CI [severe],Targeted therapy (RTK inhibitor/mAb against receptors) p value [severe],Targeted therapy (RTK inhibitor/mAb against receptors) cancer: Event/Total [severe],Targeted therapy (RTK inhibitor/mAb against receptors) Non-cancer: Event/Total [severe],Targeted therapy (RTK inhibitor/mAb against receptors) Comment [incl. name of targeted/immunotherapy],Targeted therapy (RTK inhibitor/mAb against receptors) Measure of Association (OR/RR etc.) [hospitalisation],Targeted therapy (RTK inhibitor/mAb against receptors) value [hospitalisation],Targeted therapy (RTK inhibitor/mAb against receptors) 95% confidence interval [hospitalisation],Targeted therapy (RTK inhibitor/mAb against receptors) p value [hospitalisation],Targeted therapy (RTK inhibitor/mAb against receptors) Cancer: Event/Total [hospitalisation],Targeted therapy (RTK inhibitor/mAb against receptors) Non-cancer: Event/Total [hospitalisation],Targeted therapy (RTK inhibitor/mAb against receptors) Comment,radiotherapy Total number of patients,radiotherapy percentage,radiotherapy measurement of association (OR/RR) [mortality],radiotherapy value [mortality],radiotherapy 95% CI [mortality],radiotherapy p value [mortality],radiotherapy cancer: Event/Total [mortality],radiotherapy Non-cancer: Event/Total [mortality],radiotherapy measurement of association (OR/RR) [ICU],radiotherapy value [ICU],radiotherapy 95% CI [ICU],radiotherapy p value [ICU],radiotherapy cancer: Event/Total [ICU],radiotherapy Non-cancer: Event/Total [ICU],radiotherapy measurement of association (OR/RR) [severe],radiotherapy value [severe],radiotherapy 95% CI [severe],radiotherapy p value [severe],radiotherapy cancer: Event/Total [severe],radiotherapy Non-cancer: Event/Total [severe],radiotherapy Comment [incl. name of targeted/immunotherapy],radiotherapy Measure of Association (OR/RR etc.) [hospitalisation],radiotherapy value [hospitalisation],radiotherapy 95% confidence interval [hospitalisation],radiotherapy p value [hospitalisation],radiotherapy Cancer: Event/Total [hospitalisation],radiotherapy Non-cancer: Event/Total [hospitalisation],radiotherapy Comment,immunotherapy (immune checkpoint inhibitors/CAR-T) Total number of patients,immunotherapy (immune checkpoint inhibitors/CAR-T) percentage,immunotherapy (immune checkpoint inhibitors/CAR-T) measurement of association (OR/RR) [mortality],immunotherapy (immune checkpoint inhibitors/CAR-T) value [mortality],immunotherapy (immune checkpoint inhibitors/CAR-T) 95% CI [mortality],immunotherapy (immune checkpoint inhibitors/CAR-T) p value [mortality],immunotherapy (immune checkpoint inhibitors/CAR-T) cancer: Event/Total [mortality],immunotherapy (immune checkpoint inhibitors/CAR-T) Non-cancer: Event/Total [mortality],immunotherapy (immune checkpoint inhibitors/CAR-T) measurement of association (OR/RR) [ICU],immunotherapy (immune checkpoint inhibitors/CAR-T) value [ICU],immunotherapy (immune checkpoint inhibitors/CAR-T) 95% CI [ICU],immunotherapy (immune checkpoint inhibitors/CAR-T) p value [ICU],immunotherapy (immune checkpoint inhibitors/CAR-T) cancer: Event/Total [ICU],immunotherapy (immune checkpoint inhibitors/CAR-T) Non-cancer: Event/Total [ICU],immunotherapy (immune checkpoint inhibitors/CAR-T) measurement of association (OR/RR) [severe],immunotherapy (immune checkpoint inhibitors/CAR-T) value [severe],immunotherapy (immune checkpoint inhibitors/CAR-T) 95% CI [severe],immunotherapy (immune checkpoint inhibitors/CAR-T) p value [severe],immunotherapy (immune checkpoint inhibitors/CAR-T) cancer: Event/Total [severe],immunotherapy (immune checkpoint inhibitors/CAR-T) Non-cancer: Event/Total [severe],immunotherapy (immune checkpoint inhibitors/CAR-T) Comment [incl. name of targeted/immunotherapy],immunotherapy (immune checkpoint inhibitors/CAR-T) Measure of Association (OR/RR etc.) [hospitalisation],immunotherapy (immune checkpoint inhibitors/CAR-T) value [hospitalisation],immunotherapy (immune checkpoint inhibitors/CAR-T) 95% confidence interval [hospitalisation],immunotherapy (immune checkpoint inhibitors/CAR-T) p value [hospitalisation],immunotherapy (immune checkpoint inhibitors/CAR-T) Cancer: Event/Total [hospitalisation],immunotherapy (immune checkpoint inhibitors/CAR-T) Non-cancer: Event/Total [hospitalisation],immunotherapy (immune checkpoint inhibitors/CAR-T) Comment,surgery Total number of patients,surgery percentage,surgery measurement of association (OR/RR) [mortality],surgery value [mortality],surgery 95% CI [mortality],surgery p value [mortality],surgery cancer: Event/Total [mortality],surgery Non-cancer: Event/Total [mortality],surgery measurement of association (OR/RR) [ICU],surgery value [ICU],surgery 95% CI [ICU],surgery p value [ICU],surgery cancer: Event/Total [ICU],surgery Non-cancer: Event/Total [ICU],surgery measurement of association (OR/RR) [severe],surgery value [severe],surgery 95% CI [severe],surgery p value [severe],surgery cancer: Event/Total [severe],surgery Non-cancer: Event/Total [severe],surgery Comment [incl. name of targeted/immunotherapy],surgery Measure of Association (OR/RR etc.) [hospitalisation],surgery value [hospitalisation],surgery 95% confidence interval [hospitalisation],surgery p value [hospitalisation],surgery Cancer: Event/Total [hospitalisation],surgery Non-cancer: Event/Total [hospitalisation],surgery Comment,COVID variants:,WT/Wu-1 Total Number of patients,WT/Wu-1 Percentage,WT/Wu-1 Measure of Association (OR/RR etc.) [mortality],WT/Wu-1 value [mortality],WT/Wu-1 95% CI [mortality],WT/Wu-1 p-value [mortality],WT/Wu-1 cancer: Event/Total [mortality],WT/Wu-1 Non-cancer: Event/Total [mortality],WT/Wu-1 Measure of Association (OR/RR etc.) [ICU],WT/Wu-1 value [ICU],WT/Wu-1 95% CI [ICU],WT/Wu-1 p-value [ICU],WT/Wu-1 cancer: Event/Total [ICU],WT/Wu-1 Non-cancer: Event/Total [ICU],WT/Wu-1 Measure of Association (OR/RR etc.) {severe],WT/Wu-1 value [severe],WT/Wu-1 95% CI [severe],WT/Wu-1 p-value [severe],WT/Wu-1 cancer: Event/Total [severe],WT/Wu-1 Non-cancer: Event/Total [severe],WT/Wu-1 Comment,WT/Wu-1 Measure of Association (OR/RR etc.) [hospitalisation],WT/Wu-1 value [hospitalisation],WT/Wu-1 95% confidence interval [hospitalisation],WT/Wu-1 p value [hospitalisation],WT/Wu-1 Cancer: Event/Total [hospitalisation],WT/Wu-1 Non-cancer: Event/Total [hospitalisation],WT/Wu-1 Comment,Beta Total Number of patients,Beta Percentage,Beta Measure of Association (OR/RR etc.) [mortality],Beta value [mortality],Beta 95% CI [mortality],Beta p-value [mortality],Beta cancer: Event/Total [mortality],Beta Non-cancer: Event/Total [mortality],Beta Measure of Association (OR/RR etc.) [ICU],Beta value [ICU],Beta 95% CI [ICU],Beta p-value [ICU],Beta cancer: Event/Total [ICU],Beta Non-cancer: Event/Total [ICU],Beta Measure of Association (OR/RR etc.) {severe],Beta value [severe],Beta 95% CI [severe],Beta p-value [severe],Beta cancer: Event/Total [severe],Beta Non-cancer: Event/Total [severe],Beta Comment,Beta Measure of Association (OR/RR etc.) [hospitalisation],Beta value [hospitalisation],Beta 95% confidence interval [hospitalisation],Beta p value [hospitalisation],Beta Cancer: Event/Total [hospitalisation],Beta Non-cancer: Event/Total [hospitalisation],Beta Comment,Gamma Total Number of patients,Gamma Percentage,Gamma Measure of Association (OR/RR etc.) [mortality],Gamma value [mortality],Gamma 95% CI [mortality],Gamma p-value [mortality],Gamma cancer: Event/Total [mortality],Gamma Non-cancer: Event/Total [mortality],Gamma Measure of Association (OR/RR etc.) [ICU],Gamma value [ICU],Gamma 95% CI [ICU],Gamma p-value [ICU],Gamma cancer: Event/Total [ICU],Gamma Non-cancer: Event/Total [ICU],Gamma Measure of Association (OR/RR etc.) {severe],Gamma value [severe],Gamma 95% CI [severe],Gamma p-value [severe],Gamma cancer: Event/Total [severe],Gamma Non-cancer: Event/Total [severe],Gamma Comment,Gamma Measure of Association (OR/RR etc.) [hospitalisation],Gamma value [hospitalisation],Gamma 95% confidence interval [hospitalisation],Gamma p value [hospitalisation],Gamma Cancer: Event/Total [hospitalisation],Gamma Non-cancer: Event/Total [hospitalisation],Gamma Comment,Delta Total Number of patients,Delta Percentage,Delta Measure of Association (OR/RR etc.) [mortality],Delta value [mortality],Delta 95% CI [mortality],Delta p-value [mortality],Delta cancer: Event/Total [mortality],Delta Non-cancer: Event/Total [mortality],Delta Measure of Association (OR/RR etc.) [ICU],Delta value [ICU],Delta 95% CI [ICU],Delta p-value [ICU],Delta cancer: Event/Total [ICU],Delta Non-cancer: Event/Total [ICU],Delta Measure of Association (OR/RR etc.) {severe],Delta value [severe],Delta 95% CI [severe],Delta p-value [severe],Delta cancer: Event/Total [severe],Delta Non-cancer: Event/Total [severe],Delta Comment,Delta Measure of Association (OR/RR etc.) [hospitalisation],Delta value [hospitalisation],Delta 95% confidence interval [hospitalisation],Delta p value [hospitalisation],Delta Cancer: Event/Total [hospitalisation],Delta Non-cancer: Event/Total [hospitalisation],Delta Comment,Omicron Total Number of patients,Omicron Percentage,Omicron Measure of Association (OR/RR etc.) [mortality],Omicron value [mortality],Omicron 95% CI [mortality],Omicron p-value [mortality],Omicron cancer: Event/Total [mortality],Omicron Non-cancer: Event/Total [mortality],Omicron Measure of Association (OR/RR etc.) [ICU],Omicron value [ICU],Omicron 95% CI [ICU],Omicron p-value [ICU],Omicron cancer: Event/Total [ICU],Omicron Non-cancer: Event/Total [ICU],Omicron Measure of Association (OR/RR etc.) {severe],Omicron value [severe],Omicron 95% CI [severe],Omicron p-value [severe],Omicron cancer: Event/Total [severe],Omicron Non-cancer: Event/Total [severe],Omicron Comment,Omicron Measure of Association (OR/RR etc.) [hospitalisation],Omicron value [hospitalisation],Omicron 95% confidence interval [hospitalisation],Omicron p value [hospitalisation],Omicron Cancer: Event/Total [hospitalisation],Omicron Non-cancer: Event/Total [hospitalisation],Omicron Comment,Unspecified/Total Total Number of patients,Unspecified/Total Percentage,Unspecified/Total Measure of Association (OR/RR etc.) [mortality],Unspecified/Total value [mortality],Unspecified/Total 95% CI [mortality],Unspecified/Total p-value [mortality],Unspecified/Total cancer: Event/Total [mortality],Unspecified/Total Non-cancer: Event/Total [mortality],Unspecified/Total Measure of Association (OR/RR etc.) [ICU],Unspecified/Total value [ICU],Unspecified/Total 95% CI [ICU],Unspecified/Total p-value [ICU],Unspecified/Total cancer: Event/Total [ICU],Unspecified/Total Non-cancer: Event/Total [ICU],Unspecified/Total Measure of Association (OR/RR etc.) {severe],Unspecified/Total value [severe],Unspecified/Total 95% CI [severe],Unspecified/Total p-value [severe],Unspecified/Total cancer: Event/Total [severe],Unspecified/Total Non-cancer: Event/Total [severe],Unspecified/Total Comment,Unspecified/Total Measure of Association (OR/RR etc.) [hospitalisation],Unspecified/Total value [hospitalisation],Unspecified/Total 95% confidence interval [hospitalisation],Unspecified/Total p value [hospitalisation],Unspecified/Total Cancer: Event/Total [hospitalisation],Unspecified/Total Non-cancer: Event/Total [hospitalisation],Unspecified/Total Comment,Other Total Number of patients,Other Percentage,Other Measure of Association (OR/RR etc.) [mortality],Other value [mortality],Other 95% CI [mortality],Other p-value [mortality],Other cancer: Event/Total [mortality],Other Non-cancer: Event/Total [mortality],Other Measure of Association (OR/RR etc.) [ICU],Other value [ICU],Other 95% CI [ICU],Other p-value [ICU],Other cancer: Event/Total [ICU],Other Non-cancer: Event/Total [ICU],Other Measure of Association (OR/RR etc.) {severe],Other value [severe],Other 95% CI [severe],Other p-value [severe],Other cancer: Event/Total [severe],Other Non-cancer: Event/Total [severe],Other Comment,Other Measure of Association (OR/RR etc.) [hospitalisation],Other value [hospitalisation],Other 95% confidence interval [hospitalisation],Other p value [hospitalisation],Other Cancer: Event/Total [hospitalisation],Other Non-cancer: Event/Total [hospitalisation],Other Comment,COVID vaccination status:,vaccinated Total number of patients,vaccinated Percentage,vaccinated Measure of Association (OR/RR etc) [mortality],vaccinated Value [mortality],vaccinated 95% CI [mortality],vaccinated p value [mortality],vaccinated cancer: Event/Total [mortality],vaccinated Non-cancer: Event/Total [mortality],vaccinated Measure of Association (OR/RR etc) [ICU],vaccinated Value [ICU],vaccinated 95% CI [ICU],vaccinated p value [ICU],vaccinated cancer: Event/Total [ICU],vaccinated Non-cancer: Event/Total [ICU],vaccinated Measure of Association (OR/RR etc) [severe],vaccinated Value [severe],vaccinated 95% CI [severe],vaccinated p value [severe],vaccinated cancer: Event/Total [severe],vaccinated Non-cancer: Event/Total [severe],vaccinated Measure of Association (OR/RR etc.) [hospitalisation],vaccinated value [hospitalisation],vaccinated 95% confidence interval [hospitalisation],vaccinated p value [hospitalisation],vaccinated Cancer: Event/Total [hospitalisation],vaccinated Non-cancer: Event/Total [hospitalisation],vaccinated Comment,unvaccinated Total number of patients,unvaccinated Percentage,unvaccinated Measure of Association (OR/RR etc) [mortality],unvaccinated Value [mortality],unvaccinated 95% CI [mortality],unvaccinated p value [mortality],unvaccinated cancer: Event/Total [mortality],unvaccinated Non-cancer: Event/Total [mortality],unvaccinated Measure of Association (OR/RR etc) [ICU],unvaccinated Value [ICU],unvaccinated 95% CI [ICU],unvaccinated p value [ICU],unvaccinated cancer: Event/Total [ICU],unvaccinated Non-cancer: Event/Total [ICU],unvaccinated Measure of Association (OR/RR etc) [severe],unvaccinated Value [severe],unvaccinated 95% CI [severe],unvaccinated p value [severe],unvaccinated cancer: Event/Total [severe],unvaccinated Non-cancer: Event/Total [severe],unvaccinated Measure of Association (OR/RR etc.) [hospitalisation],unvaccinated value [hospitalisation],unvaccinated 95% confidence interval [hospitalisation],unvaccinated p value [hospitalisation],unvaccinated Cancer: Event/Total [hospitalisation],unvaccinated Non-cancer: Event/Total [hospitalisation],unvaccinated Comment,Is individual patient data available?
141173,Alsakarneh 2024,Increased Risk of Breakthrough SARS-CoV-2 Infections in Patients with Colorectal Cancer: A Population-Based Propensity-Matched Analysis.,Consensus,Peer-reviewed,J. Clin. Med,TriNetX research network,2024-04,Increased Risk of Breakthrough SARS-CoV-2 Infections in Patients with Colorectal Cancer: A Population-Based Propensity-Matched Analysis,Alsakarneh S,Retrospective,Cohort,Yes,Other: non-specific,United States,N/A,Not specified,Not mentioned,2024-02-01,30832,SARS-CoV-2 infection,"emergency room (ER) visits, hospitalization, or death, all-cause critical care admission, and all-cause intubation.",Severity; Hospitalisation; ICU admission; Mortality,yes,"Aged 18 years and older; (b) had an  International Classification of Disease, Ninth Revision and Tenth Revision, Clinical  Modification (ICD-10-CM) code in their EHR for CRC; (c) had documented evidence of vaccination in their EHRs.",Same source/cohort,"Propensity score matching 1:1 for the following variables: (a) demographic informa-
tion (age, sex, race, and ethnicity) [22–24]; (b) social determinants of adverse health outcomes (SDHOs); (c) behavioral factors (tobacco smoking, alcohol abuse); (d) vaccine types; (e) cancer treatment types; and (f) comorbidities that are related to SARS-CoV-2 morbidity and mortality ","",Mean,69.6,SD,12.5,51.4%,15416,Mean,70.2,SD,12.2,50.1%,15416,Not mentioned,"",737,4.8%,736,4.8%,"","","","",9961,64.6%,10563,68.5%,"","","","",4261,27.6%,4577,29.7%,"","","","","1959 (Heart failure),
4137 (IHD)","12.7% (HF), 26.8% (IHD)","2012 (FH), 4147 (IHD)","13.1% (HF), 26.9% (IHD)","","","","",1880,12.2%,2009,13.0%,"","","","",3446,22.4%,3348,21.7%,"","","","",2888,18.7%,2982,19.3%,"","","","",3839,24.9%,3969,25.7%,"","","","",189 (HIV),1.2% (HIV),180 (HIV),1.2% (HIV),"","","","","","","","","","","","","4300 (Obesity),
7355 (Hyperlipidemia),
388 (Dementia),
2982 (Depression),
4037 (Anxiety),
2633 (substance use),
465 (Alcohol abuse)","27.9% (Obesity),
47.7% (Hyperlipidemia),
2.5% (Dementia),
19.3% (Depression),
26.2% (Anxiety),
17.1% (Substance use),
3.0% (Alcohol abuse)","4469 (Obesity),
7815 (Hyperlipidemia),
381 (Dementia),
3155 (Depression),
4294 (Anxiety),
2769 (Substance use),
463 (Alcohol abuse)","29.0% (Obesity),
50.7% (Hyperlipidemia),
2.5% (Dementia),
20.5% (Depression),
27.9% (Anxiety),
18.0% (Substance use),
3.0% (Alcohol abuse)","","","","","","","","","","","","","","","","",multivariate,Age; Sex,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",15416,aOR,1.00,0.411-2.435,1,"","",aOR,1.00,0.411-2.435,1.00,"","",aOR,1.00,0.411-2.435,1.00,"","",Intubation,aOR,3.01,2.101-2.435,<0.0001,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",4958,32.2%,"","","","","","","","","","","","","","","","","","","","","","","","","","",1011,6.6%,"","","","","","","","","","","","","","","","","","","","","","","","","","",1837,11.9%,"","","","","","","","","","","","","","","","","","","","","","","","","","",1418,9.2%,"","","","","","","","","","","","","","","","","","","","","","","","","","",10,0.1%,"","","","","","","","","","","","","","","","","","","","","","","","","","",N/A,N/A,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",aOR,1.477,0.675-3.232,0.3261,"","",aOR,0.77,0.408-1.455,0.4204,"","",aOR,1.15,0.552-2.395,0.7088,"","",aOR,0.884,0.64-1.223,0.4573,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",no
141132,Sullivan 2023,Breast Cancer (BC) and Severe COVID-19 (C-19) Outcomes: A Matched Analysis.,Consensus,Peer-reviewed,Breast Cancer Research and Treatment,Optum de-identified C-19 Electronic Health Record dataset (2007-2022),2024-04,Breast cancer (BC) and severe COVID‑19 (C‑19) outcomes: a matched analysis,Sullivan M,Retrospective,Cohort,Yes,inpatient and outpatient (with breakdown),United States,N/A,"",2020-01-01,2021-12-20,26400,Mortality,"Mechanical ventilation, ICU stay, hospitalization within 30 days ",Severity; Hospitalisation; ICU admission; Mortality,yes,"For  patients with BC, we used the International Classification of  Diseases 9th and 10th Revision (ICD-9 and ICD-10) diagnosis codes to identify those who had 2 or more BC diagnosis codes that were at least 30 days apart within 1 year before C-19 diagnosis date (n=5571)",Same cohort,"We matched (1:1:10) patients with BC and controls with-
out cancer based on age, comorbidity score, and date of C-19 diagnosis: Group 1 included patients with BC and recent cancer treatment (referred to as BC recently treated); Group 2 included patients with BC and no recent treatment (BC not recently treated); Group 3 included patients without cancer (non-cancer controls)","",Median,65,IQR,55-74,0,2200,Median,65,IQR,55-74,0,22000,Not mentioned,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",ICU stay was defined as hospitalization in an ICU without mechanical ventilation,"30-day mortality. Death data were obtained from the Social Security Administration Death Master File, including month and year of death; therefore, date of death was set as the 15th of the month.",Mechanical ventilation using HCPCS codes or ICD-10 procedure codes,multivariate,"Age; Comorbidities; Other: race and ethnicity, Severe obesity, Charles-Deyo Comorbidity Index score, recent skilled scaled nursing facility stay, insurance type and region","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2200,mOR,0.8,0.57-1.13,0.21,"","",mOR,1.07,0.84-1.37,0.57,"","",mOR,0.88,0.63-1.22,0.43,"","",Severe disease: Mechanical ventilation,mOR,0.98,0.88-1.10,0.74,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2200,mOR,0.8,0.57-1.13,0.21,"","",mOR,1.07,0.84-1.37,0.57,"","",mOR,0.88,0.63-1.22,0.43,"","",Severe disease: Mechanical ventilation,mOR,0.98,0.88-1.10,0.74,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",no
140255,Park 2024,COVID-19 Mortality and Severity in Cancer Patients and Cancer Survivors.,Consensus,Peer-reviewed,J Korean Med Sci,"Korean Disease Control and Prevention Agency-COVID19-National 
Health Insurance Service (K-COV-N) cohort",2023-11,COVID-19 Mortality and Severity in Cancer Patients and Cancer Survivors,Park JM,Retrospective,Cohort,Yes,inpatient and outpatient (with breakdown),South Korea,N/A,NA,2020-01-01,2022-03-31,3858035,Mortality,Severity,Severity; Hospitalisation; Mortality,yes,Time since cancer diagnosis was defined as the period from the date of cancer diagnosis to the date of COVID-19 diagnosis. *active cancer* up to 1 year. Cancer survivor was defined as a patient who had survived ≥ 5 years since the diagnosis of cancer,Same cohort,"After 1:1 propensity score matching, 397,050 patients with cancer and 397,050 patients without cancer were enrolled in the main analysis. We used the nearest available matching (1:1) method to estimate the propensity score using a caliper of 0.25. Balance was assessed by a standardized mean difference of < 0.1  after matching.","","","","","",42.2,"397,050","","","","",44.6,"397,050",Not mentioned,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","Severity as ambulatory state, hospitalization with mild state, or hospitalization with severe state using the COVID-19 severity scale by the World Health Organization. Hospitalization with mild state included no oxygen therapy or oxygen delivered using mask or nasal prongs. ",N/A,Not stated.,"Hospitalization with severe state included noninvasive ventilation, high-flow oxygen, intubation and mechanical ventilation, as well as ventilation combined with additional organ support such as dialysis and extracorporeal membrane oxygenation.",multivariate,"Age; Sex; Comorbidities; Other: vaccination against COVID-19, household income, and Charlson Comorbidity Index","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",mOR,1.85,1.76-1.95,"",? [Not stated]/385680,"","","","","","","",mOR,1.11,1.06-1.18,"",? [Not stated]/385680,"","",mOR,1.08,1.07-1.10,"",? [Not stated]/385680,"","","",mOR,3.85,3.35-4.42,"",? [Not stated]/11723,"","","","","","","",mOR,3.18,2.78-3.64,"",? [Not stated]/11723,"","",mOR,1.72,1.36-1.81,"",? [Not stated]/11723,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",mOR,4.95,4.60-5.34,"",4015/397050,2110/397050,"","","","","","",mOR,2.29,2.09-2.50,"",1543/397050,1562/397050,OR for cancer diagnosis < 1 year,mOR,1.82,1.77-1.87,"",44074/397050,40428/397050,OR for cancer diagnosis < 1 year,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",yes
138896,Li 2024,Outcomes and inflammation changes in different types of immunocompromised patients with critically ill COVID-19 admitted to ICU: a national multicenter study.,Consensus,Peer-reviewed,BMC Pulmonary Medicine,"multicenter retrospective observational cohort across 28 provinces in Chinese 
mainland, involving 59 ICU",2024-10,Outcomes and inflammation changes in different types of immunocompromised patients with critically ill COVID-19 admitted to ICU: a national multicenter study,Li C,Retrospective,Cohort,Yes,inpatient,China,N/A,"",2022-11-01,2023-02-11,2030,ICU mortality,Secondary infection,Mortality,no,"Cancer patients were defined as individuals with active  malignancy or those diagnosed with malignancy within  one year of developing community-acquired pneumonia  (CAP), excluding localized skin cancers and early-stage cancer.",Same multicenter cohort,"To compare outcomes, we performed a three-to-one pro pensity score (PS) matching analysis estimated by logistic regression to account for potential confounding factors.  Variables involved in the PS estimation included age and APACHE II score. Matching was based on the logit of the PS using nearest-neighbor matching (greedy-type matching) with a caliper width of 0.25. ","",Median,69,IQR,59-77,74.0%,77,Median,76,IQR,68-84,72.5%,1788,Omicron (B.1.1.529/BA.1),"",19,24.7%,473,26.5%,"","","",0.793,31,40.3%,1000,55.9%,"","","",0.010,17,22.1%,535,29.9%,"","","",0.161,"","","","","","","","","","","","","","","","",2,2.6%,17,1.0%,"","","",0.183,5,6.5%,113,6.3%,"","","",0.814,10,13.0%,221,12.4%,"","","",0.860,"","","","","","","","","","","","","","","","",17,22.1%,501,28.0%,"","","",0.299,Chronic heart disease,"",Chronic heart disease,"","","","","",Severe COVID-19 was defined by any of the following criteria: (1) shortness of breath with a respiratory rate exceeding 30 breaths per minute; (2) pulse oxygen saturation of 93% or lower at rest; or (3) a partial pressure of oxygen to fraction of inspired oxygen ratio (PaO/FiO) of 300 mmHg or lower. ,"Critical COVID-19 was characterized by any of the following: (1) respiratory failure requiring invasive ventilation; (2) shock; or (3) organ failure that necessitated ICU 
care ","ICU mortality was defined as the death of patients within the ICU, including those expected to die following the discontinuation of treatment. ",Severe COVID-19 was defined by any of the following criteria: (1) shortness of breath with a respiratory rate exceeding 30 breaths per minute; (2) pulse oxygen saturation of 93% or lower at rest; or (3) a partial pressure of oxygen to fraction of inspired oxygen ratio (PaO/FiO) of 300 mmHg or lower. ,multivariate,Age; Other: APACHE II score,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",77,mOR,2.02,1.18-3.46,0.010,59/77,1106/1788,mOR,1.43,0.90-2.30,0.133,31/77,630/1788,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",no
138865,Evans 2023,Impact of COVID-19 on immunocompromised populations during the Omicron era: insights from the observational population-based INFORM study.,Consensus,Peer-reviewed,The Lancet Regional Health - Europe,INFORM study,2023-10,Impact of COVID-19 on immunocompromised populations during the Omicron era: insights from the observational population-based INFORM study,Evans RA,Retrospective,Cohort,Yes,inpatient and outpatient (with breakdown),United Kingdom,England,N/A,2022-01-01,2022-12-31,11990730,COVID-19-related hospitalisation,"COVID-19-related ICU admission, COVID-19-related mortality",Hospitalisation; ICU admission; Mortality,yes,Solid or haematologic malignancy on active treatment: solid tumour [s] or haematologic malignancies on treatment ≤6 months prior to 1 January 2022.,General Population - same cohort.,"Comparator group: random sample of 25% of all individuals aged ≥12 years, registered and active (i.e., legal residents) in the NHS-linked national datasets on 1 January 2022.","","","","","","",36120,mean,45.2,SD,20.7,49.7%,11990730,Omicron (B.1.1.529/BA.1),"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","ICU admission within a hospitalisation episode with COVID-19 as the primary
diagnosis","COVID-19-related mortality, defined as a death in ONS mortality data with COVID-19 recorded as a cause of death, or an in-hospital death during a COVID-19 hospitalisation","",multivariate,Age; Sex; Comorbidities,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",27700,mIRR,2.58,2.00-3.33,"",0.002 (60/27700),4810/11990730 (0.0004),mIRR,2.42,1.06-5.52,"","",0.00004 (440/11990730),"","","","","","","",mIRR,3.66,3.31-4.03,"",0.016 (430/27700),0.002 (20910/11990730),"",8420,mIRR,10.12,8.20-12.50,"",0.011 (90/8420),4810/11990730 (0.0004),mIRR,37.94,25.39-56.69,"",0.003 (25/8420),0.00004 (440/11990730),"","","","","","","",mIRR,10.69,9.68-11.80,"",0.050 (420/8420),0.002 (20910/11990730),"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",no
137597,Yiğenoğlu 2020,The outcome of COVID-19 in patients with hematological malignancy.,Consensus,Peer-reviewed,Journal of Medical Virology,"Republic of Turkey, Ministry of Health Database",2020-08,"The outcome of COVID‐19 in patients with hematological
malignancy",Tugce N,Retrospective,Cohort,Yes,inpatient and outpatient (with breakdown),Turkey,N/A,"",2020-03-11,2020-06-22,1480,Comparison of COVID-19 severity and mortality between cancer patient and control ,"",Severity; Hospitalisation; ICU admission; Mortality,no,Haematological malignancy; No definition of active cancer; Active treatment not stated,"All COVID‐19 patients with hematological malignancy (n = 740) were included in the study and age, sex, and comorbidity-matched COVID‐19 patients without cancer (n = 740) at 1:1 ratio was used for comparison","Matched; 1:1; age, comorbidity, sex","",median,56,range,18-94,53.6,740,median,56,range,18-87,54.1,740,Not mentioned,"","","","","","","","","",379,51.2,378,51.1,"","","",1,198,26.8,198,26.8,"","","",1,156,21.1,135,18.2,"","","",0.2,"","","","","","","","","","","","","","","","","","","","","","","","",175,23.6,164,22.2,"","","",0.5,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","Severity assessed based on clinical symptoms (dyspnoea, respiratory failure), blood oxygen saturation, PaO2/FiO2, progression in lung infiltrates, septic shock, and organ dysfunction.",physical admission to ICU,case-fatality rate: follow up not specified,"Combined Severe and Critical groups: Severe COVID‐19 was defined as the existence of dyspnea, blood oxygen saturation less than or equal to 93%, PaO2/FiO2 < 300 and greater than 50% progression in lung infiltrates within 24 to
48 hours. Critical COVID‐19 was defined as the existence of respiratory failure, septic shock, and/or multiple organ dysfunctions.",Other: Crude,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",740,cOR,0.45,0.32-0.65,8.48e-6,0.138 (102/740),0.0676 (50/740),cOR,1.80,1.34-2.41,6.84E-05,0.189 (140/740),0.115 (85/740),cOR,1.66,1.30-2.11,3.67E-05,0.288 (213/740),0.196 (145/740),cOR,"","","","",0.611 (452/740),0.553 (409/740),"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",740,cOR,0.45,0.32-0.65,8.48e-6,0.138 (102/740),0.0676 (50/740),cOR,1.80,1.34-2.41,6.84E-05,0.189 (140/740),0.115 (85/740),cOR,1.66,1.30-2.11,3.67E-05,0.288 (213/740),0.196 (145/740),cOR,"","","","",0.611 (452/740),0.553 (409/740),"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",1480,100,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",no
137477,Zhuqing 2020,Association of Cancer with Risk and Mortality of COVID-19: Results from the UK Biobank (preprint),Consensus,Preprint,MedRxiv: Preprint Server for Health Sciences,UK Biobank.,2020-07,Association of Cancer with Risk and Mortality of COVID-19: Results from the UK Biobank ,Zhuqing S,Retrospective,Cohort,Yes,outpatient,UK,England,Nationwide,None (Included all patients from database with covid dx before end date),17-06-2020,1562,COVID-19 infection positivity and mortality.,Impact of candidate risk factors and co-morbidities on COVID-19 positivity and mortality in cancer and non-cancer subjects.,Mortality,no,Not specified.,Drawn from same national cohort.,"Data taken from a UK-wide repository - therefore the comparator group was not age, gender or comorbidity-matched (and these values do not appear similar). 

cancer : non-cancer = 256 : 1306","",Mean,"61.36
",IQR,56.5-67.5,"
58.59",256,Mean,56.11,IQR,47.5-64.5,51,1306,Not mentioned,"",154,60.16,635,48.62,uOR,1.65,1.22-2.22,"",137,53.52,552,42.27,uOR,2.69,1.978-3.65,"",44,17.19,188,14.40,uOR,2.28,1.606-3.23,"",140,54.69,532,40.734,uOR,2.90,2.13-3.94,"",11,4.30,53,4.06,uOR,1.39,0.712-2.70,"","","","","","","","","","","","","","","","","",87,34.0,392,30.0,uOR,1.16,0.851-1.59,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",Not specified.,"",multivariate,Age; Sex,"",14,mOR,1.02,0.15-4.07,0.98,0.143 (2/14),0.123 (160/1306),"","","","","","","","","","","","","","","","","","","","",47,mOR,0.3,0.05-1.03,0.11,0.043 (2/47),0.123 (160/1306),"","","","","","","","","","","","","","","","","","","","",6 ,mOR,5.45 ,0.64-46.26 ,0.09,0.333 (2/6),0.123 (160/1306),"","","","","","","","","","","","","","","","","","","","",20 ,mOR,1.84 ,0.63-4.86 ,0.23,0.300 (6/20),0.123 (160/1306),"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",20,mOR,0.45,0.07-1.62,0.29,0.100 (2/20),0.123 (160/1306),"","","","","","","","","","","","","","","","","","","","",8,mOR,4.85,0.91-22.24,0.04,0.375 (3/8),0.123 (160/1306),"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",93,mOR,1.26,0.72-2.14,0.4,0.215 (20/93),0.123 (160/1306),"","","","","","","","","","","","","","","","","","","","",2,mOR,9.21,0.31-269.78,0.15,0.500 (1/2),0.123 (160/1306),"","","","","","","","","","","","","","","","","","","","",224,"","","","",0.161 (36/224),"","","","","","","","","","","","","","","","","","","","","",32,mOR,2.12,0.92-4.61,0.06,0.313 (10/32),0.123 (160/1306),"","","","","","","","","","","","","","","","","","","","",41; 4,mOR,0.48; 2.06,0.16-1.15; 0.1-18.48,0.13; 0.55,0.122 (5/41); 0.250 (1/4),0.123 (160/1306); 0.123 (160/1306),"","","","","","","","","","","","","","","","","","","","",25,mOR,2.03,0.65-5.39,0.18,0.200 (5/25),0.123 (160/1306),"","","","","","","","","","","","","","","","","","","","","256
",mOR,1.04,0.71-1.51,0.83,0.180 (46/256),0.123 (160/1306),"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",1562,100,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",no
136941,Xiaowu 2020,Malignancy history had no marked effect on the prognosis of COVID-19: A cohort study (preprint),Consensus,Preprint,Research Square,EHRs of Central Hospital of Wuhan,2020-07,"Malignancy history had no marked effect on the
prognosis of COVID-19: A cohort study",Xiaowu Shi,Retrospective,cohort study ,Yes,inpatient,China ,Wuhan,Central Hospital of Wuhan (one of COVID-19 designated hospitals in Wuhan),2020-02-05,2020-04-10,528,"severity, progression and mortality","","Severity; Mortality; Other: progression among moderate patients 
laboratory findings (WBC, NEUT, LY, NLR, CRP, ALB)",no,diagnostic codes (ambiguous timecourse),"Controls from same hospital with no cancer diagnostic code on their EHR
","41 cancer: 487 control

cancer pts significantly older but comparable with regards to gender ","",median,66,IQR,56-73,48.78% ,41,median,58,IQR,39-68,45.79%,487,Wild Type (Ancestral/Wu-1),"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","
The disease severity of COVID-19 was defined according to the guideline of Chinese NHC. 

- moderate grade was defined as patients with fever, respiratory symptoms and lung CT changed, but
oxygen saturation exceeded 93% without oxygen

- severe grade signifies respiratory frequency ≥ 30
times/minute, blood oxygen saturation ≤ 93%, oxygenation index ≤ 300 mmHg, and/or lung infiltration progression > 50% within 24 to 48 hours

- critical grade was defined as appearance of respiratory failure, septic shock, and/or multiple organ dysfunction or failure","","","based on the guideline of Chinese NHC: 

- severe grade signifies respiratory frequency ≥ 30
times/minute, blood oxygen saturation ≤ 93%, oxygenation index ≤ 300 mmHg, and/or lung infiltration progression > 50% within 24 to 48 hours

-  critical grade was defined as appearance of respiratory failure, septic shock, and/or multiple organ dysfunction or failure

- poor progression included moderate grade progressed to severe or critical grades and even death","","","",5,"","","","","","","","","","","","","","","","","","","","","","","","","","",4,"","","","","","","","","","","","","","","","","","","","","","","","","","",2,"","","","","","","","","","","","","","","","","","","","","","","","","","",5,"","","","","","","","","","","","","","","","","","","","","","","","","","",4,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",4,"","","","","","","","","","","","","","","","","","","","","","","","","","",3,"","","","","","","","","","","","","","","","","","","","","","","","","","",2,"","","","","","","","","","","","","","","","","","","","","","","","","","",4,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",1,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",5,"","","","","","","","","","","","","","","","","","","","","","","","","","",thyroid: 2,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",41,1.79,"cancer grp: 8
non-cancer grp: 58",0.79 - 4.07,0.16,"8/41
=0.195
=19.5%","58/487
=0.119
=11.9%","","","","","","",uOR,1.64,0.6564 - 4.1147,6.51E-10,"6/41
(0.146)
","46/487
(0.09445)
","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",528,100,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",no
135365,SuryanarayanaReddy 2022,Predictors of Mortality in Hospitalized African American Covid-19 Cancer Patients (preprint),Consensus,Preprint,Research Square,Howard University Hospital,2022-03,Predictors of Mortality in Hospitalized African American Covid-19 Cancer Patients,Challa S.R.,Retrospective,Case-control.,Yes,inpatient,USA,Washington DC,Howard University Hospital,2019-12,2021-10,512,Mortality,"",ICU admission; Mortality,no,"""Patients with a prior history or current diagnosis of any cancer are considered as cases. All patients were screened for cancer-based on the presence of an International Classification of Diseases, Tenth Revision-ICD-10 diagnostic code in their medical records.""

Flowchart confirms ""Cancer (Active and or previous history)""",Same hospital.,"49 cancer vs 463 non-cancer.
No mentioning of matching.","",Mean,70.6,"","",47,49,Mean,56.3,"","",50.9,463,Not mentioned,"","","","","","","","","",39,79.5,240,51.8,"","","","",16,32.6,168,36.2,"","","","",8,16.3,87,18.7,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",All figures include active and previous history of cancer,All figures include active and previous history of cancer,All figures include active and previous history of cancer,All figures include active and previous history of cancer,"","","","","",Not described,Not described,"","","","",5,"","","","",0.2 (1/5),0.0886 (41/463),"","","","","","","","","","","","",Combined active and previous history of cancer,"","","","","","","",14,"","","","",0.143 (2/14),0.0886 (41/463),"","","","","","","","","","","","",Combined active and previous history of cancer,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",3,"","","","",0.333 (1/3),0.0886 (41/463),"","","","","","","","","","","","",Combined active and previous history of cancer,"","","","","","","",2,"","","","",0 (0/2),0.0886 (41/463),"","","","","","","","","","","","",Combined active and previous history of cancer,"","","","","","","",4,"","","","",0.25 (1/4),0.0886 (41/463),"","","","","","","","","","","","",Combined active and previous history of cancer,"","","","","","","",12,"","","","",0.0833 (1/12),0.0886 (41/463),"","","","","","","","","","","","",Combined active and previous history of cancer,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",1,"","","","",0 (0/1),0.0886 (41/463),"","","","","","","","","","","","",Combined active and previous history of cancer,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",44,"","","","",0.181 (8/44),0.0886 (41/463),"","","","","","","","","","","","",Combined active and previous history of cancer,"","","","","","","",3,"","","","",0.333 (1/3),0.0886 (41/463),"","","","","","","","","","","","",Combined active and previous history of cancer,"","","","","","","",5,"","","","",0.6 (3/5),0.0886 (41/463),"","","","","","","","","","","","",Metastasis - Combined active and previous history of cancer,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",49; 15,"","","","",0.133 (10/49); 0.154 (2/15),0.0886 (41/463),"","","","","","","","","","","","",Combined active and previous history of cancer; Active cancer only,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",no
131660,Muge 2021,"Comparison of Systemic Immune-Inflammation Index (SII), Early Warning Score (ANDC) and Prognostic Nutritional Index (PNI) in Hospitalized Patients with Malignancy, and Their Influence on Mortality from COVID-19 (preprint)",Consensus,Peer-reviewed,Infectious Agents and Cancer,"",2021-09-15,"Comparison of Systemic Immune-Inflammation
Index (SII), Early Warning Score (ANDC) and
Prognostic Nutritional Index (PNI) in Hospitalized
Patients with Malignancy, and Their Influence on
Mortality from COVID-19",Bilge M,Retrospective,Cohort,Yes,Other: Inpatient,Turkey,Istanbul,Prof. Dr. Murat Dilmener Emergency Hospital,2020-09-01,2020-12-31,186,Mortaility,ICU admission,Severity; ICU admission; Mortality,Other: No,"All cancer types, definition of active not stated, active treatment not stated",No malignancy,"Matched; 75:111; age, comorbidities","",Mean,64.69 ,Variance,12.98  ,62.7,75,Mean,64.81,Variance,6.35 ,63.0,111,Not mentioned,"","","","","","","","","",33,44%,50,45%,"","","",Not significant,20,26.7%,21,18.9%,"","","",Not significant,8,10.7%,24,21.6%,"","","",Not significant,"","","","","","","","","","","","","","","","",4,5.3%,6,5.4%,"","","",Not significant,7,9.3%,5,4.5%,"","","",Not significant,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",No definition stated,"",No definition stated,No definition stated,univariate,Age; Sex; Comorbidities,"",15,"","","","","","","","","","","","","","","","","","","","","","","","","","",7,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",7,"","","","","","","","","","","","","","","","","","","","","","","","","","",2,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",14,"","","","","","","","","","","","","","","","","","","","","","","","","","",4,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",6,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",6,"","","","","","","","","","","","","","","","","","","","","","","","","","",14,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",75,uOR,2.39,1.80−3.16,"",17.3%,2.7%,cRR,0,"","",0/75=0.00%,0/111=0.00%,cRR for moderate disease; cRR for severe disease,Moderate: 41.3/51.4=0.804; Severe: 58.7/48.6=1.21,"",Not significant; not significant,41.3%; 58.7%,51.4%; 48.6%,"No p-value stated; simply reported ""not significant"" for disease status between cancer and non-cancer groups","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",no
131410,Miyashita 2020,Do patients with cancer have a poorer prognosis of COVID-19? An experience in New York City,Consensus,Peer-reviewed,Annals of Oncology,Medical records of Mount Sinai Health System in New York City,2020-08,Do patients with cancer have a poorer prognosis of COVID-19? An experience in New York City?,Miyashita H,Retrospective,Cohort,Yes,not specified,United States,New York City,Mount Sinai Health System,2020-03-01,2020-04-06,5688,Intubation or Death,"",Severity; Mortality,no,Not reported.,Control (non-cancer) group drawn from the same source (electronic medical records of Mount Sinai Health System). Specific hospital not specified.,"Groups were not matched, but this study calculated relative risk of intubation or death in patients with or without cancer stratified by age groups (<50, 51-65, 66-80, >=81).","","","","","","",334,"","","","","",5354,Not mentioned,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",Intubation,N/A,"Not reported. Only states: ""We extracted data (sex, age, comorbidities, intubation, and mortality status as of 8 April) from patients who were positive for the COVID-19 RT-PCR test during this period.""",Intubation,univariate,"","",23,"","","","","","","","","","","","","","","","","","","","","","","","","","",57,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",16,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",74,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",334,uRR,1.15,0.84-1.57,NR,0.111 (37/334),0.0968 (518/5354),"","","","","","",uRR,1.89,1.37-2.61,NR,0.111 (37/334),0.0586 (314/5354),"p-values not reported, but is reported that RR for intubation is significant whereas RR for mortality is not significant.","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",no
128789,Joaquin 2020,Multiple Myeloma and SARS-CoV-2 Infection: Clinical Characteristics and Prognostic Factors of Inpatient Mortality (preprint),Consensus,Peer-reviewed,Blood Cancer Journal ,"This retrospective case series investigated 167 patients reported from 73 hospitals within the Spanish Myeloma Collaborative Group network in March and April, 2020. Outcomes were compared with 167 randomly selected, contemporary, age-/sex-matched noncancer patients with COVID-19 admitted at six participating hospitals. A modified version of a questionnaire proposed by the International Myeloma Society was used for data extraction. A common set of demographic, clinical, laboratory, treatment, and outcome variables were collected for the MM and noncancer cohorts of hospitalized COVID-19 patients. Specific disease status and treatment data were obtained for MM patients. Data extraction was performed locally by hematology departments in participating hospitals and centrally processed by the PETHEMA/GEM data-monitoring unit",2020-10,"Multiple myeloma and SARS-CoV-2 infection:
clinical characteristics and prognostic factors of inpatient mortality",Martínez-López J,Retrospective,Cohort,Yes,inpatient,Spain,N/A,"",2020-03-01,2020-04-30,210,"mortality, severity ","",Mortality,no,Multiple myeloma; Active disease or progression; Active treatment not stated,"167 MM patients reported from 73 hospitals within the Spanish Myeloma Collaborative Group network in March and April, 2020. Outcomes were compared with 167 randomly selected, contemporary, age-/sex-matched noncancer patients with COVID-19 admitted at six participating hospitals.

matched for age and sex 1:1","Matched; 1:1; age, sex","",median,71,IQR,62 - 78,57,167,median,71,IQR,63 - 78,57,167,Not mentioned,"","","","","","","","","",67,40,79,47,"","","","",28,17,36,22,"","","","",35,21,32,19,"","","","","","","","","","","","","","","","","","","","",32,19,13,8,"","","","",23,14,34,20,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",inpatient mortality ,"",Other: Crude,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",43 (Multiple Myeloma),cOR (Multiple Myeloma),3.24 (Multiple Myeloma),1.61 - 6.52 (Multiple Myeloma),0.00103 (Multiple Myeloma),0.488 (21/43) (Multiple Myeloma),0.228 (38/167) (Multiple Myeloma),"","","","","","","","","","","","","I calculated crude OR, CI and p-value for mortality and active MM (n=43) vs. non-cancer (n=167). Raw mortality data taken from table 1 and 2","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",no
128722,Jiahao 2020,Malignancy History Affected the Prognosis of COVID-19 Patients via Release of Interleukin-6 (preprint),Consensus,Preprint,N/A,"",2020-12-16,Malignancy History Affected the Prognosis of COVID-19 Patients via Release of Interleukin-6,Jiahao Hu,Retrospective,Cohort,Yes,inpatient,China,Wuhan,"Central Hospital of Wuhan, Wuhan University Zhongnan Hospital (unclear from main text, obtained from author affiliations)",2020-01-01,2020-03-25,585,"Disease severity of COVID19
Death in-hospital",Progression: severity increasing from moderate grade to severe or critical grade or death ,Severity; Mortality,no,Not described ,"Patients from the same hospitals 

Cancer : non-cancer = 44 : 541","Not matched 
Cancer : non-cancer = 44 : 541","",Median,67,IQR,54-80.5,54.5,44,Median,59,IQR,42-69,45.7,541,Not mentioned,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","According to guideline of Chinese national health commission 
- Moderate: fever, dry cough, fatigue and other symptoms, pulmonary CT findings were exudation or consolidation, but oxygen saturation exceeded 93% without oxygen;
- Severe: respiratory frequency ≥ 30 times/minute, blood oxygen saturation ≤ 93%, oxygenation index ≤ 300 mmHg, and/or lung infiltration progression > 50% within 24 to 48 hours
- Critical: respiratory failure, septic shock, and/or multiple organ dysfunction or failure

Authors then reported progression amongst moderate patients to severe/critical","","Not defined, just ""mortality"" - ""survivor"" or ""non-survivor""","Severe disease defined by guidelines of Chinese National health commission. 
- Moderate: fever, dry cough, fatigue and other symptoms, pulmonary CT findings were exudation or consolidation, but oxygen saturation exceeded 93% without oxygen;
- Severe: respiratory frequency ≥ 30 times/minute, blood oxygen saturation ≤ 93%, oxygenation index ≤ 300 mmHg, and/or lung infiltration progression > 50% within 24 to 48 hours
- Critical: respiratory failure, septic shock, and/or multiple organ dysfunction or failure

Primary outcome (only this has OR) is progression from moderate grade to any higher grade ",univariate; multivariate,Age; Sex,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",585,uOR;mOR ,2.77;1.937,1.3530-5.6864;0.662-5.883,0.0053;0.223,0.273 (12/44),0.107 (58/541),"","","","","","","cOR;RR
",2.51;1.87,1.27-4.95;1.25-2.82,0.00631,0.421 (16/38),0.225 (106/472),Numbers for severity are for OR of poor progression from moderate disease ,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",585,uOR;mOR ,2.77;1.937,1.3530-5.6864;0.662-5.883,0.0053;0.223,0.273 (12/44),0.107 (58/541),"","","","","","","cOR;RR
",2.51;1.87,1.27-4.95;1.25-2.82,0.00631,0.421 (16/38),0.225 (106/472),Numbers for severity are for OR of poor progression from moderate disease ,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",585,100,uOR;mOR ,2.77;1.937,1.3530-5.6864;0.662-5.883,0.0053;0.223,0.273 (12/44),0.107 (58/541),"","","","","","","cOR;RR
",2.51;1.87,1.27-4.95;1.25-2.82,0.00631,0.421 (16/38),0.225 (106/472),Numbers for severity are for OR of poor progression from moderate disease ,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",no
124497,Brijesh 2023,Outcomes of Patients with Active Cancers and Pre-Existing Cardiovascular Diseases Infected with SARS-CoV-2 (preprint),Consensus,Peer-reviewed,Cardio-Oncology,National COVID Cohort Collaborative (N3C) supported by NIH,2023-10,Outcomes of patients with active cancers and pre-existing cardiovascular diseases infected with SARS-CoV-2,Brijesh Patel,Retrospective,Cohort,Yes,inpatient and outpatient (no breakdown),USA,N/A,N/A,2020-01-01,2022-07-22,418306,"1) Major adverse cardiac events: acute heart failure, stroke, myocardial infarction, death as all-cause mortality 

2) Death all-cause mortality ",Survival probability for COVID-19 strains ,"Mortality; Other: Composite Outcome: Major Adverse Cardiac Events -  acute heart failure, stroke, myocardial infarction, death as all-cause mortality ",no,All Types Cancer; active treatment within 30 days; active treatment within 30 days,"Non-cancer cohort: Cardiovascular disease + NO cancer + Covid positive, drawn from patients from the same N3C database from hospitals across the US

Cancer (cardioonc +): control (CVD +) = 1414: 41985",Not matched,"",% of those >65 = 63.3%,"","","",50.7,1414,% of those >65 = 62.9%,"","","",56.6,41985,Wild Type (Ancestral/Wu-1); Alpha (B.1.1.7); Delta (B.1.617.2); Omicron (B.1.1.529/BA.1),"","","","","","","","","",1190,84.2,31978,76.2,"","","","",649,45.9,22283,53.1,"","","","","All patients have but specific ones - Atrial fibrillation/flutter; chronic heart failure; chronic ischaemic heart disease; history of CABG; pacemaker ICD; peripheral vascular disease; prior heart transplant; prior heart valve; valvular heart disease:
488; 623; 853; 40; 24; 945; 24; 62; 797",34.5; 44.1; 60.3; 20.8; 1.7; 66.8; 1.7; 4.4; 56.4,14086; 19785; 28195; 1319; 409; 29209; 350; 1940; 16802,33.6; 47.1; 67.2; 3.1; 1; 69.6; 0.8; 4.6; 40,"","","","",245,17.3,6852,16.3,"","","","","","","","","","","","",650,46,17063,40.6,"","","","",COPD  204,14.4,3506,8.4,"","","","",Prior heart transplant 24,1.7,350,0.8,"","","","","","","","","","","","","Alcohol abuse; asthma; dyslipidemia:
103; 81; 998
",7.3; 5.7; 70.6,2815; 1636; 28779,6.7; 3.9; 68.5,"","","","","","","","","","","","",n/a ,"",All-cause mortality ,"Composite Outcome: Major Adverse Cardiac Events -  acute heart failure, stroke, myocardial infarction, death as all-cause mortality 
",multivariate,"Age; Sex; Comorbidities; Other: BMI and other available patient characteristics

the cumulative incidences from each component in MACE including stroke, acute heart failure and MI were estimated and compared between different disease groups using competing risk analysis adjusting for the death – the terminal event.","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",1391,cOR,"1.8620
",1.6599-2.0887,"P < 0.0001
",0.324 (450/1391),0.204 (8310/40666),"","","","","","",cOR,"1.3037
",1.1715-1.4508,"P < 0.0001
",0.498 (693/1391),0.432 (17581/40666),CardioOnc+WRTCardioOnc-_CalculatedRatio: Cardio onc + / CVD+,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",1391,cOR,1.8620,1.6599-2.0887,P < 0.0001,0.324 (450/1391),0.204 (8310/40666),"","","","","","",cOR,1.3037,1.1715-1.4508,P < 0.0001,0.498 (693/1391),0.432 (17581/40666),"","","","","","","","","",791,55.9,"","","","","","","","","","","","","","","","","","","","","","","","","","",537,38,"","","","","","","","","","","","","","","","","","","","","","","","","","",382,27,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",297,21,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",737,52.1% of all cancer covid patients ,cOR,2.0391,1.7509-2.3746,P < 0.0001,0.376 (277/737),0.228 (5047/22137),"","","","","","",cOR,1.3806,1.1914-1.5998,P < 0.0001,0.545 (402/737),0.465 (10294/22137),"","","","","","","",Early strain,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",262,18.5% of all cancer covid patients,cOR,1.1457,0.8569-1.5318,P = 0.3586,0.225 (59/262),"0.167 (1075/6440)
","","","","","","",cOR,1.1753,0.9139-1.5113,P = 0.2082,0.408 (107/262),0.370 (2383/6440),"","","","","","","","",68,4.81% of all cancer covid patients,cOR,1.5941,0.8746-2.9052,P = 0.1279,0.206 (14/68),0.140 (303/2166),"","","","","","",cOR,1.0173,0.6139-1.6859,P = 0.9469,0.353 (24/68),0.349 (756/2166),"","","","","","","","",1391,100%,cOR,1.8620,1.6599-2.0887,P < 0.0001,0.324 (450/1391),0.204 (8310/40666),"","","","","","",cOR,1.3037,1.1715-1.4508,P < 0.0001,0.498 (693/1391),0.432 (17581/40666),"","","","","","","",1391 is not the same as the total number of cardioonc patients (1414) reported in table 1,324 Alpha,22.9% of all cancer covid patients,cOR,1.9037,1.4960-2.4224,P < 0.0001,0.309 (100/324),0.190 (1885/9923),"","","","","","",cOR,1.3583,1.0885 to 1.6949,P = 0.0067,0.494 (160/324),0.418 (4148/9923),"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",yes
122739,Adrian 2021,Outcomes and Risk Factors of Patients With COVID-19 and Cancer (ONCORONA): A Sub-Study of the Philippine CORONA Study (preprint),Consensus,Peer-reviewed,Frontiers in Oncology,"Database from previous clinical trial, The Philippine CORONA study (NCT04386083)",2022-04,Outcomes and Risk Factors of Patients With COVID-19 and Cancer (ONCORONA): Findings from The Philippine CORONA Study,Espiritu A. I.,Retrospective,Cohort,Yes,not specified,Philippines,Nationwide,"Asian Hospital and Medical Center, Muntinlupa City; Baguio General Hospital and Medical Center, Baguio City; Cagayan Valley Medical Center, Tuguegarao City; Capitol Medical Center, Quezon City; Cardinal Santos Medical Center, San Juan City; Chong Hua Hospital, Cebu City; De La Salle University Medical and Health Sciences Institute, Dasmariñas City; East Avenue Medical Center, Quezon City; Jose B. Lingad Memorial Regional Hospital, City of San Fernando, Pampanga; Dr. Jose N. Rodriguez Memorial and Sanitarium Hospital, Caloocan City; Jose R. Reyes Memorial Medical Center, Manila; Lung Center of the Philippines, Quezon City; Manila Doctors Hospital, Manila; Medical Center Manila, Manila; Makati Medical Center, Makati City; New Era General Hospital, Quezon City; Northern Mindanao Medical Center, Cagayan de Oro City; Quirino Memorial Medical Center, Quezon City; Ospital ng Makati, Makati City; Perpetual Succour Hospital, Cebu City; Dr. Pablo O. Torre Memorial Hospital (Riverside Medical Center, Inc.), Bacolod City; University of the Philippines—Philippine General Hospital, Manila; Philippine Heart Center, Quezon City; Research Institute for Tropical Medicine, Muntinlupa City; San Lazaro Hospital, Manila; San Juan De Dios Educational Foundation Inc.—Hospital, Pasay City; Southern Isabela Medical Center, Santiago City; St. Luke’s Medical Center, Quezon City; St. Luke’s Medical Center, Bonifacio Global City, Taguig City; Southern Philippines Medical Center, Davao City; The Medical City, Pasig City; University of the East Ramon Magsaysay Memorial Medical Center, Inc., Quezon City; University of Santo Tomas Hospital, Manila; Veterans Memorial Medical Center, Quezon City; Vicente Sotto Memorial Medical Center, Cebu City; Western Visayas Medical Center, Iloilo City; Zamboanga City Medical Center, Zamboanga City",2020-02,2020-12,10881,"Mortality, respiratory failures, duration of ventilator dependence, intensive care unit (ICU) admission, length of ICU and hospital stay","",Severity; Hospitalisation; ICU admission; Mortality,no,All types cancer; definition of active not stated; active treatment not stated,Controls from the same 37 hospitals,No matching,"","","","","",48.90%,244,"","","","",53.5%,10637,Not mentioned,"",31,12.7%,995,9.4%,"","","",<0.001,113,46.3%,3534,33.2%,"","","",<0.001,64,26.2%,2127,20.0%,"","","",0.016,20,8.2%,492,4.6%,"","","",0.009,14,5.7%,307,2.9%,"","","",0.009,1,0.4%,59,0.6%,"","","",1.000,24,9.8%,587,5.5%,"","","",0.004,12,4.9%,604,5.7%,"","","",0.611,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",Not stated,ICU admission evidenced on EPIC,in hospital mortality (before discharge/ transfer),Clinical criteria,univariate; multivariate,"Age; Sex; Comorbidities; Other: y adjusted for age group, sex, smoking history, hypertension, diabetes,
chronic cardiac disease, chronic kidney disease, chronic respiratory disease, and chronic neurologic disease","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",244,uOR; uHR; mHR,2.71; 2.07; 1.72,2.06-3.56; 1.65-2.59; 1.37-2.16,8.87E-14; nr; nr,0.328 (80/244); 0.328 (80/244); 0.328 (80/244),0.152 (1622/10637); 0.152 (1622/10637); 0.152 (1622/10637),uOR; uHR; mHR,2.54; 2.25; 1.57,1.93-3.34; 1.79-2.83; 1.24-1.97,5.73E-12; nr; nr,0.320 (78/244); 0.320 (78/244); 0.320 (78/244),0.156 (1662/10637); 0.156 (1662/10637); 0.156 (1662/10637),uOR; aOR,1.79; 1.75,1.39-2.31; 1.32-2.33,5.55E-06; nr,0.521 (125/244); 0.521 (125/244),0.374 (3936/10637); 0.374 (3936/10637),"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",10881,100,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",no
81620,Johannesen 2021,"COVID-19 in Cancer Patients, Risk Factors for Disease and Adverse Outcome, a Population-Based Study From Norway.",Consensus,Peer-reviewed,Frontiers in Oncology," Norwegian Surveillance System for Communicable
Diseases
 Data on cancer and treatment was available from the Cancer Registry of
Norway, the Norwegian Patient Registry and the Norwegian Prescription Database",2021-03,"COVID-19 in Cancer Patients, Risk
Factors for Disease and Adverse
Outcome, a Population-Based Study
From Norway",Johannesen T.B,Retrospective,Cohort study,Yes,inpatient and outpatient (no breakdown),Norway,N/A,N/A,2020-01-01,2020-05-31,8410,Death due to Covid-19 ,Combined outcome: Death and/or admitted to hospital due to COVID-19,Hospitalisation; Mortality; Other: Composite outcome: Death and/or admitted to hospital due to COVID-19,no,"Any cancer diagnosis before the confirmed diagnosis of Covid-19. Cancer group split by treatment recency <1 year, 1-5 years, >5 years since cancer diagnosis. Only data on <1 year since cancer diagnosis included below. ",Same cohort without history of cancer,No matching,"","","","","","",53,"","","","","",7841,Not mentioned,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",Death and/or admission to hospital due to Covid19,"","Norwegian Cause of Death Registry all deaths up to
May 31, 2020 were included. The registry follows the WHO
guidelines for certifying COVID-19 as a cause of death and the
ICD-10 code U07.1 was used for defining COVID-19 as the
underlying cause of death. The definition of the causal sequence
leading to death due to COVID-19 was followed and 19 patients
with COVID-19 as contributing but not underlying cause of
death were excluded",Death and/or admission to hospital due to Covid19,univariate; multivariate,"Age; Sex; Other: Multivariate model adjusted for age and gender.

Unclear about any other additional variables - potentially all variables in table 5  (all cancer, solid tumour, non solid tumour, localised/ regional disease, distant disease, unknown stage, chemo therapy, immunotherapy, steroids, radiotherapy, surgery).","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",53,"","","","","","","","","","","","",uOR; mOR,5.37; 2.08,3.08-9.35; 1.14-3.80,"",0.400 (21/53); 0.400 (21/53),0.110 (854/7841); 0.110 (854/7841),table5: Rates of death due to COVID-19 and/or admission to hospital due to COVID-19,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",53;53,"","","","","","","","","","","","",uOR; mOR,5.37; 2.08,3.08-9.35; 1.14-3.80,"",0.396 (21/53);0.396 (21/53),0.110 (854/7841);0.110 (854/7841),Non cancer mortality and /or hospitalisation due covid not given but stated as comparison group ,"","","","","","","","",71,0.130 (71/547),"","","","","","","","","","","","",uOR; mOR,5.33; 1.80,3.29-8.62; 1.07-3.01,NA,0.394 (28/71); 0.394 (28/71),"","Chemotherapy including targeted therapy
and immunotherapy last 3 months","","","","","","","",45,0.0823 (45/547),"","","","","","","","","","","","",uOR; mOR,5.89; 1.70,3.30-10.85; 0.91-3.20,NA,0.422 (19/45); 0.422 (19/45),"","","","","","","","","",NA,NA,"","","","","","","","","","","","",NA,NA,NA,NA,NA,"","","","","","","","","",7,0.0128 (7/547),"","","","","","","","","","","","",uOR; mOR,6.14; 2.67,1.37-27.46; 0.54-13.14,NA,0.423 (3/7); 0.423 (3/7),"","","","","","","","","",15,0.0274 (15/547),"","","","","","","","","","","","",uOR; mOR,5.45; 1.63,1.94-15.36; 0.55-4.81,NA,0.400 (6/15); 0.400 (6/15),"","","","","","","","","",90,0.165 (90/547),"","","","","","","","","","","","",uOR; mOR,7.16; 2.19,4.70-10.90; 1.40-3.44,NA,0.467 (42/90); 0.467 (42/90),"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",53,"","","","","","","","","","","","","",uOR; mOR,5.37; 2.08,3.08-9.35; 1.14-3.80,"",0.400 (21/53),"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",no
81415,Mohamed 2021,COVID-19 in patients with and without cancer: Examining differences in patient characteristics and outcomes.,Consensus,Peer-reviewed,Journal of Cancer Biology,Mount Sinai Health System EHRs (NYC),2021-03,COVID-19 in patients with and without cancer: Examining differences in patient characteristics and outcomes,Mohamed NE,Retrospective,Cohort,Yes,inpatient and outpatient (with breakdown),USA,"New York, USA","8 Hospitals comprising the Mount Sinai Health System (Mount Sinai Beth Israel, Mount Sinai Brooklyn, Mount Sinai Hospital, Mount Sinai Queens, Mount Sinai Morningside, Mount Sinai West, New York Eye and Ear Infirmary of Mount Sinai, Mount Sinai South Nassau).",2020-03-28,2020-04-26,4641,Mortality,Hospitalisation,Hospitalisation; Mortality,no,All cancers,All patients who tested positive for covid-19 across the same hospital group over the same period whom were not included in the cancer cohort,"Matched; 236:4641, sex","",Median,69,IQR,61-78,55.35,236,Median,57,IQR,40-70,55.20,4405,Not mentioned,"",94,39.8,797,18.1,OR (univariate),1.55,1.20 - 1.56,>.1,118,50.0,929,21.1,aOR,1.32,1.00 - 1.74,≤.1,73,30.9,672,15.3,aOR,1.27,0.95 - 1.70,≤.1,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",32,13.6,256,5.81,"","","","",11,4.6,60,1.4,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","",/,"Does not specify beyond "" during the observation period"" - unclear if this has the same cut-off dates as the inclusion period","",univariate; multivariate,"Age; Sex; Comorbidities; Other: Age, sex, smoking status, COPD, HTN, DM, Obesity, Cancer","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",236,aOR;uOR(unadjusted),1.58;0.85,1.05-2.36;0.56-1.29,NA;NA,0.123;0.123,0.081;0.081,"","","","","","","","","","","","",p value not given for MV - included in MV regression so had to have a significance of p≤0.1 on univariate to be included.,Crude OR,1.07,0.67-1.71,0.779,0.915,0.910,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",236,"","","","",0.123,0.081,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",4641,100,"","","","",0.123,0.081,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",no
80197,Challa 2022,Predictors of Mortality in Hospitalized African American Covid-19 Cancer Patients.,Consensus,Preprint,Research Square,Howard University Hospital electronic medical record,2022-03,"Predictors of Mortality in Hospitalized African
American Covid-19 Cancer Patients",Suryanarayana Reddy Challa,Retrospective,Case-control,Yes,inpatient,United States of America,Washington DC,Howard University Hospital,2019-12,2021-10,512,"ICU admission, mechanical ventilation, death during same hospital stay","",ICU admission; Mortality,no,Patients with a prior history or current diagnosis of any cancer are considered as cases.,"Yes, 49:463","The ration of cancer to non cancer is 49:463. 

No, there was no age and gender matching. 
""We have noticed cancer patients were older than non-cancer patients (Mean Age-70.6 vs.56.3 years)"".  

""Females consisted of 26 (53%) in patients with cancer and 227 (49.1%) in patients without cancer.""","",mean,70.6,"","",47,49,mean,56.3,"","",50.9,436,Not mentioned,"","","","","","","","","",39,79.5,240,51.8,"","","","",16,32.6,168,36.2,"","","","",CAD: 8,16.3,87,36.2,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",univariate; Other: Note the study says they did multivariate analysis but can't see this anywhere,"","",5,"","","","",0.200 (1/5),0.0885 (41/463),"","","","","","","","","","","","","","","","","","","","",14,"","","","",0.143 (2/14),0.0885 (41/463),"","","","","","","","","","","","","","","","","","","","","","","","","","",0.0885 (41/463),"","","","","","","","","","","","","","","","","","","","",3,"","","","",0.333 (1/3),0.0885 (41/463),"","","","","","","","","","","","","","","","","","","","",2,"","","","",0 (0/2),0.0885 (41/463),"","","","","","","","","","","","","","","","","","","","",4,"","","","",0.250 (1/4),0.0885 (41/463),"","","","","","","","","","","","","","","","","","","","",12,"","","","",0.0833 (1/12),0.0885 (41/463),"","","","","","","","","","","","","","","","","","","","","","","","","","",0.0885 (41/463),"","","","","","","","","","","","","","","","","","","","",1,"","","","",0 (0/1),0.0885 (41/463),"","","","","","","","","","","","","","","","","","","","",1,"","","","",0 (0/1),0.0885 (41/463),"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",42,"","","","",0.143 (6/42),0.0885 (41/463),"","","","","","","","","","","","","","","","","","","","",2;1,"","","","",0.500 (1/2); 0 (0/1),0.0885 (41/463),"","","","","","","","","","","","",multiple myeloma;leukaemia,"","","","","","","",1;1;2,"","","","","",0.0885 (41/463),"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",49,"","","","",0.204 (10/49),0.0885 (41/463),"","","","",0.204 (10/49); 0.306 (15/49),0.224 (104/463); 0.116 (54/463),"","","","","","",ICU admission;mechcnical ventilation,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",49,"","","","",0.204 (10/49),0.0886 (41/463),"","","","",0.306 (15/49);0.204 (10/49),0.224 (104/463); 0.116 (54/463),"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",49,100,"","","","",0.204 (10/49),0.0885 (41/463),"","","","",0.306 (15/49);0.204 (10/49),0.224 (104/463); 0.116 (54/463),"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",no
79599,Noh 2023,Interstitial lung abnormalities after hospitalization for COVID-19 in patients with cancer: A prospective cohort study.,Consensus,Peer-reviewed,Cancer Medicine,"Cancer pts: The University of Texas MD Anderson Cancer Center
Controls: The University of Texas Health Science Center at Houston, UTH",2023-07,Interstitial lung abnormalities after hospitalization for COVID-19 in patients with cancer: A prospective cohort study,Noh S,Prospective,Cohort,Yes,inpatient,USA,Texas USA,"The University of Texas MD Anderson Cancer Center and The University of Texas Health Science Center at Houston, UTH.",2020-03,2021-06,139,WHO Clinical Progression Scale,Radiographic data,Severity; ICU admission,no,"All cancers; active cancer, active treatment not stated",Patients without cancer at a tertiary referral centre (University of Texas Health Science Center at Houston UTH) both in the same city.,Matched; 95:139; sex,"",Mean,60,Range,50-69,53,94,Mean,54,Range,45-65,49,45,Not mentioned,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",WHO scale,"World Health Organization (WHO) clinical progression scale of 7, 8 or 9",not reported,"non invasive ventilation, invasive ventilation",univariate,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",94,"","","","","","",uOR,0.46,0.11 - 1.91,0.27,0.0426,0.0889,uOR,0.58,0.28 - 1.21,0.15,0.298,0.422,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",94,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",94,100,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",no
78588,Dai 2020,"Patients With Lung Cancer Have High Susceptibility of COVID-19: A Retrospective Study in Wuhan, China",Consensus,Peer-reviewed,Cancer Control,"",2020-09,"Patients With Lung Cancer Have High Susceptibility of COVID-19: A Retrospective Study in Wuhan, China",Dai MY,Retrospective,Cohort,Yes,inpatient,China,Wuhan,"6 hospitals in Wuhan, China: Zhongnan  Hospital  of  Wuhan  University,  The  Leishenshan  Hospital,  Hubei  Cancer  Hospital,  Union Hospital affiliated to Tongji Medical College, The Central Hospital of Wuhan, Wuhan Seventh hospital",2020-01-01,2020-03-01,217,"Severe event, ICU, IMV, Death",Restricted mean survival time for each of the primary outcomes,Severity; ICU admission; Mortality,no,"All cancer types, active treatment within last three months",A matched cohort of inpatients from the same six hospitals whom did not have a pre-existing diagnostic code for cancer,"Matched; 1:6 for age, sex, region and time period","",Mean,67.26,SD,8.40,80.6,31,"","","","","",186,Not mentioned,"",15,48.39,"","","","","","",9,29.03,"","","","","","",4,12.90,"","","","","","",4,12.90,"","","","","","",2,6.45,"","","","","","","","","","","","","","","","","","","","","","",3,9.68,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",5th edition of 2019 novel coronavirus disease diagnostic criteria published by the national health commission in China using clinical criteria and/or radiological criteria,Physical ICU admission (not just IMV),Death before end date of the study,"Clinical criteria: shortness of breath (RR>30 breaths/min), oxygen saturation <93% at rest, PaO2/FiO2 <30mmHg. Radiological criteria: progression of lung field lesions past 50% within 24-48h ",multivariate,"Age; Sex; Other: Smoking hx, smoking, surgey,   Radiotherapy, Chemotherapy, Targeted therapy, Immunotherapy), IL-6 (not cancer vs no controls)","",31,mHR,3.87,1.02 - 14.71,0.047,0.258 (8/31),"",mHR,4.72,1.19 - 18.72,0.027,0.322 (10/31),"",mHR,4.28,1.44 - 12.71,0.009,0.548 (17/31),"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",31,mHR,3.87,1.02 - 14.71,0.047,0.258 (8/31),"",mHR,4.72,1.19 - 18.72,0.027,0.322 (10/31),"",mHR,4.28,1.44 - 12.71,0.009,0.548 (17/31),"","","","","","","","","","",15,"","","","",0.267 (4/15),"","","","","",0.267 (4/15),"","","","","",0.467 (7/15),"","","","","","","","","",12,"","","","",0.250 (3/12),"","","","","",0.333 (4/12),"","","","","",0.583 (7/12),"","","","","","","","","",4,"","","","",0.250 (1/12),"","","","","",0.500 (2/4),"","","","","",0.500 (2/4),"","","","","","","","","","",10,32.3,aOR (MV reg),0.190,0.014 - 2.537,0.209,"","","","","","","","",aOR (MV reg),0.295,0.033 - 2.635,0.275,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",3,9.68,aOR (MV reg),NA,NA,NA,"","","","","","","","",aOR (MV reg),NA,NA,NA,"","","","","","","","","","",8,25.8,aOR (MV reg),5.150,0.332 - 79.969,0.241,"","","","","","","","",aOR (MV reg),1.555,0.137 - 17.705,0.722,"","","","","","","","","","",4,12.9,aOR (MV reg),0.983,0.047 - 20.494,0.991,"","","","","","","","",aOR (MV reg),0.368,0.025 - 5.415,0.466,"","","","","","","","","","",7,22.6,aOR (MV reg),1.255,1.019 - 4.287,0.030,"","","","","","","","",aOR (MV reg),1.342,0.049 - 2.366,0.027,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",31,100,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",yes
75567,Bazgir 2022,Comparing the COVID-19 Mortality Rate in Cancer Patients with and Without a History of Chemotherapy,Consensus,Peer-reviewed,International Journal of Cancer Management,all patients with COVID-19 who were admitted to the hospital were eligible for enrolment into the Ilam COVID-19 monitoring and evaluation project (Ilam-CEMP). The Ilam-CEMP is one of the first registries in the country (Iran) that enables near real-time monitoring of essential data and trends about the effect of COVID-19 on patients,2022-10,Comparing the COVID-19 Mortality Rate in Cancer Patients with and Without a History of Chemotherapy,Bazgir N,Retrospective,Cohort,Yes,inpatient,Iran,Ilam,urban primary and secondary academic hospital in Ilam.,2020-03-05,2021-03-21,320,This study’s primary outcome was in-hospital mortality or discharge from the hospital.,"",ICU admission; Mortality,no,"All types cancer; active cancer = receiving treatments for cancer such as adjuvant, radical, cura-tve, neo-adjuvant settings, or chemotherapy within the past two months. ","At the same time, 256 controls matched cases by age, gender, and without a history of cancer were randomly selected from the same registry dataset.","Matched; 64:256; age, gender, co-morbidities.","",Mean,63.9,SD,2.5,53.1,64,Mean,62.1,SD,0.8,52.7,256,Not mentioned,"",0,0,7,2.7,"","","","",21,32.8,97,37.9,"","","",0.45,11,17.2,64,25,"","","",0.19,14,21.9,76,29.7,"","","",0.21,8,3.1,2,3.1,"","","",1.00,"","","","","","","","",14,5.5,5,7.8,"","","",0.48,20,7.8,5,7.8,"","","",1.00,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",No definition stated.,"",univariate; multivariate,Age; Sex,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",64,uHR; mHR,2.79; 2.27,1.70-4.59; 1.25-4.13,<0.001; 0.007,0.453 (29/64); 0.453 (29/64),0.137 (35/256); 0.137 (35/256),uHR; mHR,10.8; 6.68,5.11-22.72; 2.97-15.01,<0.001; <0.001,0.563 (36/64); 0.563 (36/64),0.266 (68/256); 0.266 (68/256),"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",28,44,uHR; mHR,3.14; 1.65,1.77-5.57; 0.60-4.56,<0.001; 0.33,0.571 (16/27); 0.571 (16/27),0.137 (35/256); 0.137 (35/256),"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",no
75065,Zhou 2023,"Clinical characteristics, risk factors and outcomes of cancer patients with COVID-19: A population-based study",Consensus,Peer-reviewed,Cancer Medicine,"population based study on patients who presented to Hong Kong public hospitals and outpatient clinics using CDARS, a territory-wide database that centralizes patient information from 43 local hospitals and their associated ambulatory and outpatient facilities",2022-01,"Clinical characteristics, risk factors and outcomes of cancer patients with COVID-19: A population-based study",Zhou J,Retrospective,Cohort,Yes,inpatient and outpatient (no breakdown),China,Hong Kong,43 local hospitals and their associated ambulatory and outpatient facilities,2020-01-01,2020-12-08,6089,"composite endpoint of requirement for intubation, ICU admission and 30-day mortality. Details regarding the individual components that constitute this composite endpoint were extracted from CDARS","","Severity; ICU admission; Mortality; Other: The primary outcome was a severe composite endpoint of requirement for intubation, ICU admission and 30-day mortality.",no,"The inclusion criteria for this study were as follows: patients who had a positive RT-PCR for COVID-19, had pre-existing active malignancy diagnosed by clinical, radiological and pathological investigations and were admitted to the public hospital within the stated time period. The exclusion criteria included malignancy diagnosed after COVID-19 infection and patients in complete remission from cancer.","Same hospitals 

The following study consisted of 6089 COVID-19 patients (median age: 45.9 [27.8.1–62.7] years; 50% male), of which 142 were cancer subjects",No Matching.,"",Median,63.82,IQR,51.01–78.62,45.07,142,Median,45.22,IQR,27.62–62.33,49.87,5947,Not mentioned,"","","","","","","","","",54,38.02,845,14.2,cOR,3.71,2.62 - 5.24,0,11,7.74,132,2.21,cOR,3.70,1.95 - 7.01,0.00007,"","","","","","","","",9,6.33,112,1.88,cOR,3.53,1.75 - 7.10,0.0005,3,2.11,29,0.48,cOR,4.40,1.33 - 14.63,0.0154,1,0.7,15,0.25,cOR,2.80,0.37 - 21.38,0.3245,6,4.22,75,1.26,cOR,3.45,1.48 - 8.07,0.0042,"","","","","","","","","","","","","","","","","systemic embolism 1, gastrointestinal bleeding 12, obesity 1, dementia and alzheimer's 3, heart failure 1, atrial fibrillation 5, ventricular tachycardia/fibrillation 3, acute MI 6, ischaemic heart disease 16, peripheral vascular disease 2","systemic embolism 0.7, gastrointestinal bleeding 8.45, obesity 0.7, dementia and alzheimer's 2,11, heart failure 0.70, atrial fibrillation 3.52, ventricular tachycardia/fibrillation 2.11, acute MI 4.22, ischaemic heart disease 11.26, peripheral vascular disease 1.4","systemic embolism 16, gastrointestinal bleeding 103, obesity 23, dementia and alzheimer's 22, heart failure 31, atrial fibrillation 84, ventricular tachycardia/fibrillation 28, acute MI 68, ischaemic heart disease 180, peripheral vascular disease 25","systemic embolism 0.26, gastrointestinal bleeding 1.73, obesity 0.38, dementia and alzheimer's 0.36, heart failure 0.52, atrial fibrillation 1.41, ventricular tachycardia/fibrillation 0.47, acute MI 1.14, ischaemic heart disease 3.02, peripheral vascular disease 0.42","","","","","CVD has been separated out in ""others""

Chronic lung disease = COPD

Cerebrovascular disease = stroke/TIA","","","","",Self-calculated,Self-calculated,Self-calculated,"","The primary outcome was a composite endpoint 
of patients who required intubation, required intensive care unit (ICU) admission and/or suffered 30-day mortality.",30 day mortality; no definition ,"The primary outcome was a severe composite endpoint of requirement for intubation, ICU admission and 30-day mortality.",univariate; multivariate,Age; Sex; Comorbidities; Other: multivariate analysis is also adjusted for medication treatments ,"",lung 9,"","","","","","","","","","","","",aHR,3.19,0.88 - 11.54,0.0766,"","",outcome = severe COVID-19 composite outcome in hospitalized patients,"","","","","","","",27,"","","","","","","","","","","","",aHR,2.73,0.76 - 9.79,0.1222,"","",outcome = severe COVID-19 composite outcome in hospitalized patients,"","","","","","","",gastrointestinal 14,"","","","","","","","","","","","",aHR,3.79,1.12 - 12.88,0.0325,"","",outcome = severe COVID-19 composite outcome in hospitalized patients,"","","","","","","",colorectal 11,"","","","","","","","","","","","",aHR,5.07,1.5 - 17.17 ,0.0091,"","",outcome = severe COVID-19 composite outcome in hospitalized patients,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",genitourinary 8,"","","","","","","","","","","","",aHR,2.63,0.67 - 10.31,0.1659,"","",outcome = severe COVID-19 composite outcome in hospitalized patients,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",85,"","","","","","","","","","","","",aHR,1.34,0.58 - 3.11,0.4897,"","",outcome = severe COVID-19 composite outcome in hospitalized patients,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",154,"","","","","","","","","","","","",aHR,3.77,1.63 - 8.72 ,0.0019,"","",outcome = severe COVID-19 composite outcome in hospitalized patients; Composite outcome of intubation ICU admission and/or 30-day mortality,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",no
74954,Kodde 2023,Mortality in cancer patients with SARS-CoV-2 or seasonal influenza: an observational cohort study from a German-wide hospital network,Consensus,Peer-reviewed,Infection,QlikView,2022-06-03,"Mortality in cancer patients with SARS‑CoV‑2 or seasonal influenza: 
an observational cohort study from a German‑wide hospital network",Kodde C,Retrospective,Cohort,Yes,inpatient,Germany,"",Helios group hospitals (85),2020-01,2021-08,36726,"Mortality, mechanical ventilation","",Severity; Mortality,no,"The cancer cohort was defined by the presence of any of the three related Elixhauser comorbidities (lymphoma, meta-
static cancer, solid tumor).",Same hospital group,No matching,"",Mean,72.2,SD,11.8,58.2,1625,Mean,68.0,SD,17.6,52.1,27659,Not mentioned,"","","","","","","","","",952,58.6%,"","","","","","",487,29.9%,"","","","","","",402,24.7,"","","","","","","","","","","","","","",116,7.1%,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",Mechanical ventilation,Not specified,In-hospital mortality; cause undefined,"",univariate; multivariate,Age; Sex; Comorbidities; Other: comorbidities: Elixhauser index,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",1625,mOR,2.10,1.88-2.35,<0.01,0.349 (530/1519),0.203 (5483/27015),"","","","",0.294 (477/1625),0.276 (8076/29284),mOR,0.82,0.72-0.94,<0.01,"","","","","","","","","","","",1391,"","","","","","","","","","","","","","","","","","","","","","","","","","",629,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",no
73818,Ghadamgahi 2023,Mortality Rate and Effects of COVID-19 in Cancer Patients versus Non-cancer Patients: A Propensity Score Matching Study,Consensus,Peer-reviewed,The Open Public Health Journal,"",2023-07,Mortality Rate and Effects of COVID-19 in Cancer Patients versus Non-cancer Patients: A Propensity Score Matching Study,"Ghadamgahi, F",Retrospective,Case-control,Yes,inpatient,Iran,N/A,N/A,N/A,N/A,240,"Mortality rate, Survival time",Clinical/Laboratory characteristics,Severity; ICU admission; Mortality,no,Definition of cancer patients not described.,"Control group were inpatients with a positive PCR test who were hospitalised during the same time span as cancer patients. However, further details (e.g. hospital, country) not specified.","Propensity score matching was performed in a 1:3 ratio (three control patients for every one cancer patient). Control patients had similar age, sex, smoking status and underlying disease status (including hypertension, diabetes, lung and heart disease).","",Mean,61.37,SD,13.47,61.7,60,Mean,63.19,SD,13.95,63.3,180,Not mentioned,"",3,5,12,6.7,uOR,0.74,0.20-2.70,0.77,15,25,41,22.8,uOR,1.13,0.57-2.23,0.86,14,23.3,25,13.9,uOR,1.89,0.91-3.92,0.13,7,11.7,17,9.4,uOR,1.27,0.50-3.22,0.80,"","","","","","","","","","","","","","","","",6,10,11,6.1,uOR,1.71,0.60-4.83,0.38,4,6.7,13,7.2,uOR,0.92,0.29-2.93,0.99,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",Mechanical ventilation,Not described,"""In this study, two outcomes were considered, including a binary clinical outcome (death or recovery) and survival time. Survival time was considered as the time from admission to the hospital to death or discharge from the hospital (in days).""",Mechanical ventilation.,univariate; multivariate,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",60,uOR; mOR; uHR; mHR,"3.68; 5.03, 2.34; 2.43",1.89-7.19; 2.04-13.26; 1.33-4.14; 1.30-4.54,<0.01; <0.01; <0.01; <0.01,0.383 (23/60),0.144 (26/180),uOR,1.82,1.01-3.30,0.06,0.483 (29/60),0.339 (61/180),uOR,2.59,1.34-4.99,0.01,0.35 (21/60),0.172 (31/180),Severe = mechanical ventilation,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",no
73804,Starkey 2023,A population-scale temporal case-control evaluation of COVID-19 disease phenotype and related outcome rates in patients with cancer in England (UKCCP),Consensus,Peer-reviewed,Nature Scientific Reports,National Cancer Registry UK and National Immunisation Management Service (NIMS),2023-07,A population‑scale temporal case–control evaluation of COVID‑19 disease phenotype and related outcome rates in patients with cancer in England (UKCCP),"Starkey, T",Retrospective,Cohort,Yes,inpatient and outpatient (no breakdown),England,Population Scale (England),Population Scale (England),2020-11-01,2022-08-31,15928326,"Hospitalisation, ICU, COVID-19 mortality",Hospital assessment,Hospitalisation; ICU admission; Mortality,yes,"1. All cancer types 
2. On national cancer registry UK 
3. Active treatment not stated ",Same National Cohort (National Immunisation Management Service (NIMS) of the UK),Not matched.,"","","","","",50.48,127322,"","","","",43.05,15801004,Other: ORs and base rates are given for each of the four outcomes for each two month period so could be used to generate these figures,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","Any of: hospital assessment, inpatient hospitalisation, intensive care 
admission, COVID-19 mortality",physical ICU admission (not just IMV),SARS-COV-2-mortality,"",multivariate,"Age; Sex; Other: age, sex, ethnicity and deprivation.","","",uOR;mOR of respiratory and intrathoracic organs; uOR;mOR of lungs ,12.13;4.43;18.55;4.97,8.62-17.08;3.04-6.44;16.75-20.55;4.45-5.56,<0.00001;<0.00001;<0.00001;<0.00001,"","",uOR;mOR of respiratory and intrathoracic organs; uOR;mOR of lungs ,13.5;6.47;5.58;2.53,6.40-28.45;2.88-14.51;3.70-8.42;1.64-3.89,<0.00001;<0.00001;<0.00001;0.00003,"","","","","","","","","",uOR;mOR of respiratory and intrathoracic organs; uOR;mOR of lungs ,9.55;3.60;7.28;3.39,8.83-10.33;3.32-3.92;5.71-9.28;2.60-4.41,<0.00001;<0.00001;<0.00001;<0.00001,"","","","",uOR;mOR,2.53;1.66,2.23-2.88;1.45-1.91,<0.00001;<0.00001,"","",uOR;mOR,0.56;0.58,0.29-1.07;0.29-1.16,0.07973;0.12508,"","","","","","","","","",uOR;mOR,1.78;1.14,1.64-1.93;1.05-1.24,<0.00001;0.00308,"","","","",uOR;mOR (includes small bowel and hepatobiliary),17.34;5.85,15.22-19.76;5.08-6.74,<0.00001;<0.00001,"","",uOR;mOR (includes small bowel and hepatobiliary),1.51;0.78,0.56-4.02;0.29-2.09,0.41298;0.62780,"","","","","","","","","",uOR;mOR (including small bowel and hepatobiliary),7.48;3.17,6.72-8.33;2.83-3.55,<0.00001;<0.00001,"","","","",uOR;mOR (colorectal only),8.11;2.36,7.31-9.00;2.10-2.64,<0.00001;<0.00001,"","",uOR;mOR (colorectal only),4.91;2.76,3.60-6.71;2.01-3.79,<0.00001;<0.00001,"","","","","","","","","",uOR;mOR (colorectal only),4.49;2.01,4.17-4.84;1.86-2.18,<0.00001;<0.00001,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",uOR;mOR of male urological; uOR;mOR of prostate; uOR;mOR of urinary tract,2.19;2.76;4.76;1.08; 8.99;1.86,1.27-3.78;1.54-4.95;4.30-5.28;0.97-1.20;7.89-10.23;1.62-2.15,0.00502;0.00069;<0.00001;0.18331;<0.00001;<0.00001,"","",uOR;mOR of male urological; uOR;mOR of prostate; uOR;mOR of urinary tract,1.95;2.13;2.38;0.89;4.18;1.80,0.49-7.80;0.53-8.53;1.69-3.36;0.61-1.28;2.69-6.49;1.13-2.86,0.34593;0.28740;<0.00001;0.52082;<0.00001;0.01341,"","","","","","","","","",uOR;mOR of male urological;uOR;mOR of prostate; uOR;mOR of urinary tract,1.65;2.04;3.19;1.25;4.93;1.78,1.19-2.29;1.43-2.90;2.98-3.41;1.16-1.34;4.49-5.41;1.61-1.97,0.00271;0.00007;<0.00001;<0.00001;<0.00001;<0.00001,"","","","",uOR;mOR,4.32;2.80,3.61-5.18;2.30-3.41,<0.00001;<0.00001,"","",uOR;mOR,2.06;1.78,1.11-3.84;0.96-3.31,0.02220;0.06927,"","","","","","","","","",uOR;mOR,2.64;1.77,2.34-2.98;1.56-2.02,<0.00001;<0.00001,"","","","",uOR;mOR,9.94;11.35,7.26-13.61;7.93-16.23,<0.00001;<0.00001,"","",uOR;mOR,4.05;4.37,1.30-12.60;1.40-13.60,0.01554;0.01098,"","","","","","","","","",uOR;mOR,4.64;4.02,3.64-5.92;3.07-5.28,<0.00001;<0.00001,"","","","",uOR;mOR,5.32;2.79,4.03-7.03;2.08-3.74,<0.00001;<0.00001,"","",uOR;mOR,7.77;5.24,4.50-13.41;3.03-9.06,<0.00001;<0.00001,"","","","","","","","","",uOR;mOR,3.86;2.24,3.24-4.60;1.86-2.70,<0.00001;<0.00001,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",uOR;mOR,10.43;4.08,8.08-13.47;3.09-5.39,<0.00001;<0.00001,"","",uOR;mOR,2.80;1.78,0.90-8.71;0.57-5.52,0.07451;0.32148,"","","","","","","","","",uOR;mOR,5.02;2.51,4.12-6.11;2.03-3.11,<0.00001;<0.00001,"","","","",uOR;mOR,6.42;2.27,6.15-6.71;2.17-2.38,<0.00001;<0.00001,"","",uOR;mOR,2.77;1.64,2.38-3.23;1.39-1.92,<0.00001;<0.00001,"","","","","","","","","",uOR;mOR,3.67;1.80,3.56-3.78;1.74-1.86,<0.00001;<0.00001,"","","","",uOR;mOR,11.46;4.27,10.57-12.42;3.91-4.66,<0.00001;<0.00001,"","",uOR;mOR,13.05;7.70,10.96-15.54;6.43-9.22,<0.00001;<0.00001,"","","","","","","","","",uOR;mOR,7.82;4.12,7.41-8.25;3.89-4.37,<0.00001;<0.00001,"","","","",uOR;mOR of endocrine glands,1.92;2.29,1.15-3.19;1.30-4.04,"","","",uOR;mOR of endocrine glands,1.48;0.00,0.37-5.93;0.00-5.11E+46,0.57912;0.87726,"","","","","","","","","",uOR;mOR of endocrine glands,1.91;2.00,1.46-2.49;1.50-2.66,<0.00001;<0.00001,"","","","",uOR;mOR,"","","","","","","","","","","","","","","","","","","","","","","","","",127322,uOR;mOR,7.12;2.54,6.85-7.40;2.44-2.65,<0.00001;<0.00001,0.0752; 0.0752,0.00715; 0.00715,uOR;mOR,4.22;2.53,3.76-4.74;2.24 - 2.86,<0.00001;<0.00001,0.00892;0.00892,0.00229;0.00229,"","","","","","","",uOR;mOR,4.22;2.10,4.11-4.33;2.04 - 2.16,<0.00001;<0.00001,0.128;0.128,0.0261;0.0261,"","","",uOR;mOR stage I; uOR;mOR stage II; uOR;mOR stage III,3.68;1.38;4.55;1.75;8.22;2.66,3.31-4.09;1.23-1.54;4.03-5.14;1.54-1.99;7.44-9.08;2.39-2.95,<0.00001;<0.00001;<0.00001;<0.00001;<0.00001;<0.00001,"","",uOR;mOR stage I; uOR;mOR stage II; uOR;mOR stage III,1.89;1.12;3.32;2.11;1.70;0.86,1.33-2.69;0.77-1.63;2.37-4.65;1.48-3.01;1.02-2.82;0.51-1.46,0.00042;0.53783;<0.00001;0.00004;0.04105;0.58374,"","","","","","","","","",uOR;mOR stage I; uOR;mOR stage II; uOR;mOR stage III,2.62;1.29;3.12;1.57;4.46;2.01,2.46-2.80;1.21-1.39;2.88-3.37;1.44-1.70;4.15-4.79;1.86-2.16,<0.00001;<0.00001;<0.00001;<0.00001;<0.00001;<0.00001,"","","","",uOR;mOR,19.71;6.66,17.69-21.97;5.90-7.52,<0.00001;<0.00001,"","",uOR;mOR,8.36;3.98,5.79-12.05;2.70-5.87,<0.00001;<0.00001,"","","","","","","","","",uOR;mOR ,7.66;3.57,6.98-8.40;3.24-3.94,<0.00001;<0.00001,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",uOR;mOR,11.58;7.69,10.81-12.40;7.13-8.29,<0.00001;<0.00001,"","",uOR;mOR,7.53;5.51,6.20-9.15;4.50-6.74,<0.00001;<0.00001,"","","","","","","","","",uOR;mOR,6.29;4.14,5.98-6.61;3.92-4.36,<0.00001;<0.00001,"","","","","",uOR;mOR,11.32;3.17,7.36-17.40;2.03-4.95,<0.00001;<0.00001,"","",uOR;mOR,2.85;1.21,0.40-20.25;0.17-8.63,0.29636;0.84867,"","","","","","","","","",uOR;mOR,9.18;4.07,6.86-12.27;3.00-5.53,<0.00001;<0.00001,"","","","","",uOR;mOR,20.61;14.12,16.38-25.93;10.93-18.25,<0.00001;<0.00001,"","",uOR;mOR,28.91;21.97,18.73-44.62;14.17-34.05,<0.00001;<0.00001,"","","","","","","","",B/T-cell antibody therapy,uOR;mOR,13.03;9.38,11.02-15.41;7.83-11.24,<0.00001;<0.00001,"","","","","",uOR;mOR,8.12;4.29,7.38-8.93;3.88-4.76,<0.00001;<0.00001,"","",uOR;mOR,3.68;2.53,2.65-5.10;1.81-3.56,<0.00001;<0.00001,"","","","","","","","","",uOR;mOR,4.17;2.39,3.88-4.47;2.21-2.57,<0.00001;<0.00001,"","","","","",uOR;mOR,11.10;3.76,6.99-17.63;2.32-6.10,<0.00001;<0.00001,"","",uOR;mOR,0.00;0.00,0.00-1.95E+37;0.00-1.37E+36,0.87403;0.86020,"","","","","","","","","",uOR;mOR,7.56;3.06,5.64-10.12;2.26-4.15,<0.00001;<0.00001,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",15928326,100,uOR;mOR,7.12;2.54,6.85-7.40;2.44-2.65,<0.00001;<0.00001,"","",uOR;mOR,4.22;2.53,3.76-4.74;2.24-2.86,<0.00001;<0.00001,"","","","","","","","","",uOR;mOR,4.22;2.53,3.76-4.74;2.24-2.86,<0.00001;<0.00001,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",cancer: 156187; non-cancer:14028232,cancer: 78.56%; non-cancer:77.13%,"","","","","","","","","","","","","","","","","","","","","","","","",1+ Dose,cancer: 42632; non-cancer: 4160341,cancer: 21.44%; non-cancer:22.87%,"","","","","","","","","","","","","","","","","","","","","","","","",0 Doses,no
73512,Johansson 2023,"Were cancer patients worse off than the general population during the COVID-19 pandemic? A population-based study from Norway, Denmark and Iceland during the pre-vaccination era",Consensus,Peer-reviewed,The Lancet,"National health registry data from Norway, Denmark, and Iceland",2023-07,"Were cancer patients worse off than the general population during the COVID-19 pandemic? A population-based study from Norway, Denmark and Iceland during the pre-vaccination era",Johansson A. L. V,Retrospective,Cohort,Yes,inpatient and outpatient (with breakdown),"Denmark, Iceland, Norway",N/A,N/A,2020-03-01,2020-12-31,9223270,"COVID-19 hospitalisation
COVID-19 ICU admission
COVID-19 ICU mechanical ventilation
COVID-19 death","",Severity; Hospitalisation; ICU admission; Mortality,no,"All types cancer (except non-melanoma skin cancer);  diagnosed within 1 year, active treatment not stated","Same country, general population",No Matching; 949:9222321.,"",Median (Norway); Median (Denmark); Median (Iceland),60-64; 65-69; 18-69,25th centile (Norway); 75th centile (Norway); 25th centile (Denmark); 75th centile (Denmark); 25th centile (Iceland); 75th centile (Iceland),50-54; 75-79; 50-54; 75-79; 18-69; >70,52.1,949,"","","","","",9222321,"Newer Omicron subvariants (BA.2,BA.4/5); Not mentioned","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",ICU mechanical ventilation.,"""Intensive care admission due to COVID-19 was defined as admission to an ICU with a primary discharge diagnosis of COVID-19""",30 day mortality; covid-19 specific mortality.,ICU mechanical ventilation - invasive and non-invasive.,univariate,"","",11; 63,SIR (Norway lung); SIR (Denmark lung),4.07; 5.42,0.84-11.90; 2.71-9.70,NR; NR,(<5/11); (11/63),(407/41468); (1019/166522),SIR (Norway lung); SIR (Denmark lung),0; 1.29,N/A; 0.16-4.65,NR; NR,(0/11); (<5/63),(379/41468); (911/166522),SIR (Norway lung); SIR (Denmark lung),0; 1,N/A; 0.03-5.57,NR; NR,(0/11); (<5/13),(293/41468); (577/166522),"",SIR (Norway lung); SIR (Denmark lung),1.94; 2.25,0.63-4.53; 1.47-3.30,NR; NR,(5/11); (26/63),(2361/41468); (8230/166522),Norway (lung); Denmark (lung),28; 100,SIR (Norway); SIR (Denmark),3.29; 0.62,0.40-11.87; 0.02-3.44,NR; NR,(<5/28); (<5/100),(407/41468); (1019/166522),SIR (Norway); SIR (Denmark),0; 2.12,N/A; 0.26-7.66,NR; NR,(0/28); (<5/100),(379/41468); (911/166522),SIR (Norway); SIR (Denmark),0; 3.24,N/A; 0.39-11.71,NR; NR,(0/28); (<5/100),(293/41468); (577/166522),"",SIR (Norway); SIR (Denmark),2.49; 1.46,0.91-5.41; 0.84-2.38,NR; NR,(6/28); (16/100),(2361/41468); (8230/166522),Norway; Denmark,"","","","","","","","","","","","","","","","","","","","","","","","","","","",24; 92,SIR (Norway colorectal); SIR (Denmark colorectal),0.64; 1.30,0.02-3.58; 0.35-3.33,NR; NR,(<5/24); (<5/92),(407/41468); (1019/166522),SIR (Norway colorectal); SIR (Denmark colorectal),4.03; 3.87,0.83-11.79; 1.55-7.97,NR; NR,(<5/24); (7/92),(379/41468); (911/166522),SIR (Norway colorectal); SIR (Denmark colorectal),1.76; 2.61,0.04-9.79; 0.54-7.63,NR; NR,(<5/24); (<5/92),(293/41468); (577/166522),"",SIR (Norway colorectal); SIR (Denmark colorectal),1.93; 2.13,0.83-3.80; 1.45-3.00,NR; NR,(8/24); (32/92),(2361/41468); (8230/166522),Norway (colorectal); Denmark (colorectal),"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",35; 76,SIR (Norway prostate); SIR (Denmark prostate),0.69; 1.19,0.02-3.87; 0.33-3.06,NR; NR,(<5/35); (<5/76),(407/41468); (1019/166522),SIR (Norway prostate); SIR (Denmark prostate),2.18; 0.35,0.45-6.37; 0.01-1.94,NR; NR,(<5/35); (<5/76),(379/41468); (911/166522),SIR (Norway prostate); SIR (Denmark prostate),2.78; 0.54,0.57-8.13; 0.01-3.01,NR; NR,(<5/35); (<5/76),(293/41468); (577/166522),"",SIR (Norway prostate); SIR (Denmark prostate),2.16; 1.18,1.11-3.77; 0.73-1.81,NR; NR,(12/35); (21/76),(2361/41468); (8230/166522),Norway (prostate); Denmark (prostate),"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",21; 59,SIR (Norway melanoma); SIR (Denmark melanoma),N/A; 0.79,N/A; 0.02-4.42,NR; NR,(0/21); (<5/59),(407/41468); (1019/166522),SIR (Norway melanoma); SIR (Denmark melanoma),N/A; 3.33,N/A; 0.69-9.74,NR; NR,(0/21); (<5/59),(379/41468); (911/166522),SIR (Norway melanoma); SIR (Denmark melanoma),0; 3.47,N/A; 0.42-12.55,NR; NR,(0/21); (<5/59),(293/41468); (577/166522),"",SIR (Norway melanoma); SIR (Denmark melanoma),1.73; 1.35,0.47-4.44; 0.65-2.49,NR; NR,(4/21); (10/59),(2361/41468); (8230/166522),Norway (melanoma); Denmark (melanoma),"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",28; 123,SIR (Norway); SIR (Denmark),5.64; 4.15,1.83-13.16; 2.32-6.85,NR; NR,(5/28); (15/123),(407/41468); (1019/166522),SIR (Norway); SIR (Denmark),7.64; 5.93,2.08-19.56; 3.24-9.94,NR; NR,(<5/28); (14/123),(379/41468); (911/166522),SIR (Norway); SIR (Denmark),7.39; 8.57,1.52-21.59; 4.56-14.66,NR; NR,(<5/28); (13/123),(293/41468); (577/166522),"",SIR (Norway); SIR (Denmark),4.37; 3.96,2.26-7.63; 3.10-4.98,NR; NR,(12/28); (73/123),(2361/41468); (8230/166522),Norway; Denmark,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",203; 727; 19,SIR (Norway); SIR (Denmark); SIR (Iceland),2.18; 2.29; NR,1.29-3.45; 1.66-3.07; NR,NR; NR; NR,(18/203); (44/727); NR,(407/41468); (1019/166522); NR,SIR (Norway); SIR (Denmark); SIR (Iceland),3.19; 2.52; NR,1.86-5.11; 1.75-3.50; NR,NR; NR; NR,(17/203); (35/727); NR,(379/41468); (911/166522); NR,SIR (Norway); SIR (Denmark); SIR (Iceland),1.94; 3.02; NR,0.84-3.82; 1.99-4.39; NR,NR; NR; NR,(8/203); (27/727); NR,(293/41468); (577/166522); (25/284563),"",SIR (Norway); SIR (Denmark); SIR (Iceland),2.43; 2.23; NR,1.89-3.09; 1.96-2.54; NR,NR; NR; NR,(67/203); (241/727); NR,(2361/41468); (8230/166522); NR,Norway; Denmark; Iceland,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",56; 35; 176; 167,27.6; 17.2; 24.2; 23.0,SIR; SIR; SIR; SIR,2.74; 2.49; 6.30; 6.61,0.56-8.00; 0.30-9.01; 3.73-9.96; 3.92-10.44,"",(<5/56); (<5/35); (18/176); (18/167),(407/41468); (407/41468); (1019/166522); (1019/166522),SIR; SIR; SIR; SIR,5.35; 6.61; 7.27; 6.94,1.96-11.64; 2.15-15.42; 4.44-11.24; 4.11-10.97,"",(6/56); (5/35); (20/176);  (18/167),(379/41468); (379/41468);(911/166522); (911/166522),"","","","","","","",SIR; SIR; SIR; SIR,4.10; 4.75; 4.92; 4.89,2.60-6.15; 2.81-7.50; 3.99-5.99; 3.94-5.99,"",(23/56); (18/35); (98/176); (92/167),(2361/41468); (2361/41468); (8230/166522); (8230/166522),"Norway ""CT any""; Norway ""CT only""; Denmark ""CT any""; 
Denmark ""CT only""

(For non-cancer column, just Norway; Denmark)","","","","","","","","","","","","","","","","","","","","","","","","","","","","",79,10.9,SIR,5.73,2.47-11.29,"",(8/79),(1019/166522),SIR,9.55,4.77-17.08,"",(11/79),(911/166522),"","","","","","","",SIR,5.70,4.23-7.52,"",(50/79),(8230/166522),Denmark,24; 77,11.8; 10.6%,SIR; SIR,1.50; 5.95,0.04-8.38; 2.72-11.30,"",(<5/24); (9/77),(407/41468); (1019/166522),SIR; SIR,1.86; 2.26,0.05-10.36; 0.47-6.60,"",(<5/24); (<5/77),(379/41468); (911/166522),"","","","","","","",SIR; SIR,3.27; 2.97,1.49-6.21; 1.99-4.26,"",(9/24); (29/77),(2361/41468); (8230/166522),"Norway ""RT any""; 
Denmark ""RT any""

(For non-cancer column, just Norway; Denmark)",51,7.0,SIR,8.26,3.32-17.03,"",(7/51),(1019/166522),SIR,5.79,1.58-14.82,"",(<5/51),(911/166522),"","","","","","","",SIR,4.59,2.97-6.78,"",(25/51),(8230/166522),Denmark,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",no
73383,Hosseini-Moghaddam 2023,"SARS-CoV-2 Infection, Hospitalization, and Mortality in Adults With and Without Cancer",Consensus,Peer-reviewed,JAMA Network Open,COVID-19 Integrated Testing Database; Ontario Registered Persons Database; Canadian Institute for Health Information's Discharge Abstract Database.,2023-08,"SARS-CoV-2 Infection, Hospitalization, and Mortality
in Adults With and Without Cancer","Hosseini-Moghaddam, S M",Retrospective,Cohort,Yes,outpatient,Canada,Ontario,"",2020-01-01,2021-12-31,464574,COVID-19 infection positivity.,"Hospitalisation, ICU admission and mortality.",Hospitalisation; ICU admission; Mortality,yes,All Types Cancer; active treatment in last 6 months or diagnosis in OCR within past year before index ,Drawn from same national cohort. ,No Matching; ratio cancer:non cancer 8378:456196,"",Mean,59.61,SD,18.05,40.6,8378,Mean,45.95,SD,18.24,48.96,456196,Not mentioned,"","","","","","","","","",4219,50.4,108968,23.9,cOR,3.23,"3.10-3.38
","",2475,29.5,69480,15.2,cOR,2.33,2.23-2.45,"",1499,17.9,26250,5.8,cOR,3.57,3.37-3.78,"",207,2.5,4248,0.9,cOR,2.70,2.34-3.10,"",124,1.5,1102,0.2,cOR,6.20,5.15-7.48,"",779,9.3,11959,2.6,cOR,3.81,3.53-4.11,"",2035,24.3,83958,18.4,cOR,1.42,1.35-1.50,"",128,1.5,1715,0.4,cOR,"","","","","","","","","","","",88; 647,1.1; 7.7,2797; 16094,0.6; 3.5,cOR,1.72; 2.29,1.39-2.13; 2.11-2.48,"","IBD; Dementia

taken from eTable4 in supps","IBD; Dementia 

taken from eTable4 in supps","IBD; Dementia

data taken from eTable2 and cancer data from eTable4 has been subtracted to get non-cancer cohort data",IBD; Dementia,"",IBD; Dementia,IBD; Dementia,I calculated crude OR and CI and have left p-values for James as discussed,"",21-day ICU admission,28-day mortality; covid-19 specific mortality  ,"",univariate; multivariate; Other: Crude,"Age; Sex; Comorbidities; Other: Past healthcare utilisation, income, rurality, PHU region, Ontario Marginalisation Index, 2016 Canada census variables.","",321,"","","","",0.178 (57/321),"","","","","","","","","","","","","","","","","","",0.312 (100/321),"","",1272,"","","","",0.061 (78/1272),"","","","","","","","","","","","","","","","","","",0.134 (171/1272),"","",132,"","","","",0.106 (14/132),"","","","","","","","","","","","","","","","","","",0.257 (34/132),"","",676,"","","","",0.095 (64/676),"","","","","","","","","","","","","","","","","","",0.204 (138/676),"","",71,"","","","",0.113 (8/71),"","","","","","","","","","","","","","","","","","",0.225 (16/71),"","",271,"","","","",0.077 (21/271),"","","","","","","","","","","","","","","","","","",0.155 (42/271),"","",1336,"","","","",0.099 (132/1336),"","","","","","","","","","","","","","","","","","",0.208 (278/1336),"","",1797,"","","","",0.015 (27/1797),"","","","","","","","","","","","","","","","","","",0.0573 (103/1797),"","",47,"","","","",0.128 (6/47),"","","","","","","","","","","","","","","","","","",0.255 (12/47),"","",698,"","","","",0.016 (11/698),"","","","","","","","","","","","","","","","","","",0.113 (79/698),"","",125,"","","","",0.080 (10/125),"","","","","","","","","","","","","","","","","","",0.096 (12/125),"","","","","","","","","","","","","","","","","","","","","","","","","","","","","",7185,aHR,1.31,1.19-1.44,"",0.066 (475/7185),"",aHR,0.93,0.82-1.05,"",0.366 (388/1060),"","","","","","","","",aHR,1.11,1.05-1.18,"",0.148 (1061/7185),"",adjusted HRs taken from eTable10 in supps,1193,aHR,2.04,1.74-2.38,"",0.137 (163/1193),"",aHR,1.14,0.93-1.40,"",0.405 (130/321),"","","","","","","","",aHR,1.75,1.57-1.96,"",0.269 (321/1193),"",adjusted HRs taken from eTable10 in supps,439; 357,"","","","",0.107 (47/439); 0.151 (54/357),"","","","","","","","","","","","","","","","","","",0.173 (76/439); 0.303 (108/357),"",other solid tumour; other haematological malignancy ,"","","","","","","","","","","","","","","","","","","","","","","","","","","",8378,"","","","","",0.0466 (21267/456188),"","","","","",0.345 (10207/29582),"","","","","","","non-cancer EVENT/TOTAL taken from graphs in figure 1. We have subtracted number survived at end of period from number survived at start of period to get number who died. 

cancer EVENT/TOTAL taken from eTable11 in supps","","","","","",0.094 (42886/456034),"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",43046,9.3,aHR (1 dose); aHR ( >2 dose),0.57; 0.50,0.51-0.63; 0.45-0.57,"","","",aHR (1 dose); aHR ( >2 dose),0.76; 0.74,0.68-0.85; 0.63-0.87,"","","","","","","","","",aHR (1 dose); aHR ( >2 dose),0.68; 0.42,0.64-0.71; 0.39-0.46,"","","","raw data taken from supps eTable2. Vaccinated is sum of dose 1, dose 2 and dose 3. Data taken for covid-19 positive cohort 

HRs taken from eTable10 (1dose; >2 dose). Note: it is not comparing cancer to non-cancer but vaccinated to unvaccinated so data may not be relevant ",421528,90.7,"","","","","","","","","","","","","","","","","","","","","","","","","",no
73036,S 2021,"Clinical characteristics, laboratory parameters and outcomes of COVID-19 in cancer and non-cancer patients from a tertiary Cancer Centre in India(rerun)",Consensus,Peer-reviewed,Cancer Medicine,Records from Tata Memorial Centre,2021-11-16,"Clinical characteristics, laboratory parameters and outcomes of COVID-19 in cancer and non-cancer patients from a tertiary Cancer Centre in India",Mirgh S. P.,Retrospective,Cohort,Yes,inpatient,India,Navi Mumbai,Tata Memorial Centre,2020-05-22,2020-12-01,200,Overall mortality,"Duration of hospitalisation 
Factors affecting mortality 
Baseline covid-19 severity",Severity; Mortality,no,"All Types Cancer (haematological and solid organ malignancies); Cancer not in remission (remission defined as absence of disease at last follow-up before contracting SARS-CoV-2 infection); 79% on ""active anti-cancer treatment"" defined as any chemotherapy or radiotherapy or major surgery within 4 weeks of SARS-CoV-2 positivity",Non-cancer COVID-19 positive patients from the same hospital,No matching; No matching ratio,"",Median,51,IQR,33-62,58.7,109,Median,38,IQR,32-49,68.1,91,Not mentioned,"","","","","","","","","",19,17.1,21,23.6,"","","","",9,8.1,13,14.6,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",First date of SARS-CoV-2 RT-PCR positivity until date of death during hospital stay; all-cause mortality,"",univariate,"","",4 (lung),"","","","","","","","","","","","","","","","","","","","","","","","","","",18,"","","","","","","","","","","","","","","","","","","","","","","","","","",8 (gastrointestinal),"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",11 (genitourinary),"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",12,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","7 (bone, soft tissue)","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",48,"","","","","","","","","","","","","","","","","","","","","","","","","","",Unknown primary 1,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",109,uOR,7.04,1.25-39.54,0.027,0.101 (11/109),0.0110 (1/91),"","","","","","","","","","",0.110 (12/109); 0.312 (34/109),0.0220 (2/91); 0.147 (16/109),Baseline covid-19 severity (severe = score of 2 or 3); Oxygen support during hospitalization ,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",109,uOR,7.04,1.25-39.54,0.027,0.101 (11/109),0.0110 (1/91),"","","","","","","","","","",0.110 (12/109); 0.312 (34/109),0.0220 (2/91); 0.147 (16/109),"Baseline covid-19 severity (severe = score of 2 or 3), Oxygen support during hospitalization ","","","","","","","","",82,75.2,uOR,11.10,1.37-89.62,"",9/82,1/109,"","","","","","","","","","","","",In preceding one month,"","","","","","","They have a discrepancy btw in-text number of chemo patients (79) and the table 4 (82), we used table 4 value to calculated crude OR ","","","","","","","","","","","","","","","","","","","","","","","","","","","","",9,8.26,"","","","","","","","","","","","","","","","","","",Rituximab within 6mo of infection ,"","","","","","","",7,6.4,"","","","","","","","","","","","","","","","","","",In preceiding 1 month of coid infection ,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",9,8.2,"","","","","","","","","","","","","","","","","","",In preceiding 1 month of coid infection ,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",109,100,uOR,7.04,1.25-39.54,0.027,0.101 (11/109),0.0110 (1/91),"","","","","","","","","","",0.110 (12/109); 0.312 (34/109),0.0220 (2/91); 0.147 (16/109),"Baseline covid-19 severity (severe = score of 2 or 3), Oxygen support during hospitalization ","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",no
72989,Q 2020,Cancer increases risk of in-hospital death from COVID-19 in persons <65 years and those not in complete remission(rerun),Consensus,Peer-reviewed,Leukemia - Nature,"",2020-07-20,Cancer increases risk of in-hospital death from COVID-19 in persons <65 years and those not in complete remission,Li Q,Retrospective,Cohort,Yes,inpatient,China,Wuhan,"Union Hospital, Wuhan Central Hospital, General Hospital of Central Theater Command, PLA, Wuhan Jinyintan Hospital",2020-01-20,2020-04-04,1812,"Death
COVID-19 severity","Time from illness onset to ICU admission
Time from illness onset to repeated negative SARSCOV2 tests
Time from illness onset to admission, progression, or outcome (discharged alive or died)
Time from diagnosis to outcome (discharged alive or died)
Time from admission to outcome (discharged alive or died)",Severity; ICU admission; Mortality,no,All types cancer;  active = less than complete remission (remission defined as complete remission for >=1 year).,Not explicitly matched,No Matching;  18:1794.,"",Median,54,IQR,27-66,61,18,Median,59,IQR,45-68,50,1794,Not mentioned,"",3,17,105,6,"","","","",3,17,559,31,"","","","",0,0,250,14,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","Severity of COVID-19 was graded as follows: (1) mild; mild clinical symptoms, no pneumonia on lung CT; (2) common: fever, cough and lung CT with pneumonia; (3) severe: respiratory distress (respiratory rate > 30 min−1, oxygen saturation (O2Sat) ≤ 93% at rest and/or ratio of arterial oxygen partial pressure to fractional inspired oxygen ≤ 300 mmHg (PaO2/FIO2); and (4) critical: aforementioned criteria of respiratory failure receiving mechanical ventilation, shock and/or organ failure other than lung and/or intensive care unit (ICU) hospitalisation.",Critical: aforementioned criteria of respiratory failure receiving mechanical ventilation; shock; and/or organ failure other than lung; and/or intensive care unit (ICU) hospitalisation.,No definition stated.,Clinical criteria: (3) = severe.,multivariate,"Age; Sex; Comorbidities; Other: lab results including inflammatory markers, cell counts,  cytokines","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",18,NR,NR,NR,NR,0.500 (9/18),0.106 (191/1794),NR,NR,NR,NR,0.056 (1/18),NR ,NR,NR,NR,NR,0.444 (8/18),NR,"NB: 'critical' disease is also a category in this paper.
Data pulled from suppl table 7 (limited data available).","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",no
72919,M 2022,Thrombotic and Clinical Outcomes in Patients with Hematologic Malignancy and COVID-19(rerun),Consensus,Peer-reviewed,"Clinical Lymphoma, Myeloma and Leukemia",MedStar electronic health record at MedStar Georgetown University Hospital and/or Washington Hospital Center,2022-07,Thrombotic and Clinical Outcomes in Patients with Hematologic Malignancy and COVID-19,Cook MR,Retrospective,Cohort,Yes,inpatient,USA,Washington D.C.,MedStar Georgetown University Hospital and Washington Hospital Center,2020-03,2020-05,762,VTE and Cerebrovascular accident,"VTE + CVA composite, ICU admission, COVID-related mortality",ICU admission; Mortality,no,Doesn't specify beyond: haematological malignancy and control cohorts extracted from the REDCap database,Non-haematological malignancy patients who had a positive COVID-19 test at ED or as an inpatient at the same hospital group.,Not matched for age,"",Mean,69.40,SD,14.80,52.4,124*,Mean,53.95,SD,16.81,48.8,709,Not mentioned,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",none,physical ICU admission (which was presented as a different outcome to respiratory support),"heterogenous follow up: "" date of last clinical follow-up or date of death.""",none,univariate,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",0,"","","","","","","","","","","","","","","","","","","","","","","","","","",53,uOR,uOR == 4.37,2.38-8.03,3.20E-07,0.358,0.113,uOR,mOR ==1.32,0.68-2.59,0.414,0.226,0.181,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",53,uOR,uOR == 4.37,2.38-8.03,3.20E-07,0.358,0.113,uOR, mOR == 1.32,0.68-2.59,0.414,0.226,0.181,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",53,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",762,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",no
72884,M 2021,Cancer and COVID-19: Analysis of patient outcomes(rerun),Consensus,Peer-reviewed,Future Oncology ,REDCap electronic data capture tools hosted at Tulane Medical Center,2021-07,"Cancer and COVID-19: analysis of patient
outcomes",Mohamed A,Retrospective,Cohort,Yes,inpatient,USA,"Louisiana, New Orleans",Tulane Medical Center,2020-02-27,2020-04-27,214,in-hospital mortality ,"risk of ICU admission, risk of endotracheal intubation, duration of mechanical ventilation and length of hospital stay ",ICU admission; Mortality,no,"Cancer patients were divided into patients receiving treatment as active cancer and patients in remission with
nonactive cancer 

*active cancer*","same hospitals 

This cohort of COVID-19 patients is representative of the patient population at two university hospitals in New Orleans, Louisiana",No Matching; ratio cancer:non cancer 11:203,"",mean,60.7,SD,9.3,54.5,11,mean,58.7,SD,14.6,45.5,203,Not mentioned,"","","",44,22.9,"","","","",9,81.8,152,74.9,uOR,1.51,0.32 - 7.22,0.603447,1,9.1,84,41.4,uOR,0.14,0.02 - 1.13,0.330,1,9.1,22,10.8,uOR,0.82,0.10 - 6.74,0.855459,"","",25,12.3,"","","","","","","","","","","","",2,18.2,27,13.3,uOR,1.45,0.30 - 7.07,0.645025,"","",48,23.6,"","","","","","","","","","","","","","","","","","","","",4,36.4,125,63.8,uOR,0.36,0.10 - 1.26,0.096026,"Other = obesity, Chronic lung disease = COPD + Asthma ","","","","","","","","",Intensive care admission,no definition stated , ,univariate; Other: Crude,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",11,uOR,1.93,0.49 - 7.67,0.355,0.273 (3/11),0.163 (33/203),uOR,5.0,1.43 - 17.45,0.012,0.455 (5/11),0.143 (29/203),"","","","","","","I calculated crude OR, CI and p-values for mortality and ICU admission using data in table 1 for non-cancer patients and table 3 for active cancer patients ","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",214,100,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",no
72866,L 2021,Rates of COVID-19-Related Outcomes in Cancer Compared With Noncancer Patients(rerun),Consensus,Peer-reviewed,JNCI Cancer Spectrum,Penn Medicine BioBank.,2021-01,Rates of COVID-19–Related Outcomes in Cancer Compared With Noncancer Patients,Sun L,Retrospective,Cohort,Yes,outpatient,USA,Pennsylvania,"","","",323,"Hospitalisation, ICU admission and 30-day mortality.","",Hospitalisation; ICU admission; Mortality,no,"Any cancer diagnosis: 67 (20.7%) had a cancer diagnosis (80.6% with solid tumor malignancy; 26.9% with active cancer).
at least 1 of 3 criteria: 1) 3 or more International Classification of Diseases 10th Revision (ICD-10) billing codes for an invasive cancer, 2) inclusion in the Penn Medicine Cancer Registry, and 3) 1 visit within a Cancer Service Line clinic",Drawn from same regional cohort.,"Comparator group was not matched for age, gender or co-morbidities.
Cancer : Control = 67 : 256","",Median,62,IQR,53-71,53.7,67,Median,50,IQR,37-60,39.5,256,Not mentioned,"",30,44.8,166,64.8,"","","",0.003,38,56.7,117,45.7,"","","",0.11,22,32.8,72,28.1,"","","",0.45,11,16.4,29,11.3,"","","",0.26,3,4.5,8,3.1,"","","",0.59,"","","","","","","","","","","","","","","","",14,20.9,36,14.1,"","","",0.17,5,7.5,11,4.3,"","","",0.29,"","","","","","","","",12 (Obesity); 8 (Mood disorder),17.9(Obesity); 11.9 (Mood disorder),76 (Obesity); 37(Mood disorder),29.7 (Obesity);14.5(Mood disorder),"","","",0.05 (Obesity); 0.60(Mood disorder),"","","","","","","","","",ICU admission,30-day mortality.,"",multivariate,"Age; Sex; Comorbidities; Other: Smoking, Socioeconomic status, Race.","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",67;67,uOR;mOR,9.78;5.67,2.91-32.85;1.49-21.59,"",0.134(9/67);0.134(9/67),0.016(4/256);0.016(4/256),uOR;mOR,2.56;1.91,1.31-5.00;0.90-4.06,"",0.254(17/67);0.254(17/67),0.117(30/256);0.117(30/256),"","","","","","","",uOR;mOR,3.03;2.16,1.75-5.27;1.12-4.18,"",0.552(37/67);0.552(37/67),0.289(74/256);0.289(74/256),"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",no
72854,Konermann 2023,High In-Hospital Mortality in SARS-CoV-2-Infected Patients with Active Cancer Disease during Omicron Phase of the Pandemic: Insights from the CORONA Germany Study.(rerun),Consensus,Peer-reviewed,Oncology Research and Treatment,"ClinicalTrials.gov, NCT04659187",2023-02,High In-Hospital Mortality in SARS-CoV-2-Infected Patients with Active Cancer Disease during Omicron Phase of the Pandemic: Insights from the CORONA Germany Study,Konermann F M,Prospective,Cohort,Yes,inpatient,Germany,N/A,The hospital network Asklepios,2020-03-11; 2020-03-11 (WT to Delta); 2022-01-01 (Omicron),2022-07-20; 2022-01-01 (WT to Delta); 2022-07-20 (Omicron),26425,"""Survival status at discharge from hospital is the primary end-point of the investigation."" ","""Additionally, we differentiated patients with solid and hematological malignancies with regard to the primary endpoint.""",Mortality,no,"1. All cancer types, 2. Active diagnosis of cancer with ICD-10 codes C00-C97, 3. No statement on treatment ","Same country, but involved multiple centers across Germany",Not matched,"","Active Cancer/ WT-D; Active Cancer/Omicron

Median",75; 74,IQR,65 - 82; 64 - 81,58; 62,1513,"No Cancer/WT-D;
No Cancer/Omicron

Median",70; 72,IQR,54 - 82; 53 - 83,52; 49,24912,Wild Type (Ancestral/Wu-1); Delta (B.1.617.2); Omicron (B.1.1.529/BA.1),"","","","","","","","","","","","","","","","","",166 (Active Cancer/ WT-D);  138(Active Cancer/Omicron),21; 19,3644(No Cancer/WT-D);1890(No Cancer/Omicron),24; 19,"","","","",120 (Active Cancer/ WT-D); 103 (Active Cancer/Omicron),15; 14,1962(No Cancer/WT-D); 1342(No Cancer/Omicron),13; 14,"","","","",45 (Active Cancer/ WT-D); 33(Active Cancer/Omicron),5.8; 4.5,997(No Cancer/WT-D); 676(No Cancer/Omicron),6.6; 6.8,"","","","",11 (Active Cancer/ WT-D); 15(Active Cancer/Omicron),1.4; 2.0,94(No Cancer/WT-D); 85(No Cancer/Omicron),0.6; 0.9,"","","","","136 (Active Cancer/ WT-D); 110 (Active Cancer/Omicron)

",18; 15,2332(No Cancer/WT-D); 1334(No Cancer/Omicron),16; 13,"","","","",99( Active Cancer/ WT-D); 73(Active Cancer/Omicron),13; 9.9,1396 (No Cancer/WT-D); 842(No Cancer/Omicron),9.3; 8.5,"","","","","","","","","","","","","","","","","","","","","127 (Dyslipidemia
Active Cancer/ WT-D); A95 (Dyslipidemia active Cancer/Omicron)
29 (Obesity Active Cancer/ WT-D); 19 (Obesity Active Cancer/Omicron)","16 (Dyslipidemia); 13 (Dyslipidemia)
3.7 (Obesity); 2.6 (Obesity)
","2334 (Dyslipidemia No Cancer/WT-D); 1521 (Dyslipidemia No Cancer/Omicron)

992 (Obesity No Cancer/WT-D); 382(Obesity No Cancer/Omicron)","16 (Dyslipidemia No Cancer/WT-D); 15 (Dyslipidemia No Cancer/Omicron)
6.6 (Obesity No Cancer/WT-D); 3.9 (Obesity No Cancer/Omicron)","","","","","","","","","","","","",Mechanical ventilation (intubation),"",Death in-hospital,"",multivariate,Sex; Comorbidities,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",1172,cOR,NR,NR,NR,0.234 (274/1172),0.220 (2000/9089),"","","","","","","","","","","","","","","","","","","","",341,cOR,NR,NR,NR,0.237 (81/341),0.220 (2000/9089),"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",1513,mOR,1.685,1.686 - 2.064,NR,0.235 (355/1513),0.220 (2000/9089),"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","WT/D cancer patients
777",51.4 of cancer patients,mOR,1.940,1.646 - 2.285,NR,0.272 (211/777),0.161 (2418/14998),"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",736 cancer patients,48.6 of cancer patients,mOR,2.864,2.354 - 3.486,NR,0.196 (144/736),0.0783 (776/9914),"","","","","","","","","","","","","","","","","","","","",1513,100,cOR,"","","",0.235 (355/1513),0.220 (2000/9089),"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",no
72749,F 2020,"Clinical characteristics and risk factors associated with COVID-19 severity in patients with haematological malignancies in Italy: a retrospective, multicentre, cohort study(rerun)",Consensus,Peer-reviewed,Lancet Haematology,medical records,2020-08,"Clinical characteristics and risk factors associated with COVID-19 severity in patients with haematological malignancies in Italy: a retrospective, multicentre, cohort study",Passamonti F,Retrospective,Cohort,Yes,inpatient and outpatient (with breakdown),Italy,"","",2020-02-25,2020-06-22,536,"Mortality among patients with haematological malignancies and COVID-19 and evaluation of potential predictive parameters of mortality including biochemical parameters, haematological malignancy characteristics (disease type, disease status, and therapy status), and COVID-19 severity.","Epidemiology of patients with haematological malignancies infected by SARS-CoV-2 (ie, type of haematological malignancy, ICU admission 
rate, laboratory abnormalities, and haematological malignancy-specific treatments)
Evolution of haematological malignancies
Dynamics of viral load",Severity; ICU admission; Mortality,no,"Haematological malignancies; 
diagnosis in the past 6 years; active treatment not stated ",general Italian population,"Matched; no matching ratio; sex, age","",Mean;Median,66.8;68,SD for mean;IQR for median,13.3;58-77,63,536,Median,61,"","",45.8,239627 (Italian population with COVID-19 on 22nd June 2020),Not mentioned,"","","","","","","","","","","","","","","","","",72,13,"","","","","","","","","","","","","","","","","","","","","","",34,6,"","","","","","",42,8,"","","","","","",43,8,"","","","","","","","","","","","","","","","","","","","","","","82 (Heart disease);
91 (Vascular disease);
13 (Connective tissue diseases)","15 (Heart disease);
17 (Vascular disease);
2 (Connective tissue diseases)","","","","","","","","","","","","","","","radiological results, symptomology","Critical = respiratory failure, septic shock, or multiple organ disfunction or failure.",no definition stated; covid-19 specific mortality,clinical criteria,univariate,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",536,uOR,3.60,3.02-4.30,4.812E-42,0.369 (198/536),0.140 (33498/239627),3.60,"","","",0.153,"","","","","",0.362,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",See haematological row,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",no
72735,F 2021,COVID-19 in hematopoietic cell transplant recipients(rerun),Consensus,Peer-reviewed,Bone Marrow Transplantation,"",2020-10-28,COVID-19 in hematopoietic cell transplant recipients,Altuntas F,Retrospective,Cohort,Yes,inpatient,Turkey,N/A ,N/A ,2020-03-11,2020-05-29,994,"Hospital stay duration 
ICU stay duration 
ICU admission 
Mechanical ventilation 
COVID-19 severity 
Case fatality rate","",Severity; Hospitalisation; ICU admission; Mortality,no,"Hematopoietic cell transplant recipients with cancer, Non-HCT recipients with cancer; No definition of timeline of diagnosis; Active treatment not stated",Hospitalised COVID-19 patients without cancer from the Republic of Turkey Ministry of Health database ,"Matched; Haematopoietic cell transplant recipients with cancer 32:497, Non-HCT recipients with cancer 465:497; age, comorbidity","",Median (Haematological cell transplant recipients w cancer); Median (non-HCT recipients with cancer),56.5; 57,Range (Haematological cell transplant recipients w cancer); Range (non-HCT recipients with cancer),19-74; 18-93,78.1; 53.8,32; 465,Median,55,Range,19-87,54.1,497,Not mentioned,"","","","","","","","","",18; 201,56.3; 43.2,200,40.2,"","","",0.2,7; 111,21.9; 23.9,114,22.9,"","","",0.9,5; 69,15.6; 14.8,63,12.7,"","","",0.6,"","","","","","","","","","","","","","","","","","","","","","","","",10; 86,31.3; 18.5,86,17.3,"","","",0.1,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",Haematological cell transplant recipients w cancer; non-HCT recipients with cancer,Not explained,Rate of ICU admission,Duration of follow up not defined; case fatality rate,Not explained HENCE NOT FOR INCLUSION IN DATA EXTRACTION,Other: Crude,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",32; 465,cOR (haematological cell transplant age and comorbid matched); cOR (non-haematological cell transplant age and comorbid matched),3.10; 2.25,1.11-8.67; 1.40-3.61,0.0308; 0.0008,0.156 (5/32); 0.118 (55/465),0.0563 (28/497); 0.0563 (28/497),cOR (haematological cell transplant age and comorbid matched); cOR (non-haematological cell transplant age and comorbid matched),2.21; 25.69,0.912-5.33; 15.25-43.27,0.0792; <0.0001,0.219 (7/32); 0.211 (98/465),0.113 (56/497); 0.113 (56/497),cOR (severe/critical in haematological cell transplant age and comorbid matched); cOR (severe/critical in non-haematological cell transplant age and comorbid matched); cOR (mechanical ventilation in haematological cell transplant age and comorbid matched); cOR (mechanical ventilation in non-haematological cell transplant age and comorbid matched),2.13; 1.81; 2.37; 2.269,0.995-4.570; 1.345-2.431; 0.861-6.529; 1.485-3.467,0.0515; 0.0001; 0.0947; 0.0002,0.344 (11/32); 0.308 (143/465); 0.156 (5/32); 0.151 (70/465),0.197 (98/497); 0.197 (98/497); 0.0724 (36/497); 0.0724 (36/497),"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",no
72612,A 2021,Descriptive Comparative Analysis of Patients with Cancer Referring to the Emergency Department of an Italian University Hospital across the Severe Acute Respiratory Syndrome Coronavirus 2 Waves(rerun),Consensus,Peer-reviewed,JCO Oncology Practice,"Electronic Database of the San Luigi Gonzaga University Hospital (Orbassano-Turin, Italy) in a 3-week time frame during the first and second COVID-19 waves. We considered ED admissions
from March 9 to March 29, 2020, for the first wave. From October 24 to November 13, 2020, for the second
wave.",2021-07,"Descriptive Comparative Analysis of
Patients With Cancer Referring to the Emergency
Department of an Italian University Hospital
Across the SARS-CoV-2 Waves","Mariniello, AM",Retrospective,Cohort,Yes,not specified,Italy,"Turin, Italy",San Luigi Gonzaga University Hospital,2020-03-09 (1st wave); 2020-10-24 (2nd wave) ,2020-03-29 (1st wave);  2020-11-13 (2nd wave),739,"Symptoms at ED - None, Fever, Respiratory, GI, Respiratory Failure","Whether patients were discharged, ICU, HDU or deceased ",Severity; Hospitalisation; ICU admission; Mortality,no,"Thoracic Cancer; haematological Cancer; Urological Cancer; Other Cancers; histologically confirmed solid or haematological cancer, must not have been radically treated and disease free for more than 12 months; active treatment not specified ",Yes,No Matching,"",Median,"73(1st wave), 68(2nd wave)",IQR,63-80(1st wave); 45-75(2nd wave),"87% male(1st wave); 
56% male(2nd wave)",8 (1st wave); 39 (2nd wave),Median,59(1st wave); 63(2nd wave),IQR,49-73(1st wave); 45-75(2nd wave),"61% male(1st wave); 
58% male(2nd wave)",155 (1st wave); 537 (2nd wave) ,Not mentioned,"","","","","","","","","","","","","","","","","","
3 (1st wave); 
7 (2nd wave)","27.5% (1st wave); 
17.9% (2nd wave)","42(1st wave); 
105 (2nd wave)","27% (1st wave); 
19.6% (2nd wave)","","","",0.9 (overall); 0.9 (overall),5 (1st wave); 25 (2nd wave) ,"62.5% (1st wave); 
64% (2nd wave)","69 (1st wave); 
215 (2nd wave)","44.5% (1st wave); 
40% (2nd wave)","","","","","","","","","","","","","","","","","","","","","","","","","","","","","2(1st wave); 
6(2nd wave)","25%(1st wave); 
15.4%(2nd wave)","17(1st wave); 
49(2nd wave)","11%(1st wave); 
9.1%(2nd wave)","","","","",2(1st wave); 4(2nd wave),"25%(1st wave); 
10.3%(2nd wave)","6(1st wave); 
16(2nd wave)","3.9%(1st wave); 
3%(1st wave)","","","","","","","","","","","","","","","","","","","","","","","","","","","","",Respiratory failure,Admitted to ICU ,Deceased at Emergency Department,Respiratory failure ,univariate,"","","4(1st wave); 
7(2nd wave)","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","3(1st wave);  
6(2nd wave) ","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","1(1st wave); 
13(2nd wave) ","","","","","","","","","","","","","","","","","","","","","","","","","","",NR; 6 (2nd wave) ,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","8 (1st wave); 
39 (2nd wave)",NR; NR,NR; NR,NR; NR,NR; NR,0/ 8 (1st wave);   3/39(2nd wave) ,1/155(1st wave); 0/537 (2nd wave) ,NR; NR,NR; NR,No statistical significance (no further information given); No statistical significance (no further information given),0.5 - No statistical significance in ICU admission between cohorts for 1st and 2nd wave together; overall value provided,3/8 (1st wave); 6/39 (2nd wave) ,33/155 (1st wave); 41/537 (2nd wave) ,NR; NR,NR; NR,NR; NR,"0.049 (1st and 2nd wave) also says this but not sure what it means ""However, the higher frequency of
respiratory fai
lure in C19-CP was significant even when
stratifying for pandemic wave (Mantel-Haenszel test
P 5 .045); overall value provided",6/8 (1st wave); 23/39 (2nd wave) ,90/155 (1st wave);  231/537 (2nd wave) ,"dates = start: 2020-03-09 (1st wave): 2020-10-24 (2nd wave); 
end: 2020-11-13 (1st wave); 2020-11-13 ",NR; NR,"
NR; NR","",0.0004 (overall across 1st and 2nd wave); 0.0004 (overall across 1st and 2nd wave),7/8 (1st wave);  30/39 (2nd wave) ,118/155 (wave 1);  246/537 (wave 2)  ,"dates = start: 2020-03-09 (1st wave): 2020-10-24 (2nd wave); 
end: 2020-11-13 (1st wave); 2020-11-13 ","","","","","","","","","","","","","","","","","","","","","","","","","","","","","Stage 3 and 4 - Advanced disease
5/8 in first wave; 
28/39 in second wave","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","1(1st wave);
18(2nd wave)","16%(1st wave); 
66.7%(2nd wave)","","","","","","","","","","","","","","","","","","","","","","","","","","","1(1st wave); 
4(2nd wave)","16%(1st wave); 
14.8%(2nd wave)","","","","","","","","","","","","","","","","","","","","","","","","","","","TK Inhibitors
1(1st wave); 
2(2nd wave)","TK Inhibitors
16%(1st); 
7.4%(2nd wave)","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","2(1st wave); 
2(2nd wave)","33%(1st); 
7.4%(2nd)","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",no
72593,A 2021,SARS-CoV-2 Clinical Outcomes in Patients with Cancer in a Large Integrated Health Care System in Northern California(rerun),Consensus,Peer-reviewed,The Oncologist ,"",2020-12,SARS-CoV-2 Clinical Outcomes in Patients with Cancer in a Large Integrated Health Care System in Northern California,"Anantharaman, A",Retrospective,Cohort Study,Yes,inpatient and outpatient (no breakdown),USA,Northern California ,n/a,2020-02-25,2020-06-08,4627,"Emergency department visit, inpatient hospitalisation, ICU stay, mechanical ventilation, non invasive ventilation and mortality between Covid-19 diagnosis and first 45 days of diagnosis or end of study",Distinct primary and secondary outcomes not stated,"Severity; Hospitalisation; ICU admission; Mortality; Other: ED visit, non invasive ventilation ",no,All Types Cancers; Patients having active treatment for cancer in the 180 days prior to COVID-19 diagnosis; On active treatment,"Adults with positive lab test for Covid-19 with no cancer history. Adults with positive lab test for Covid-19 with history of cancer in Kaiser Permanente Northern California (KPNC) cancer registry but no active treatment cancer in 180 days prior to Covid-19 diagnosis and no history of cancer. 

N.b.Adjusted ORs calculated adjusting for demographic and clinical characteristics (cancer history, age, sex, race/ethnicity, body mass index, charlson comorbidity index, hypertension, diabetes, smoking status, neighbourhood deprivation index) and week of Covid-19 diagnosis to account for changing testing and treatment guidelines. ",No matching,"","","",Age groups,18-59: 39%; 60-69: 24%; 70+: 36%,45%,33,"","",Age groups,18-59: 77%; 60-69: 13%; 70+: 10%,48%,4380,Not mentioned,"","",39,"",25,"","","","","",42,"",13,"","","","","",18,"",13,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",Invasive mechanical ventilation,"",45-day mortality; Cause not stated,Requiring invasive mechanical ventilation,multivariate,"Age; Sex; Comorbidities; Other: cancer history, age, sex, race/ethnicity, body mass ass index, Charlson comorbidity index, hypertension, diabetes, smoking status, and neighborhood deprivation index and week of COVID-19 diagnosis","","","","","","","","","","","","","","","","","","","","","","","","","","","","",9,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",7,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",33,mOR,2.78,0.92-8.43,NR,NR,NR,mOR,1.30,0.41-4.08,NR,NR,NR,mOR,0.81,0.18-3.75,NR,NR,NR,Severity = invasive ventilator ,mOR,1.55,0.67-3.59,NR,NR,NR,"No p values or absolute numbers stated. Also have pooled outcomes, ED visit, non invasive ventilation cancer vs non cancer if relevant.","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",33,mOR,2.78,0.92-8.43,NR,NR,NR,mOR,1.30,0.41-4.08,NR,NR,NR,mOR,0.81,0.18-3.75,NR,NR,NR,"",mOR,1.55,0.67-3.59,NR,NR,NR,"","",12,"","","","","","","","","","","","","","","","","","","","","","","","","","","",11,"","","","","","","","","","","","","","","","","","","","","","","","","","","",14,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",4413,100,mOR,2.78,0.92-8.43,NR,NR,NR,mOR,1.30,0.41-4.08,NR,NR,NR,mOR,0.81,0.18-3.75,NR,NR,NR,"",mOR,1.55,0.67-3.59,NR,NR,NR,NR,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",no
71915,Leuva 2022,"Influence of Cancer on COVID-19 Incidence, Outcomes, and Vaccine Effectiveness: A Prospective Cohort Study of U.S. Veterans.",Consensus,Peer-reviewed,Seminars in Oncology,A COVID-19 Shared Data Resource (CSDR) data using the Veterans Administration Informatics and Computing Infrastructure (VINCI).,2022-07,"Influence of Cancer on COVID-19 Incidence, Outcomes, and Vaccine
Effectiveness: A Prospective Cohort Study of U.S. Veterans","Leuva, H",Prospective,Cohort,Yes,inpatient,USA,"",N/A, 2020-12-14,2022-01-25 ,"21,051","Death within 60 days in the Covid Infected, COVID infection rate","",Mortality; Other: Covid-19 infection,yes,All Types Cancer; Veterans with an active diagnosis of new or previously established cancer in the 2 years preceding the index date; active treatment not stated,"Yes - Gender, Comorbidity and age matched - see supplementary table 2
157,072 Cancer: 157,072 Control - 1:1 Matching","Matched; 1:1; age, sex, comorbidity","",Median (not vaccinated); Median (vaccinated),72 (not vaccinated); 72 (vaccinated),IQR (not vaccinated); IQR (vaccinated),64-76 (not vaccinated); 67-76 (vaccinated),"94% (not vaccinated), 95%(vaccinated)",10355,Median (not vaccinated); Median (vaccinated),72 (not vaccinated); 73 (vaccinated),IQR (not vaccinated); IQR (vaccinated),64-76 (not vaccinated); 68-77(vaccinated),"94% (not vaccinated), 95% (vaccinated)",10696,Not mentioned,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",60 day mortality; all-cause ,"",univariate; multivariate,"Age; Sex; Comorbidities; Other: age, gender, race, BMI, smoking, rurality of normal residence, Elixhauser index and time during the pandemic","",728,aOR,1.955,1.486-2.572,<0.0001,0.095(69/728),0.048(509/10696),"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",475,aOR,1.458,0.98-2.170,>0.001,0.061(29/475),0.048(509/10696),"","","","","","","","","","","","","","","","","","","",Colon Cancer,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",3224,aOR,0.698,0.559-0.870,>0.001,0.032(102/3224) ,0.048(509/10696),"","","","","","","","","","","","","","","","","","","",Prostate,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",8513,aOR,0.960,0.835-1.105,>0.001,0.043(370/8513),0.048(509/10696),"","","","","","","","","","","","","","","","","","","","",1842,aOR,2.154,1.788-2.597,<0.0001,0.095(175/1842),0.048(509/10696),"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",10355,aOR,1.168,1.028-1.326,p>0.001,0.052 (545/10355),0.048(509/10696),"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",10355,aOR,1.168,"1.028-1.326
",>0.001,"0.052 (545/10355)
",0.048(509/10696),"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",10355,100,aOR,1.168,"1.028-1.326
",>0.001,"0.052 (545/10355)
",0.048(509/10696),"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",10355,"",aOR,1.168,1.028-1.326,>0.001,0.050 (545/10355),0.048(509/10696),"","","","","","","","","","","","","","","","","","","",12884,"",aOR,0.934,0.861-1.012,>0.001,0.100 (1310/12884),0.102(1310/12884),"","","","","","","","","","","","","","","","","","","",no
71781,Martin 2023,SARS-CoV-2 Virus in Cancer Patients: A New Unknown in an Unsolved Equation.,Consensus,Peer-reviewed,Oncology,Research Electronic Data Capture (REDCap) electronic data capture tools hosted at IRYCIS,2022-09,SARS-CoV-2 Virus in Cancer Patients: A New Unknown in an Unsolved Equation,Martin M.,Retrospective,Cohort,Yes,inpatient,Spain,Madrid,Hospital Universitario Ramón y Cajal,2020-03,2020-09,2772,Mortality,"",Mortality,no,All cancers; on active treatment,81 (active cancer treatment) vs 164 (cancer survival) vs 2527 (control),Not matching,"",Median,71,IQR,62-79,60.5,81,Median,69,IQR,55-81,58.8,2527,Not mentioned,"","","","","","","","","",39,48.1,1093,43.3,"","","",0.01,21,25.9,466,18.5,"","","",0.04,14,17.3,458,18.1,"","","",0.01,"","","","","","","","","","","","","","","","",4,4.9,197,7.8,"","","",0.01,10,12.3,282,11.2,"","","",0.01,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",N/A,N/A,Definition not stated,N/A,univariate; multivariate,Age; Comorbidities; Other: Active cancer treatment,"",10,uOR,9.6,2.4-37.3,N/A,0.7 (7/10),0.4 (4/10),"","","","","","","","","","","","","","","","","","","","",19,uOR,0.7,0.2-2.6,N/A,0.158 (3/19),0.125 (2/16),"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2,uOR,N/A,"",N/A,0.5 (1/2),0 (0/3),"","","","","","","","","","","","","","","","","","","","",3,uOR,N/A,"",N/A,0,0.333 (4/12),"","","","","","","","","","","","","","","","","","","","",16,uOR,2.4,0.8-6.8,N/A,0.375 (6/16),0.313 (10/32),"","","","","","","","","","","","","Bladder cancer has no death, and is classified in another group in the paper","","","","","","","",1,uOR,N/A,"",N/A,0,0 (0/2),"","","","","","","","","","","","","","","","","","","","",1,uOR,N/A,"",N/A,0,0/0,"","","","","","","","","","","","","","","","","","","","",4,uOR,N/A,"",N/A,0,0.6 (3/5),"","","","","","","","","","","","","","","","","","","","",1,uOR,N/A,"",N/A,1 (1/1),0.286 (4/14),"","","","","","","","","","","","","","","","","","","","",2,uOR,N/A,"",N/A,0.5 (1/2),0.333 (1/3),"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",8,uOR,2.4,0.5-10.3,N/A,0.375 (3/8),0.286 (4/14),"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",81,uOR,2.259,1.35-3.77,0.002,0.333 (27/81),0.268 (44/164 ),"","","","","","","","","","","","","multivariate analysis of
risk of death in patients under active
oncological treatment","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",30,37.0% (30/81),OR,"3.15 (univariate)

3.624","1.52-6.53

1.17-11.17","0.002

0.025",0.467 (14/30),"","","","","","","","","","","","","","","","","","","","",Chemotherapy treatment versus other treatment,25,"","","","","",0.32 (8/25),"","","","","","","","","","","","","","","","","","","","","",7,"","","","","",0,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",11,"","","","","",0.364 (4/11),"","","","","","","","","","","","","","","","","","","","","",6,"","","","","",0.167 (1/6),"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",no
71633,Raad 2023,International multicenter study comparing COVID-19 in patients with cancer to patients without cancer: Impact of risk factors and treatment modalities on survivorship.,Consensus,Peer-reviewed,eLife,"",2023-01,"International multicenter study 
comparing COVID-19 in patients with 
cancer to patients without cancer: Impact 
of risk factors and treatment modalities 
on survivorship",Raad I. I.,Retrospective,Cohort,Yes,inpatient and outpatient (no breakdown),"Australia, Brazil, France, Japan, Lebanon, Singapore, South Korea, Spain, USA","","",2020-01-04,2020-11-15,3966,30 day mortality,"Hospital readmissions within 30 days after 
COVID-19 diagnosis,
mechanical ventilation, progression to lower respiratory tract infection, co-infection",Hospitalisation; ICU admission; Mortality,Other: No,All types cancer; diagnosed or treated within 1 year before the diagnosis of COVID-19; active treatment not stated,Same multinational cohort,Matched; 1:2.56; country,"",Median,61,Range,18-100,45,1115,Median,50,Range,18-100,47,2851,Not mentioned,"",409,38,348,17,"","","",<0.0001,546,49,1020,36,"","","",<0.0001,299,27,6599,23,"","","",<0.0001,85,12,240,12,"","","",<0.001,"","","","","","","","","","","","","","","","","","","","","","","","",75,7,175,9,"","","",0.07,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",multivariate,"Age; Other: Country, tocilizumab treatment, convalescent plasma treatment","",64,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",632,"","","","","","","","","","","","","","","","","","","","","","","","","","",283,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",1115,mOR (multiple imputations),1.23,0.87-1.75,0.24,"","",cRR,(141/1100)/(225/1846)=1.05,"",0.62,141/1100,225/1846,"","","",0.98,135/1096=12.3%,130/1052=12.4%,"",cRR,(63/481)/(60/806)=1.76,"",<0.0001,63/481=13.1%,60/806=7.44%,Hospitalisation referred to hospital re-admission within 30 days of COVID-19 diagnosis,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",no
71628,Turtle 2023,Outcome of COVID-19 in hospitalised immunocompromised patients: An analysis of the WHO ISARIC CCP-UK prospective cohort study.,Consensus,Peer-reviewed,PLOS Medicine, ISARIC WHO Clinical Characterisation Protocol UK prospective observational cohort study (ISARIC4C),2023-01,Outcome of COVID-19 in hospitalised immunocompromised patients: An analysis of the WHO ISARIC CCP-UK prospective cohort study,Turtle L,Prospective,Cohort,Yes,inpatient,United Kingdom,N/A,N/A,2020-01-17; 2020-01-17 (wave 1/D614G); 2020-09-01 (wave 2/Alpha); 2021-04-01 (wave 3/Delta); 2021-12-13 (wave 4/Omicron),2022-02-28; 2020-08-31 (wave 1/D614G); 2021-03-31 (wave 2/Alpha); 2021-12-12 (wave 3/Delta); 2022-02-28 (wave 4/Omicron),139714,In-hospital mortality ,"4C mortality score - illness severity at presentation until 28 days after admission 

In-hospital interventions:
Use of oxygen 
Noninvasive ventilation 
Invasive mechanical ventilation 
Admission to critical care ",Severity; ICU admission; Mortality,yes,"All Types Cancer; ""Active cancer diagnosis""; on active treatment","Drawn from the same multinational cohort

Includes patients with a 'history of malignant neoplasm'",No matching; No matching ratio,"",median,72.0,IQR,62.0-79.7,58.1,5116,median,69.5,IQR,53.4-82.0,55.3,134598,Wild Type (Ancestral/Wu-1); Alpha (B.1.1.7); Delta (B.1.617.2); Omicron (B.1.1.529/BA.1),"",1621,31.7,33798,25.1,"","","","",2049,40.1,57117,42.4,"","","","",1188,23.2,36322,27.0,"","","","",1318,25.8,35597,26.4,"","","","","","","","","","","","",229,4.5,3800,2.8,"","","","",790,15.4,18901,14.0,"","","","",946,18.5,18495,13.7,"","","","",5116,100,0,0,"","","","","","","","","","","","",Asthma;chronic neurological disorder;chronic haematologic disease;dementia;malnutrition;Rheumatologic disease 511;385;1132;160;559,10;7.5;22.1;5.6;3.1;10.9,17720;13957;3665;15328;2417;12901,13.2;10.4;2.7;11.4;1.8;9.6,"","","","","","","","","","","","",4C Mortality Score,Critical care admission ,28 day mortality; all cause,"Non-invasive or invasive ventilation required, 4C mortality score (respiratory rate (breaths per min), Glasgow Coma Scale, oxygen saturation (%), blood urea (mmol/L), blood C-reactive protein (CRP, mg/L)",multivariate,"Age; Sex; Comorbidities; Other: Ethnicity, deprivation index, vaccination, ","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",5116,mOR,2.00,1.87-2.15,<0.001,0.355 (1818/5116),0.213 (28608/134598),mOR,0.77,0.70-0.85,<0.001,0.867 (4437/5116),0.154 (20710/134598),mOR;mOR,0.93;0.65,0.86-1.01;0.56-0.76,0.095;<0.001,0.179 (918/5116);0.0461(236/5116),0.182 (24445/134598);0.0644 (8665/134598),Noninvasive;invasive,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",5116,mOR,2.00,1.87-2.15,<0.01,0.365 (1818/5116),0.219 (28608/134598),mOR,0.77,0.70-0.85,<0.001,0.873 (4437/5116),0.155 (20710/134598),mOR;mOR,0.93;0.65,0.86-1.01;0.56-0.76,0.095;<0.001,0.182 (918/5116);0.047(236/5116),0.185 (24445/134598);0.066 (8665/134598),Noninvasive;invasive,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",mOR,1.28,1.20-1.36,<0.001,"","","","","","","","","","","","","","",Compared to immunocompetent wave 1 hence may not be useful,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",mOR,0.83,0.76-0.91,<0.001,"","","","","","","","","","","","","","",Compared to immunocompetent wave 1 hence may not be useful,"","","","","","","","","",mOR,0.66,0.54-0.80,<0.001,"","","","","","","","","","","","","","",Compared to immunocompetent wave 1 hence may not be useful,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",Alpha,"",mOR,1.19,1.12-1.26,<0.001,"","","","","","","","","","","","","","",Alpha: Compared to immunocompetent wave 1 hence may not be useful,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",yes
71512,Nolan 2023,"Relations of Current and Past Cancer with Severe Outcomes among 104,590 Hospitalized COVID-19 Patients: The COVID EHR Cohort at the University of Wisconsin.",Consensus,Peer-reviewed,"CANCER EPIDEMIOLOGY, BIOMARKERS & PREVENTION",COVID EHR Cohort,2023-01,"Relations of Current and Past Cancer with Severe Outcomes among 104,590 Hospitalized COVID-19 Patients: The COVID EHR Cohort at the University of Wisconsin","Nolan, M. B.",Retrospective,Cohort,Yes,inpatient,USA,"","Duke University, Hackensack Meridian Health, Mayo Clinic (3 locations: Phoenix, AZ, Jacksonville, FL, Rochester, MN), Memorial Sloan Kettering Cancer Center, Mount Sinai, New York University, Northwestern University, University of California-Davis, University of California-San Francisco, University of Chicago, University of Illinois at Chicago, University of Kansas, University of Maryland, University of Michigan, University of North Carolina, University of Utah, University of Wisoconsin, Vanderbilt University, Virginia Commonweatlth University, Washington University, Yale University",2020-02-01,2021-09-30,104590,in-hospital mortality and ICU admission,"",ICU admission; Mortality,yes,All Types Cancer; Any ICD-10 cancer diagnosis recorded during the index COVID-19 hospitalisation; Active treatment not stated.,same databases,No matching,"","","","","",55.0,7141,"","","","",49.2,90700,Not mentioned,"",3616,50.6,33647,36.9,"","","",0.079,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",icu admission,In-hospital mortality (no further definition stated),"",multivariate,Age; Sex; Comorbidities; Other: BMI,"",732,uOr; mOR,2.47; 1.93,2.04-2.99; 1.59-2.36,<0.001; <0.001,nr; nr,0.092 (8384/90700); 0.092 (8384/90700),"","","","","","","","","","","","","","","","","","","","",611,uOr; mOR,1.47; 1.57,1.14-1.88; 1.21-2.03,<0.001; <0.001,nr; nr,0.092 (8384/90700); 0.092 (8384/90700),"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",1062,uOr; mOR,1.70; 1.40,1.42-2.04; 1.17-1.69,<0.001; <0.001,nr; nr,0.092 (8384/90700); 0.092 (8384/90700),"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",628,uOr; mOR,1.88; 1.05,1.49-2.36; 0.83-1.33,<0.001; 0.66,nr; nr,0.092 (8384/90700); 0.092 (8384/90700),"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2012 (metastatic); 2012 (metastatic); 4337 (solid tumour without metastasis);  4337 (solid tumour without metastasis),uOR (metastatic); mOR (metastatic);  uOR (solid tumour without metastasis); mOR  (solid tumour without metastasis),2.28 (metastatic); 1.94 (metastatic); 1.82 (solid tumour without metastasis); 1.48 (solid tumour without metastasis),2.01-2.58 (metastatic); 1.71-2.21 (metastatic); 1.66-1.99 (solid tumour without metastasis); 1.35-1.62 (solid tumour without metastasis),<0.001 (metastatic); <0.001 (metastatic); <0.001 (solid tumour without metastasis);  <0.001 (solid tumour without metastasis),nr (metastatic); nr (metastatic); nr (solid tumour without metastasis); nr (solid tumour without metastasis),0.092 (8384/90700) (metastatic); 0.092 (8384/90700) (metastatic); 0.092 (8384/90700) (solid tumour without metastasis); 0.092 (8384/90700) (solid tumour without metastasis),"","","","","","","","","","","","","","","","","","","","",2482,uOr; mOR,2.02; 1.71,1.80-2.26; 1.52-1.92,<0.001; <0.001,nr; nr,0.092 (8384/90700); 0.092 (8384/90700),"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",7141,uOr; mOR,1.91; 1.58,1.78-2.06; 1.46-1.70,<0.001; <0.001,0.146 (1040/7141); 0.146(1040/7141),0.092 (8384/90700); 0.092 (8384/90700),uOR; mOR,1.31; 1.24,1.24-1.39; 1.17-1.32,<0.001; <0.001,0.247 (1763/7141); 0.247(1763/7141),0.199 (18063/90700); 0.199 (18063/90700),"","","","","","","","","","","","","","","",4337,uOR; mOR,1.82; 1.48,1.66-1.99; 1.35-1.62,<0.001; <0.001,nr; nr,0.92 (8384/90700); 0.92 (8384/90700),"","","","","","","","","","","","","","","","","","","","",2012,uOR; mOR,2.28; 1.94,2.01-2.58; 1.71-2.21,<0.001; <0.001,nr; nr,0.92 (8384/90700); 0.92 (8384/90700),"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",6344 ,11.5,"","","","",0.104 (76/733),0.052 (252/4848),"","","","",0.205 (150/733),0.163 (790/4848),"","","","","","","","","","","","","",48639,88.5,"","","","",0.131 (403/3074),0.076 (3237/42593),"","","","",0.241 (741/3074),0.182 (7752/42593),"","","","","","","","","","","","","",no
71402,Salvatore 2023,"COVID-19 Outcomes by Cancer Status, Site, Treatment, and Vaccination.",Consensus,Peer-reviewed,"Cancer Epidemiology, Biomarkers & Prevention","Electronic health record data from Michigan Medicine (University of Michigan, Ann Arbor, MI)",2022-04,"COVID-19 outcomes by cancer status, type, treatment, and vaccination","Salvatore, M",Retrospective,Cohort,Yes,inpatient and outpatient (with breakdown),USA,Michigan,N/A,2020-03-10,2022-02-02,44410,"COVID-19 related hospitalization, ICU admission, all-cause mortality, composite severe COVID (union of first three outcomes)",N/A,"Hospitalisation; ICU admission; Mortality; Other: Composite outcome: covid-19 hospitalization, ICU admission, all-cause mortality",yes,"Bladder, Breast, Colorectal, Kidney, Lung, Melanoma, Prostate and Haematological Cancers; diagnosed within the last 3 years; proportion on active treatment ",Those testing positive for COVID-19 and did not have cancer from the same electronic health record data from a large academic healthcare system (Michigan Medicine),No Matching,"","","","","","",6143,"","","","","",38267,Not mentioned,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","Composite score of covid-19 hospitalization, ICU admission, all-cause mortality",% of those admitted to ICU,60 day mortality; all-cause,"unit (ICU) admission, mortality ",multivariate,Age; Sex; Comorbidities; Other: Neighborhood disadvantage index ,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",6143,mOR,1.68,1.39-2.04,"",NR (NR/6143),NR (NR/38267),mOR,1.19,0.97-1.46,"","NR (NR/6143)
",NR (NR/38267),mOR,1.48,1.35-1.63,"","NR (NR/6143)
",NR (NR/38267),Composite Outcome as above ,mOR,1.43,1.29-1.58,"",NR (NR/6143),"NR (NR/38267)
",most recent diagnosis within past 3 years,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",6143,mOR,1.68,1.39-2.04,"",NR (NR/6143),"NR (NR/38267)
",mOR,1.19,0.97-1.46,"",NR (NR/6143),NR (NR/38267),mOR,1.48,1.35-1.63,"",NR (NR/6143),NR (NR/38267),"",mOR,1.43,1.29-1.58,"",NR (NR/6143),NR (NR/38267),Most recent diagnosis within past 3 years,"",1168;537,19; 8.7,mOR;mOR,3.01;2.04,2.26-4.02;1.27-3.29,"",NR (NR/1168); NR (NR/537),NR (NR/38267); NR (NR/38267),mOR;mOR,1.90;1.58,1.37-2.62;0.95-2.62,"",NR (NR/1168); NR (NR/537) ,NR (NR/38267); NR(NR/38267),mOR;mOR,2.90;1.68,2.49-3.38;1.30-2.16,"",NR (NR/1168); NR (NR/537),NR (NR/38267); NR(NR/38267),Most recent chemo within past year; most recent chemo one to 3 years ago ,mOR,2.75;1.59,2.34-3.22;1.22-2.08,"",NR (NR/1168); NR (NR/537),NR (NR/38267); NR (NR/38267),Most recent chemo within past year; most recent chemo one to 3 years ago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mOR,1.68,1.39-2.04,"",NR (NR/6143),NR (NR/38267),mOR,1.19,0.97-1.46,"",NR (NR/6143),NR (NR/38267),mOR,1.48,1.35-1.63,"",NR (NR/6143),NR (NR/38267),"",mOR,1.43,1.29-1.58,"",NR (NR/6143),NR (NR/38267),Most recent initial diagnosis Within past 3 years ,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",mOR; mOR;mOR,"1.38, 1.54, 1.82","0.84-2.27, 1.09-2.18, 1.39-2.37","","","","","","","","","",partially vaccinated; fully vaccinated; boosted,"","","","","","","","","","","","","","",mOR,1.20,1.10-1.31,"","","","","","","","","",before vaccination,no
71373,Zhang 2022,Early COVID-19 Hospitalizations Among New York State Residents with a History of Invasive Cancer.,Consensus,Peer-reviewed,Journal of registry management,"NYSCR Surveillance, Epidemiology, and End Results Data Management System (SEER*DMS) database",2022-12,"Early COVID-19 Hospitalizations Among New York 
State Residents with a History of Invasive Cancer",Xiuling Zhang,Retrospective,cohort study,Yes,inpatient,United States,New York State (NYS),NA,2020-01-01,2020-03-31,1257377,"to understanding the association between cancer history and severe COVID-19 outcomes (hospitalisation), and explore the factors associated with outcome in this population ","",Hospitalisation; Mortality,no,"- the study includes patients with a history of cancer but does not specify any particular cancer types, but they categorised all cancer diagnoses into 24 cancer types and examined covid-19 hospitalisations by cancer types
",all the included patients were with history of cancer... they did analyses based on cancer with covid hospitalisations vs cancer without covid hospitalisation,"","",mean ,"with covid hospitalisation: 74.0

without covid hospitalisation: 68.2 ",-,-,"with covid hospitalisation: 55.1%

without covid hospitalisation: 45.9%","with covid hospitalisation: 10210

without covid hospitalisation: 1247167k","","","","","","",Not mentioned,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","The study identified COVID-19 hospitalizations using International Classification of Diseases, Tenth Revision, Clinical Modification (ICD-10-CM). 

The primary diagnosis code is U07.1 and  code B97.29 was used for discharge dates

When a patient had a COVID-19 diagnosis code as the principal diagnosis on one or more linked inpatient claims records, it was counted as one COVID-19 hospitalization.","","",multivariate,"Age; Sex; Other: race/ethnicity, region of residency, stage, history of multiple tumors, and time since cancer diagnosis","","hospitalisation: 852 
death: 235 ",ratio of observed to expected (O/E),1.11,0.97-1.26,"","total deceased cases (n-=2328) 

% = 235/2328=10.1%","","","","","","","","","","","","","","",ratio of observed to expected (O/E),1.54,1.44-1.65,"",852/10210 = 8.34% ,"","","hospitalisation: 1427 
death: 267 ",ratio of observed to expected (O/E),0.73,0.64-0.82,"",267/2328 = 11.5%,"","","","","","","","","","","","","","",ratio of observed to expected (O/E),0.79,0.75-0.83,"",1427/10210 = 13.98% ,"","","hospitalisation: 
- esophagus: 46 
- stomach: 127 

deaths: 
- esophagus: 12
- stomach: 27",ratio of observed to expected (O/E),"- esophagus: 1.14
- stomach: 0.88","- esophagus: 0.59-2.00
- stomach: 0.58-1.28","","- esophagus: 12/2328=0.515%
- stomach: 27/2328 = 1.16%","","","","","","","","","","","","","","",ratio of observed to expected (O/E),"esophagus: 1.05 
stomach: 1.04 ","eso: 0.77-1.41
stomach: 0.87-1.24 ","","esophagus: 46/10210=0.451%
stomach: 127/10210=1.24%","","","hospitalisation: 889 
death: 207
",ratio of observed to expected (O/E),0.89,0.77-1.02,"","","","","","","","","","","","","","","","",ratio of observed to expected (O/E),1.06 ,0.99-1.14 ,"",889/10210 = 8.71%,"","","hospitalisation: 
- liver and intrahepatic bile duct: 115 
- pancreas: 100 

deaths: 
- liver and intrahepatic bile duct: 33
- pancreas: 24",ratio of observed to expected (O/E),"- liver and intrahepatic bile duct: 1.32
- pancreas: 1.07","- liver and intrahepatic bile duct: 0.91-1.86
- pancreas: 0.68-1.59","","- liver and intrahepatic bile duct: 33/2328 = 0.988%
- pancreas: 24/2328=1.03%","","","","","","","","","","","","","","",ratio of observed to expected (O/E),"liver and intrahepatic bile duct: 1.44
pancreas: 1.02","liver and intrahepatic bile duct: 1.19-1.72
pancreas: 0.83-1.25","","liver and intrahepatic bile duct: 115 / 10210 = 1.13%
pancreas: 100 / 10210 = 0.979%","","",437 ,ratio of observed to expected (O/E),0.94,0.76-1.14,"",437/2328=18.8%,"","","","","","","","","","","","","","",ratio of observed to expected (O/E),1.29,1.17-1.41,"",437/10210=0.428%,"","","hospitalisation: 
- bladder: 550 
- prostate: 2070 
- testis: 36 

deaths: 
- bladder: 153
- prostate: 532
- testis: <11 ",ratio of observed to expected (O/E),"- bladder: 0.97
- prostate: 0.96
- testis: 0.34","- bladder: 0.83-1.14
- prostate: 0.88-1.05
- testis: 0.04-1.24","","- bladder: 153/2328=6.57%
- prostate: 53222.8%
- testis: <11 /2328=<0.473%","","","","","","","","","","","","","","",ratio of observed to expected (O/E),"bladder: 1.00
prostate: 0.86
testis: 0.43 ","bladder: 0.92-1.09
prostate: 0.83-0.90
testis: 0.30-0.59 ","","bladder: 550/10210=5.39%
prostate: 2070/10210=20.27%","","","hospitalisations: 

ovary: 94 
cervix uteri: 74 
corpus uterus: 408 

deaths: 

ovary: 12
cervix uteri: 14
corpus uterus: 75",ratio of observed to expected (O/E),"- ovary: 0.61
cervix uteri: 0.83
corpus uterus: 0.76","ovary: 0.32-1.07
cervix uteri: 0.45-1.40
corpus uterus: 0.60-0.96","","ovary: 12/2328=0.515%
cervix uteri: 14/2328 = 0.601%
corpus uterus: 75/2328 = 3.22%","","","","","","","","","","","","","","",ratio of observed to expected (O/E),"ovary: 0.93
cervix uteri: 0.73
corpus uterus: 1.02","ovary: 0.75-1.13 
cervix uteri: 0.57-0.91
corpus uterus: 0.92-1.12 ","","ovary: 94/10210=0.921%
cervix uteri: 74/10210=0.725%
corpus uterus: 408/10210=4.00%","","","hospitalisations: 58 
deaths: <11",ratio of observed to expected (O/E),0.85,0.39-1.62,"",<11 /2328=<0.473%,"","","","","","","","","","","","","","",ratio of observed to expected (O/E),0.83,0.63-1.07,"",58/10210=0.568%,"","","hospitalisation: 

thyroid: 257 
larynx: 71 
oral cavity and pharynx: 172 

deaths: 
thyroid: 37
larynx: 15
oral cavity and pharynx: 36",ratio of observed to expected (O/E),"thyroid: 0.67
larynx: 0.85
oral cavity and pharynx: 0.88","thyroid: 0.47-0.93
larynx: 0.48-1.41
oral cavity and pharynx: 0.61-1.21","","thyroid: 37/2328 = 1.59%
larynx: 15 / 2328 = 0.644%
oral cavity and pharynx: 36/2328 = 1.55%","","","","","","","","","","","","","","",ratio of observed to expected (O/E),"thyroid: 0.70 
larynx: 1.01  
oral cavity and pharynx: 0.84","thyroid: 0.62-0.79 
larynx: 0.79-1.27
oral cavity and pharynx: 0.72-0.98","","thyroid: 257/10210=2.52%
larynx: 71=0.695%
oral cavity and pharynx: 172/10210=1.68%","","","hospitalisation: 268
deaths: 46",ratio of observed to expected (O/E),0.64,0.47-0.85,"",46/2328 = 1.98%,"","","","","","","","","","","","","","",ratio of observed to expected (O/E),2.21,1.95-2.49,"",268/10210=2.62%,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","hospitalisation: 
- multiple myeloma: 268
- hodgkin lymphoma: 54
- non-hodgkin lymphoma: 586 
- other malignancies of haematopoietic or lymphopoietic origin: 243
- leukemia=491

deaths: 
- multiple myeloma: 65
- hodgkin lymphoma: 12
- non-hodgkin lymphoma: 140
- other malignancies of haematopoietic or lymphopoietic origin: 58
- leukemia=113",ratio of observed to expected (O/E),"- multiple myeloma: 1.04
- hodgkin lymphoma: 1.13
- non-hodgkin lymphoma: 1.01
- other malignancies of haematopoietic or lymphopoietic origin: 0.94
- leukemia=1.03","- multiple myeloma: 0.80-1.33
- hodgkin lymphoma: 0.58-1.97
- non-hodgkin lymphoma: 0.85-1.19
- other malignancies of haematopoietic or lymphopoietic origin: 0.72-1.22
- leukemia=0.85-1.24","","- multiple myeloma: 65/2328=2.79%
- hodgkin lymphoma: 12/2328=0.515%
- non-hodgkin lymphoma: 140/2328=6.01%
- other malignancies of haematopoietic or lymphopoietic origin: 58/2328=2.49%
- leukemia=113/2328=4.85%","","","","","","","","","","","","","","",ratio of observed to expected (O/E),"multiple myeloma: 2.21
hodgkin lymphoma: 0.74
non-hodgkin lymphoma: 1.38
other malignancies of haematopoietic or lymphopoietic origin: 1.46

leukemia: 1.91","multiple myeloma: 1.95-2.49
hodgkin lymphoma: 0.56-0.97
non-hodgkin lymphoma: 1.27-1.50
other malignancies of haematopoietic or lymphopoietic origin: 1.29-1.66

leukemia: 1.74-2.09","multiple myeloma: 268
hodgkin lymphoma: 54
non-hodgkin lymphoma: 586 
other malignancies of haematopoietic or lymphopoietic origin: 243
leukemia=491","multiple myeloma: 268/10210=2.62%
hodgkin lymphoma: 54/10210=0.528%
non-hodgkin lymphoma: 586 /10210=5.74%
other malignancies of haematopoietic or lymphopoietic origin: 243/10210=2.38%
leukemia=491/10210 = 491/10210=4.87%","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","hospitalisation: 10210 

deceased at discharge among all the hospitaliations: 2328 ","crude proportion
adjusted proportion",1.16,1.14-1.19,"","","","","","","","","","","","","","","","",ratio of observed to expected (O/E),1.16,1.14-1.19,"","","","","","hospitalisation: 

local: 4926
regional:  1628

mortality: 
local: 1072 
regional: 354",OR,regional: 1.07,regional: 0.92-1.23,"","local: 46.1% 

regional: 15.2%","","","","","","","","","","","","","","","odds ratio, using local stage of cancer as the reference 

 ","local: ref 
regional: 1.09",regional: 1.03-1.15 ,"","local:48.2%
regional: 15.9%","","","hospitalistion: 
distant: 1983

mortality: 
distant: 474",OR,distant: 1.12,distant: 0.98-1.30,"",20.4%,"","","","","","","","","","","","","","","odds ratio, using local stage of cancer as the reference 

 ","distant: 1.69 
",distant: 1.61-1.79,"",distant: 19.4%,"","","hospitalisation: 
unknwon stage: 1673

mortality: 
unknown: 428 ",OR,unknown stage: 1.12,unknown: 0.98-1.29,"",18.4%,"","","","","","","","","","","","","","","odds ratio, using local stage of cancer as the reference 

 ",0.79 ,unknown: 0.75-0.84,"",unknown: 16.4%,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",no
71018,Mathews 2022,The clinical impact of COVID-19 on patients with cancer in British Columbia: An observational study.,Consensus,Peer-reviewed,Heliyon,Electronic Health Records in British Columbia,2022-11,The clinical impact of COVID-19 on patients with cancer in British Columbia: An observational study,Angela S. Mathews ,Retrospective,Cohort ,Yes,Other: Not specified,Canada,British Columbia (BC),"Almost all cancer care in the province
is centralized within one network of oncology clinics (BC Cancer)",2020-03-03,2021-01-21,631,30-day COVID-19-specific mortality,"",Mortality,Other: No,"Patients with active or prior cancer; excluded liquid cancers (leukaemia and lymphoma); patients were classified as on active anticancer therapy if the last dose was received within 12 months prior to a COVID-19 diagnosis, and untreated if over 12 months had passed.



",Patients seen for hereditary cancer screening or assessment/treatment of benign tumours but who did not have active or prior cancer diagnoses; patients without a malignant cancer diagnosis,"Cancer: non-cancer = 506:122 = 4.15:1
","",Median,66,IQR,53-76,48.7%,509,estimated_mean,45.3,"","",41.0%,122,Not mentioned,"",173,37.8%,"","","","","","",196,39.5%,"","","","","","",100,20.2%,"","","","","","","19
(defined as congestive heart failure)","3.8%
(defined as congestive heart failure)","","","","","","","","","","","","","","","5
(defined as cirrhosis)","1.0%
(defined as cirrhosis)","","","","","","",25,5.0%,"","","","","","","34
(defined as COPD)","6.9%
(defined as COPD)","","","","","","","","","","","","","","","","","","","","","","",Asthma: 28; Rheumatological disease: 18; Obstructive sleep apnoea: 24,Asthma - 5.6%; Rheumatological disease - 3.6%; Obstructive sleep apnoea - 4.8%,"","","","","","","","","","","","","","","","","Patients were assumed to have died from COVID-19 if there was evidence of this in the EHR through chart review (i.e., COVID-19, virus identified) or if the death was within 30 days of their positive test (ie. 30day mortality)

Patients were classified as having died due to non-COVID-19-related causes if their date of death was over 30 days from the date of their positive test, and if they
died due to other health concerns related to progression of their cancer or other comorbidities (e.g., cardiac arrest, unknown causes, medical assistance in dying due to reasons unrelated to COVID-19, etc.",-,multivariate,"","",49,"","","","","","","","","","","","","","","","","","","","","","","","","","",96,"","","","","","","","","","","","","","","","","","","","","","","","","","",Total GI: 58,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",66,"","","","","","","","","","","","","","","","","","","","","","","","","","",32,"","","","","","","","","","","","","","","","","","","","","","","","","","",20,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",321,"","","","","","","","","","","","","","","","","","","","","","","","","","",85; leukemia: 25; lymphoma: 60,"","","","","","","","","","","","","","","","","","","","","","","","","","",100,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",506,mHR (overall);mHR (covid-specific) ,9.74; 7.59,4.77-19.92; 3.37-17.12,0.0053; 0.018,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",Hazard ratio for COVID-19 survival,3.70,1.77-7.73,<0.0001,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",64,12.6% ,"","","","","","","","","","","","","","","","","","","","","","","","","","",55,10.9%,"","","","","","","","","","","","","","","","","","","","","","","","","","",10,1.98%,"","","","","","","","","","","","","","","","","","","","","","","","","","",46,9.09%,"","","","","","","","","","","","","","","","","","","","","","","","","","",6,1.19%,"","","","","","","","","","","","","","","","","","","","","","","","","","",10,1.98%,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",Other: No
70896,Abuhelwa 2022,In-Hospital Mortality and Morbidity in Cancer Patients with COVID-19: A Nationwide Analysis from the United States.,Consensus,Peer-reviewed,Cancers,the Healthcare Cost and Utilization Project Nationwide Inpatient Sample (NIS) 2020 database,2022-12,"
In-Hospital Mortality and Morbidity in Cancer Patients with
COVID-19: A Nationwide Analysis from the United States
",Abuhelwa Z,Retrospective,Cohort,Yes,inpatient,USA,N/A,N/A,2020-01-01,2020-12-31,1050045,All-cause in-hospital mortality,"(i) morbidity as measured by the rates of septic shock, acute respiratory failure, acute respiratory distress syndrome, and mechanical ventilation (ii) resource utilization as measured by length of hospital stay and total hospitalization charges.",Severity; ICU admission; Mortality,no,"All cancer; active cancer, active treatment not stated",Patient with a COVID-19 diagnosis without a cancer diagnosis,"Matched; 27760:1022285; age, sex, race, comorbidities","",mean,70.92,95% CI,70.52-71.32,56.57,27760,mean,64.57,95% CI,64.41-64.74,52.7,1022285,Not mentioned,"",10110,36.42,273260,26.73,"","","",<0.001,19380,69.81,692565,67.75,"","","",<0.001,9585,34.53,419910,41.08,"","","","",6175,22.24,186725,18.27,"","","",<0.001,"","","","","","","","",1320,4.76,44360,4.34,"","","",0.151,4790,17.26,150100,14.68,"","","",<0.001,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",No mention of CVD. I put in numbers of coronary artery disease.,"","","","","","","",N/A,Mechanical ventilation,Mortality; all cause,N/A,multivariate,"Age; Sex; Comorbidities; Other: age, sex, race, admission type, admission day, hospital bed size, hospital teaching status, hospital region, insurance status, median annual income, and comorbidities.","",4400,mOR,1.57,1.31-1.88,<0.001,0.209 (920/4400),"","","","","","","","","","","","","",lung,"","","","","","","",3340,mOR,0.96,0.73-1.27,0.763,0.103 (345/3340),"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",1675,mOR,1.45,1.07-1.96,0.015,0.191 (320/1675),"","","","","","","","","","","","","",colorectal,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",4080,mOR,0.94,0.77-1.14,0.533,0.190 (775/4080),"","","","","","","","","","","","","",prostate,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",13495,"","","","",0.175 (2360/13495),"","","","","","","","","","","","","","","","","","","","","",13550,mOR;mOR;mOR,1.22;1.30;1.20,1.02-1.45;1.05-1.61;0.94-1.52,0.028;0.016;0.137,0.224;0.156;0.108,"","","","","","","","","","","","","",leukemia;lymphoma;multiple myeloma,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",27760,mOR,1.21,1.12-1.31,<0.001,0.176 (4880/27760),0.120 (122451/1022285),mOR(mechanical_ventilation),0.98,0.88-1.09,0.767,"","",OR,0.93, 0.8–1.07,0.31,0.499,0.522,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",no
70028,Sanchez-Pina 2020,Clinical course and risk factors for mortality from COVID-19 in patients with haematological malignancies,Consensus,Peer-reviewed,European Journal of Haematology,"",2020-07-20,Clinical course and risk factors for mortality from COVID-19 in patients with haematological malignancies,Sanchez-Pina JM,Retrospective,Cohort,Yes,inpatient and outpatient (no breakdown),Spain,Madrid,"Universitario “12 de Octubre”, Instituto de Investigación Sanitaria Hospital ",2020-03-07,2020-04-07,92,Mortality,"",Severity; Hospitalisation; ICU admission; Mortality,no,Haematological malignancy patients who are currently treated at a haematological unit. ,We also compared the outcome of this cohort of patients with a contemporaneous control population of patients with COVID-19 and similar characteristics but without haematological malignancies at our hospital,Matched; 39:53; age and severity at admission,"",Mean,64.7,Range,36-88,59,39,Mean,65.7,Range,41-89,62.3,53,Not mentioned,"","","","","","","","","",19,48.7,26,49.1,"","","",0.974,7,20,11,20.8,"","","",0.737,6,15.4,8,15.1,"","","",0.969,"","","","","","","","","","","","","","","","","","","","","","","","",2,5.1,9,17,"","","",0.083,"","","","","","","","","","","","","","","","",Thrombosis: 4,10.3,1,1.9,"","","",0.080,"","","","","","","","","Based on the WHO severity scale, patients were classified as mild, moderate and severe.","",53-day Mortality,"Based on the WHO severity scale, patients were classified as mild, moderate and severe.",univariate; multivariate,"Age; Sex; Comorbidities; Other: hypertension, therapy with ACE-I/ARB, need of oxygen therapy, severity/moderate disease, CRP on admission","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",39,uOR;mOR,3.680;6.652,1.314-10.305;1.868-23.688,0.013;0.003,0.359(14/39);0.359(14/39),0.132(7/53);0.132(7/53),"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",39,uOR;mOR,3.680;6.652,1.314-10.305;1.868-23.688,0.013;0.003,0.359(14/39);0.359(14/39),0.132(7/53);0.132(7/53),"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",4,10.3,"","","","",4/14 (0.286),"","","","","","","","","","","","","","","","","","","","","",12,30.8,"","","","",4/14 (0.286),"","","","","","","","","","","","","","","","","","","","","",Targeted 5; ITK 2; mAb 5; Proteasome inhibitor 7 ,Targeted 12.8; ITK 5.1; mAb 12.8; Proteasome inhibitor 17.9,"","","","",Targeted 0.143; ITK 0; mAb 0.714; Proteasome inhibitor 0.143,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",IMIDs 3,7.7,"","","","",0.143,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",yes
70019,Klein 2021,Impact of Cancer History on Outcomes Among Hospitalized Patients with COVID-19,Consensus,Peer-reviewed,The Oncologist,"Medical record at  Brigham and Women’s Hospital, Dana-Farber Cancer Institute, and Massachusetts General Hospital ",2021-05,Impact of Cancer History on Outcomes Among Hospitalized Patients with COVID-19,Klein I.A.,Retrospective,Cohort,Yes,inpatient,USA,Massachusetts,"Brigham and Women’s Hospital, Dana-Farber Cancer Institute, and Massachusetts General Hospital",2020-03-13,2020-05-10,401,death or hospice admission during hospitalization for COVID-19,intubation and admission to the intensive care unit (ICU),"ICU admission; Mortality; Other: Hospice admission, intubation",no,"Patients with a history of cancer were defined as those with a current diagnosis of, or a history of, invasive cancer or hematologic malignancy; patients with a history of noninvasive cancers, cutaneous squamous or basal cell carcinomas, or premalignant hematologic conditions were excluded.",Matched with the patients from the same databases (multi-hospital).,"Matched; 1:2; age, admission date, sex, race","",Median,69.0,range,30-98,56.2,77,Median,68.5,range,30-96,56.2,324,Not mentioned,"","","","","","","","","","","","","","","","","","","",132,40.7,"","","","","","",111,34.3,"","","","","","","","","","","","","","",12,3.7,"","","","","","",83,25.6,"","","","","","",59,18.2,"","","","","","",28,8.6,"","","","","","","","","","","","","","",48,14.8,"","","","","","","","","","","","","",[],In patient death or discharge to hospice; all cause,N/A,univariate; multivariate,Comorbidities,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",77,uOR;mOR,1.98; 2.18,0.99-3.96; 0.82-5.77,0.053; 0.12,"","",uOR;mOR,0.53; 0.39,0.29-0.96; 0.17-0.89,0.03; 0.03,"","",uOR;aOR,0.65;0.54,0.34-1.16;0.23-1.24,0.14;0.15,"","","Primary outcome is defined as ""mortality OR admission to hospice"". Severity defined as ARDS","","","","","","",Table 4 and 5,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",77 (100%),uOR;mOR,1.98; 2.18,0.99-3.96; 0.82-5.77,0.053; 0.12,"","",uOR;mOR,0.53; 0.39,0.29-0.96; 0.17-0.89,0.03; 0.03,"","",uOR;aOR,0.65;0.54,0.34-1.16;0.23-1.24,0.14;0.15,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",77,100%,uOR;mOR,1.98; 2.18,0.99-3.96; 0.82-5.77,0.053; 0.12,"","",uOR;mOR,0.53; 0.39,0.29-0.96; 0.17-0.89,0.03; 0.03,"","",uOR;aOR,0.65;0.54,0.34-1.16;0.23-1.24,0.14;0.15,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",no
70002,M 2021,Multivariate mortality analyses in COVID-19: Comparing patients with cancer and patients without cancer in Louisiana,Consensus,Peer-reviewed,Cancer,Ochsner Health System,2020-10 ,Multivariate Mortality Analyses in COVID-19: Comparing Patients With Cancer and Patients Without Cancer in Louisiana,Lunski MJ,Retrospective,cohort ,Yes,Other: non-specific,USA,Louisiana,"36 different hospitals and clinics across the state, which ranged from tertiary care centres to primary care office",2020-03-01,2020-04-30,5145,Mortality of patients,hospitalization,Hospitalisation; Mortality,no,"All types Cancer; < 5 years from therapy or no evidence of disease; chemo-, immuno or targeted therapy",Also from the same population - Ochsner’s electronic health record system (Epic),Matched; 1:15; not listed,"","","","","",45.5%,312,"","","","",38.7%,4833,Not mentioned,"","","","","","","","","",246,78.9%,1709,35.4%,aOR,0.60,0.47-0.78,"",116,37.2%,872,18.0%,aOR,0.92,0.70-1.21,"",34,10.9%,192,4.0%,aOR,1.43,0.99-2.08,"","","","","","","","","",10,3.2%,20,0.4%,aOR,"","","",80,25.6%,902,18.7%,aOR,3.84,2.98-4.93,"",35,11.2%,334,6.9%,aOR,1.34,0.96-1.88,"","","","","","","","","","","","","","","","","",143 (obesity),45.8%,2339,48.4%,aOR,1.30,1.03-1.63,"","","","","","","","","","","",no definition stated; covid-19 specific mortality,"",multivariate,Sex; Comorbidities,"",26 (lung),uOR,4.69,2.03-10.86,0.0003,0.308 (8/26),0.087 (418/4833),"","","","","","","","","","","","","","","","","","","","",70 ,uOR,1.36,0.65-2.87,0.425,0.114 (8/70),0.087 (418/4833),"","","","","","","","","","","","","","","","","","","","",32 (GI in general),uOR,1.96,0.75-5.11,0.174,0.156 (5/32),0.087 (418/4833),"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",74 (genitourinary),uOR,3.39,1.98-5.83,1.227E-05,0.243 (18/74),0.087 (418/4833),"","","","","","","","","","","","","","","","","","","","",13,uOR,0.88,0.11-6.79,1.084,0.077 (1/13),0.087 (418/4833),"","","","","","","","","","","","","","","","","","","","",2,uOR,"","","",0,"","","","","","","","","","","","","","","","","","","","","",8,uOR,3.52,0.71-17.50,0.126,0.250 (2/8),0.087 (418/4833),"","","","","","","","","","","","","","","","","","","","",3 (skin and soft tissue),uOR,5.28,0.48-58.37,0.178,0.333 (1/3),0.087 (418/4833),"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",251,uOR,2.43,1.74-3.39,2.687E-07,0.187 (47/251),0.087 (418/4833),"","","","","","","","","","","","","","","","","","","","",61,uOR,4.78,2.75-8.29,5.034E-08,0.311 (19/61),0.087 (418/4833),"","","","","","","","","","","","","","","","","","","","",23 (endocrine),uOR (endocrine),2.22 (endocrine),0.75-6.57,0.151,0.174 (4/23),0.087 (418/4833),"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",312,uOR;aOR,2.87;2.03,2.14-3.85;1.44-2.87,P < 0.0001;P < 0.0001,0.212 (66/312);0.212 (66/312),0.087 (418/4833);0.087 (418/4833),"","","","","","","","","","","","","",uOR,2.34,1.86-2.95,2.073E-12,0.503 (157/312),0.302 (1460/4833),no p values reported overall. In uOR it's self calculated,"",207,uOR,2.00,1.36-2.95,0.0004,0.159 (33/207),0.086 (418/4833),"","","","","","","","","","","","","","","","","","","","",48,uOR,4.80,2.59-8.91,1.020E-06,0.3125 (15/48),0.086 (418/4833),"","","","","","","","","","","","","","","","","","","","",18,"","","","","","","","","","","","","","","","","","","","","","","","","","","",19,6.1% (19/312),uOR,6.16,2.41-15.73,0.0002,36.8% (7/19),0.086 (418/4833),"","","","","","","","","","","","","","","","","","","","",51,16.3% (51/312),uOR,1.68,0.75-3.75,0.210,13.7% (7/51),0.086 (418/4833),"","","","","","","","","","","","","","","","","","","","",13,4.2% (13/312),uOR,4.69,1.44-15.31,0.011,30.8 (4/13),0.086 (418/4833),"","","","","","","","","","","","","","","","","","","","",2, 0.6% (2/312),"","","","",0%,0.086 (418/4833),"","","","","","","","","","","","","","","","","","","","",4,1.2% (4/312),"","","","",0%,0.086 (418/4833),"","","","","","","","","","","","","","","","","","","","",5,1.6% (5/312),"","","","",0%,0.086 (418/4833),"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",yes
69998,D 2021,"Prevalence, determinants, and outcomes of SARS-COV-2 infection among cancer patients. A population-based study in northern Italy",Consensus,Peer-reviewed,Cancer Medicine,"""For the aims of this investigation, the following data sources were used: microbiological laboratory records; hospital discharge database; Johns Hopkins Adjusted Clinical Group (ACG) system® database; cancer registry; diabetes registry; and municipal registries.""",2021-11,"Prevalence, determinants, and outcomes of SARS-COV-2 infection among cancer patients. A population-based study in northern Italy","Serraino, D",Retrospective,Cohort,Yes,not specified,Italy,Friuli Venezia Giulia (FVG) region (northeastern Italy),"",2020-02-26,2020-12-31,263042,"- Odds of positive COVID PCR result in cancer vs non-cancer patients;
- Risk of admission to ICU for COVID-positive cancer vs non-cancer patients (all-cause);
- Risk of death for COVID-positive cancer vs non-cancer patients (all-cause)","",ICU admission; Mortality,no,"Breast Cancer, Prostate Cancer, Colon Cancer, Skin Melanoma, Kidney Cancer, Lung and Larynx Cancer, Thyroid Cancer, Bladder Cancer, Endometrium Cancer, Non-Hodgkin Lymphomas, Leukaemia, Multiple Myeloma, Hodgkin Myeloma; diagnosed in last 3 months; active treatment not stated ",Controls recruited from the same data sources as cancer patients (microbiological laboratory records; hospital discharge database; Johns Hopkins Adjusted Clinical Group (ACG) system® database; cancer registry; diabetes registry; and municipal registries).,No Matching ,"","","","","",1452 (46.9),3098,"","","","",17876(46.7),38268,Not mentioned,"","","","","","","","","","","","","","","","","",650,21.0,3132,8.18,OR,2.98,2.71-3.27,"",1405,45.4,7205,18.8,OR,3.58,3.32-3.86,"","","","","","","","","","","","","","","","","","","","","","","","","",425,13.7,1986,5.19,OR,2.90,2.60-3.25,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","""The hospital discharge database (updated on 31 December 2021) was used to assess admissions to ICUs"" - no further information given re defining ICU admission",37 days; all cause ,"",multivariate,Age; Sex,"","","","","","","","","","","","","","","","","","","","","","","","","","","","",673,mHR,0.92,0.72-1.17,NR,0.104 (70/673),0.0500 (1914/38268),mHR,0.98,0.48-2.00,NR,0.0119 (8/673),0.013 (502/3826),"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",407,mHR,1.34,1.10-1.65,NR,0.241 (98/407),0.0500 (1914/38268),mHR,1.40,0.86-2.27,NR,0.0418 (17/407),0.013 (502/3826),"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",460,mHR,1.04,0.85-1.27,NR,0.235 (108/460),0.0500 (1914/38268),mHR,1.15,0.77-1.71,NR,0.0587 (27/460),0.013 (502/3826),"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2818,mHR,1.19,1.07-1.31,NR,0.172 (486/2818),0.0500 (1914/38268),mHR,1.04,0.82-1.32,NR,0.0291 (82/2818),0.013 (502/3826),"","","","","","","","","","","","","","",280,mHR,1.79,1.36-2.34,NR,0.193 (54/280),0.0500 (1914/38268),mHR,1.50,0.83-2.73,NR,0.0393 (11/280),0.013 (502/3826),"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",466,mHR,1.93,1.61-2.33,NR,0.255 (119/466),0.0500 (1914/38268),mHR,0.90,0.52-1.56,NR,0.0280 (13/466),0.013 (502/3826),"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",no
69989,Costa 2021,Higher severity and risk of in-hospital mortality for COVID-19 patients with cancer during the year 2020 in Brazil: A countrywide analysis of secondary data,Consensus,Peer-reviewed,Cancer,"Influenza Epidemiological Surveillance Information System (Sistema de Informação de Vigilância Epidemiológica da Gripe [SIVEP-Gripe] in Portuguese)
- publicly available online 
- retrieved on 2021-01-17",2021-08-03,Higher Severity and Risk of In-Hospital Mortality for COVID-19 Patients With Cancer During the Year 2020 in Brazil: A Countrywide Analysis of Secondary Data,Guilherme Jorge Costa,Retrospective,Cohort,Yes,inpatient,Brazil,N/A,N/A,2020-03-01,2020-12-31,322816,"ICU admission 
need for respiratory support (noninvasive vs invasive) 
time in ICU 
in-ICU mortality
hospital length of stay
in-hospital mortality ","",Severity; Hospitalisation; ICU admission; Mortality,no,All types of cancer; no definition active; active treatment not stated ,"Cancer:control matching = 7406 : 315410 

Drawn from same population of hospitalized adult patients w COVID19 diagnosis in Brazil ",Not matched ,"",Mean; median,66; 67,SD of mean; range of median,16; NR,52.6,7406,Mean; median,61; 62,SD of mean; range of median,145; NR,56.3,315410,Not mentioned,"","","","","","","","","","","","","","","","","",1561,33.1,85640,52.7,uOR,0.44,0.42-0.47,<0.001,2405,47.5,116738,67,uOR,0.45,0.42-0.47,<0.001,"","","","","","","","",146,3.6,3015,2.3,uOR,1.59,1.340-1.88,<0.001,460,10.8,14456,10.8,uOR,1.00,0.906-1.10,0.458,521,12.3,13162,9.8,uOR,1.29,1.176-1.42,<0.001,1846,39.6,7723,5.9,uOR,10.46,9.818-11.14,<0.001,"","","","","","","","",Obesity 257; neurological disease 320; asthma 129,6.3; 7.6; 3.1,20735;14020; 8833,15.6;10.4; 6.7,uOR; uOR;uOR,0.36; 0.71; 0.45,0.32-0.41; 0.631-0.80; 0.373-0.53,<0.001; <0.001; <0.001,"","","","","","","","",Need for respiratory support (noninvasive vs invasive),% admitted to ICU,All cause mortality ,Non invasive ventilation; invasive ventilation ,univariate; multivariate,Age; Comorbidities; Other: Males also adjusted fo,"","",mOR,2.9,NR,"","","","","","","","","","","","","","","","","","","","","","","","",mOR,1.4,NR,"","","","","","","","","","","","","","","","","","","","","","","","",mOR,2.9,NR,"","","","","","","","","","","","","","","","","","","","","","","","",mOR,1.4,NR,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",mOR of bladder; mOR of prostate,1.8; 1.1,NR; NR,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",uOR both sexes; mOR both sexes,2.59;1.83,2.46-2.72;1.72-1.95,<0.01;<0.01,"","","","","","","","","","","","","","","","","","","","","","","",uOR both sexes; mOR both sexes,3.27;2.85,2.86-3.80; 2.41-3.38,<0.01;<0.01,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",7406; 7406,uOR both sexes; mOR both sexes,2.66;1.94,2.54-2.80;1.83-2.06,<0.01;<0.01,Total in-hospital: 0.605 (4479/7406); NA,Total in-hospital: 0.365 (115066/315410); NA ,"","","","",0.427 (3159/7406),0.360 (113481/315410),cOR invasive ventilation; NR noninvasive ventilation,1.33; NR,1.25-1.40; NR,<0.001; NR,0.243 (1802/7406); 0.454 (3360/7406),0.191 (60197/315410; 0.455 (143446/315410),invasive resp support; Noninvasive resp support,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",7406; 7406,uOR;mOR,2.66;1.94,2.54-2.80;1.83-2.06,<0.01;<0.01,0.605 (4479/7406);0.605 (4479/7406),0.365 (115066/315410);0.365 (115066/315410),"","","","",0.427 (3159/7406),0.360 (113481/315410),% requiring noninvasive; % requiring invasive ventilation,"","","",0.454 (3360/7406);0.243 (1802/7406),0.455 (143446/315410);0.191 (60197/315410),Noninvasive resp support; invasive resp support,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",7406;7406,100;100,uOR;mOR,2.66;1.94,2.54-2.80;1.83-2.06,<0.01;<0.01,0.605 (4479/7406);0.605 (4479/7406),0.365 (115066/315410);0.365 (115066/315410),"","","","",0.427 (3159/7406),0.360 (113481/315410),% of those requiring noninvasive ventilation; % of those requiring  invasive ventilation,"","","",0.454 (3360/7406);0.243 (1802/7406),0.455 (143446/315410);0.191 (60197/315410),Noninvasive resp support; invasive resp support,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",yes
69975,Sahin 2021,The clinical outcomes of COVID-19 infection in patients with a history of thyroid cancer: A nationwide study,Consensus,Peer-reviewed,Clinical Endocrinology,Turkish Ministry of Health National Electronic Database,2021-04,The clinical outcomes of COVID- 19 infection in patients with a history of thyroid cancer: A nationwide study,Sahin M,Retrospective,Cohort,Yes,not specified,Turkey,N/A,"Public hospitals
University hospitals
Private centres",2020-03-11,2020-05-30,776,The primary endpoint was all-cause mortality.,The secondary outcomes were the length of stay in the hospital and admitted to the intensive care unit (ICU) or mechanical ventilation need during hospitalization.,Severity; Hospitalisation; ICU admission; Mortality,no,Thyroid Cancer; no definition of active;  active treatment not specified  ,"Yes, 1:1","Matched; 1:1, age, sex ","",Median,53,IQR,19,24,388,Median,53,IQR,19,24,388,Not mentioned,"",36,14.4,48,18.2,uOR,0.72,0.46 - 1.14,0.0166,246,63.4,203,52.3,uOR,1.58,1.18 - 2.10,0.00177,182,47.4,104,27.4,uOR,2.41,1.79 - 3.26,6.47 e-9,21,5.4,21,5.4,uOR,1,0.54 - 1.86,1,6,1.5,5,1.3,uOR,1.20,0.36 - 3.98,0.761,"","","","","","","","",15,9.9,18,11.9,uOR,0.83,0.41 - 1.66,0.594,133,34.3,116,29.9,uOR,1.22,0.90 - 1.65,0.191,"","","","","","","","","","","","","","","","",Dyslipidaemia; Obesity: 125; 24,32.2; 48.0,85; 16,21.9; 36.4,uOR,1.69; 1.53,1.23 - 2.34; 0.80 - 2.93,0.00123; 0.194,"","","","","","","","",n/a,"",All cause mortality ,Invasive ventilation ,univariate; multivariate,"Age; Sex; Comorbidities; Other: Multivariate analysis was only done for hospitalisation. The analysis adjusts for age, sex, pulmonary CT findings of COVID-19, hypertension, dyslipidemia, asthma/COPD, type 2 diabetes mellitus, cardiovascular disease (CVD), and thyroid cancer.","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",388,uOR,0.93,0.46 - 1.92,0.855,0.0387 (15/388),0.0412 (16/388),"uOR ICU; ICU > 4 days 
",0.84; 1.31,0.50 - 1.41; 0.48 - 3.56,0.511; 0.599,0.139 (29/208); 0.552 (16/ 29),0.119 (34/ 286); 0.485 (16/33),uOR,1.07,0.52 - 2.19,0.855,0.0770 (16/208),0.0524 (15/286),"",uOR Hospitalisation; uOR Hospitalisation > 8 days; mOR Hospitalisation,0.41; 0.62; 0.38,0.30 - 0.56; 0.46 - 0.84; 0.27 - 0.54,5.83e-9; 0.00203; <0.001,"0.536 (208/388); 0.495 (103/ 208); NA
 ",0.737 (286/388); 0.500 (143/286); NA,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",388,uOR,0.93,0.46 - 1.92,0.855,0.0387 (15/388),0.0412 (16/388),"uOR ICU; ICU > 4 days 
",0.84; 1.31,0.50 - 1.41; 0.48 - 3.56,0.511; 0.599,0.139 (29/208); 0.552 (16/ 29),0.119 (34/ 286); 0.485 (16/33),uOR,1.07,0.52 - 2.19,0.855,0.0770 (16/208),0.0524 (15/286),"",uOR Hospitalisation; uOR Hospitalisation > 8 days; mOR Hospitalisation,0.41; 0.62; 0.38,0.30 - 0.56; 0.46 - 0.84; 0.27 - 0.54,5.83e-9; 0.00203; <0.001,0.536 (208/388); 0.495 (103/ 208); NA,0.737 (286/388); 0.500 (143/286); NA,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",388,uOR,0.93,0.46 - 1.92,0.855,0.0387 (15/388),0.0412 (16/388),uOR ICU; ICU > 4 days ,0.84; 1.31,0.50 - 1.41; 0.48 - 3.56,0.511; 0.599,0.139 (29/208); 0.552 (16/ 29),0.119 (34/ 286); 0.485 (16/33),uOR,1.07,0.52 - 2.19,0.855,0.0770 (16/208),0.0524 (15/286),"",uOR Hospitalisation; uOR Hospitalisation > 8 days; mOR Hospitalisation,0.41; 0.62; 0.38,0.30 - 0.56; 0.46 - 0.84; 0.27 - 0.54,5.83e-9; 0.00203; <0.001,0.536 (208/388); 0.495 (103/ 208); NA,0.737 (286/388); 0.500 (143/286); NA,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",776,uOR,0.93,0.46 - 1.92,0.855,0.0387 (15/388),0.0412 (16/388),uOR ,0.84,0.50 - 1.41,0.511,0.139 (29/208),0.119 (34/286),uOR,1.07,0.52 - 2.19,0.511,0.0770 (16/208),0.0524 (15/286),"",uOR,0.41,0.30 - 0.56,5.83e-9,0.536 (208/388),0.737 (286/388),"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",72,18.556,cOR,0.66,0.15-2.95,0.589,"0.0278 (2/72)
",0.0412 (16/388),cOR ICU; ICU> 4 days,"1.00; 0.20
",0.37 - 2.72; 0.02 - 2.05,0.998; 0.146,0.119 (5/42); 0.200 (1/5),0.119 (34/286); 0.552 (16/29),cOR,"1.39
",0.38 - 5.02,0.614,0.0714 (3/42),0.0524 (15/286),"","cOR
hospitalisation; hospitalisation > 8 days",0.50; 1.00,0.30 - 0.84; 0.52 -1.91,0.00807; 1.00,0.583 (42/72); 0.500 (21/42),0.737 (286/388); 0.500 (143/286),"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",776,100,uOR,0.93,0.46 - 1.92,0.855,0.0387 (15/388),0.0412 (16/388),uOR,0.84,0.50 - 1.41,0.511,0.139 (29/208),0.119 (34/286),uOR,1.07,0.52 - 2.19,0.511,0.0770 (16/208),0.0524 (15/286),"",uOR,0.41,0.30 - 0.56,5.83e-9,0.536 (208/388),0.737 (286/388),"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",no
68513,S 2022,High mortality in patients with active malignancy and severe COVID-19: Results from an Austrian multicenter registry during the first period of the COVID-19 pandemic,Consensus,Peer-reviewed,Magazine of European medical oncology ,"",2022-05,"High mortality in patients with active malignancy and severe
COVID-19",Udovica S ,Retrospective,Cohort,Yes,inpatient,Austria ,Vienna ,"245 consecutive patients admitted for severe COVID-19 at four
different COVID-19 units in four different oncologic
departments in Austria. Non-cancer control from 
Department of Medicine I at
the Clinic Ottakring in Vienna ",2020/03/01,2021/03/31,245,covid-19 specific in hospital mortality ,"",Mortality,no,"Pa-
tients with active malignancy were defined through
one of the following criteria: (1) diagnosis of any
histologically proven malignant disease within the
last 6 months (excluding basalioma), (2) receiving
treatment for a malignant condition within the last
6 months, (3) metastatic or recurrent malignant disease.","Same country but different hospital 

This was a 12-month retrospective analysis of 245 consecutive patients admitted for severe COVID-19 at four
different COVID-19 units in four different oncologic
departments in Austria. The noncancer control group consisted of
patients admitted at the Department of Medicine I at
the Clinic Ottakring in Vienna for severe COVID-19
but had no history of cancer within the last 5 years","Matched; ratio cancer to noncancer 89:156; age, gender, comorbidity","",median ,74,range ,51-95,50.6,89,median ,76,range ,26-97,54.6,156,"Other: participants were not tested for strain but paper includes: "" Of
note, our study was performed between March 2020
and March 2021. In that period the SARS-CoV-2 back-
ground strain and the SARS-CoV-2 alpha variant were
the most commonly observed variants and vaccines
were not available.""","","","","","","","","","","","","","","","","","",14,15.7,45,28.8,cOR,0.46,0.24-0.9,"",47,52.8,71,45.5,cOR,1.34,0.79-2.26,"","","","","","","","","",10,11.2,10,6.4,cOR,1.85,0.74-4.63,"",10,11.2,16,10.3,cOR,1.11,0.48-2.56,"",22,24.7,24,15.4,cOR,1.81,0.94-3.46,"","","","","","","","","","","","","","","","","",17; 27; 8,19.1; 19.1; 9.0,49; 37; 35,31.4; 23.7; 22.6,cOR,0.52; 0.76; 0.34,0.28-0.97; 0.40-1.45; 0.15-0.77,"",others = obesity; neurological disease; dementia,others = obesity; neurological disease; dementia,others = obesity; neurological disease; dementia,others = obesity; neurological disease; dementia,"",others = obesity; neurological disease; dementia,others = obesity; neurological disease; dementia,I calculated crude OR and CI but have left p-values blank for James to calculate as discussed with him ,"","","Covid-19 specific in-hospital mortality defined as death during a COVID-19 infection requiring at least supplemental
oxygen ≥6 l/min; or with signs of pulmonary manifestations of COVID-19 on chest X-ray; or death in an
ICU due to respiratory or multiorgan failure. ","",univariate; multivariate; Other: Crude,Age; Comorbidities; Other: ECOG performance status,"",10,"","","","","","","","","","","","","","","","","","","","","","","","","","",9,"","","","","","","","","","","","","","","","","","","","","","","","","","",15,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",8,"","","","","","","","","","","","","","","","","","","","","","","","","","",4,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",5,"","","","","","","","","","","","","","","","","","","","","","","","","","",3,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",54,"","","","","","","","","","","","","","","","","","","","","","","","","","",35,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",89,uOR; mOR ,2.56; 4.59,1.47-4.47; 2.26-9.30,< 0.001; < 0.001,41/89; 41/89,43/156; 43/156,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",45,50.1,"","","","","","","","","","","","","","","","","","","","","","","","","","",5,5.6,"","","","","","","","","","","","","","","","","","","","","","","","","","",13,14.6,"","","","","","","","","","","","","","","","","","","","","","","","","","",5,5.6,"","","","","","","","","","","","","","","","","","","","","","","","","","",4,4.5,"","","","","","","","","","","","","","","","","","","","","","","","","","",9,10.1,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",245,100,"","","","","","","","","","","","","","","","","","","","","","","","","","","Of
note, our study was performed between March 2020
and March 2021. In that period the SARS-CoV-2 back-
ground strain and the SARS-CoV-2 alpha variant were
the most commonly observed variants and vaccines
were not available","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",245,100%,"","","","","","","","","","","","","","","","","","","","","","","","","",no
68304,R 2022,Changing characteristics of cancer patients during the COVID-19 pandemic,Consensus,Peer-reviewed,The Journal of Infection in Developing Countries,"Bakirkoy Dr. Sadi Konuk Training and Research 
Hospital centre database",2021-14,Changing characteristics of cancer patients during the COVID-19 pandemic,Korkusuz RK,Retrospective,Cohort,Yes,not specified,Turkey,N/A,"Bakirkoy Dr. Sadi Konuk Training and Research 
Hospital Centre",2020-03-15 ,2021-02-01,1793,"The aim of this retrospective study, conducted in the 
largest pandemic centre in Istanbul, was to evaluate 
how cancer patients were affected by COVID-19 
infection in the second wave of the pandemic in Turkey 
and to investigate the clinical course and factors 
affecting mortality.",ICU Admission and hospital length of stay(days),Hospitalisation; ICU admission; Mortality,no,All types of cancer; All patients had at least Stage 1 cancer; Active treatment not stated.,Same hospital ,No matching,"",Median,64,Range,18-97,64.35,216,Median,63,Range,21-103,58.17,1511,Not mentioned,"","","","","","","","","",31 (first wave); 71 (second wave); 102 (total),47 (first wave); 32.9 (second wave); 36.2 (total),nr (first wave); 726 (second wave); 726 (total),nr (first wave); 48.04 (second wave); 48.04 (total),"","","","",24 (first wave); 57 (second wave); 81 (total),36.4 (first wave); 26.4 (second wave); 28.7 (total),nr (first wave); 503 (second wave); 503 (total),nr (first wave); 33.28 (second wave); 33.28 (total),"","","","",2 (first wave); 15 (second wave); 17 (total),3 (first wave); 6.9 (second wave); 6.03 (total),nr; (first wave) 217 (second wave); 217 (total),nr (first wave); 14.36 (second wave); 14.36 (total),"","","","",5 (first wave); 9 (second wave); 14 (total),7.6 (first wave); 4.2 (second wave); 4.96 (total),nr (first wave); 53 (second wave); 53 (total),nr (first wave); 3.5 (second wave); 3.5 (total),"","","","","","","","","","","","",7 (first wave); 11 (second wave); 18 (total),10.6 (first wave); 5.1 (second wave); 6.38 (total),nr (first wave); 67 (second wave); 67 (total) ,nr (first wave); 4.43 (second wave); 4.43 (total),"","","","",17 (first wave); 34 (second wave); 51 (total),25.8 (first wave); 15.7 (second wave); 18.1 (total),nr (first wave); 62 (second wave); 62 (total),nr (first wave); 4.1 (second wave); 4.1 (total),"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",Severity of pneumonia as visualised on CT.,Admission to ICU,No definition stated,Pneumonia with >75% involvement of the lungs on CT.,univariate; multivariate,Age; Sex; Comorbidities,"",7 (first wave); 41 (second wave); 48 (total),"","","","",NR (first wave); NR (second wave); 0.375 (18/48) (total),nr (first wave); 0.0876 (133/1511) (second wave); 0.0876 (133/1511) (total),"","","","","","","","","","","","","","","","","","","","",11 (first wave); 21 (second wave); 32 (total),"","","","",nr (first wave); nr (second wave); 0.219 (7/32) (total),nr (first wave); 0.0876 (133/1511) (second wave); 0.0876 (133/1511) (total),"","","","","","","","","","","","","","","","","","","","",19 (first wave); 58 (second wave); 77 (total),"","","","",NR (first wave); NR (second wave); 0.338 (26/77) (total),nr (first wave); 0.0876 (133/1511) (second wave); 0.0876 (133/1511) (total),"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",12 (first wave); 31 (second wave); 43 (total),"","","","",NR (first wave); NR (second wave); 12/43 (0.279) (total),nr (first wave); 0.0876  (133/1511) (second wave); 0.0876 (133/1511) (total),"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",57 (first wave); 182 (second wave); 239 (total),"","","","",NR (first wave); NR (second wave); 0.318 (76/239) (total),nr (first wave); 0.0876  (133/1511) (second wave); 0.0876 (133/1511) (total),"","","","","","","","","","","","","","","","","","","","",9 (first wave); 34 (second wave); 43 (total),"","","","",nr (first wave); nr (second wave); 0.535 (23/43 ) (total),nr (first wave); 0.0876 (133/1511) (second wave); 0.0876 (133/1511) (total),"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",66 (first wave); 216 (second wave); 282 (total),"","","","",0.227 (15/66) (first wave); 0.389 (84/216) (second wave); 0.351 (99/282) (total),nr (first wave); 0.0876 (133/1511) (second wave); 0.0876 (133/1511) (total),"","","","",0.242 (16/66) (first wave); 0.361 (78/261) (second wave); 0.333 (94/282) (total),nr (first wave); 0.108 (164/1511) (second wave); 0.108 (164/1511) (total),"","","","",0.159 (10/66) (first wave); 0.243 (51/216) (second wave); 0.216 (61/282) (total),nr (first wave); 0.300 (455/1511) (second wave); 0.300 (455/1511) (total),"","","","","","","","","",51 (first wave); 104 (second wave); 155 (total),"","","","",nr (first wave); nr (second wave); 0.245 (38/155) (total),nr (first wave); 0.0876 (133/1511) (second wave) ; 0.0876 (133/1511) (total) ,"","","","","","","","","","","","",first wave; second wave; combined total,"","","","","","","",15 (first wave); 112 (second wave); 127 (total),"","","","",nr (first wave); nr (second wave); 0.480 (61/127) (total),nr (first wave); 0.0876 (133/1511) (second wave); 0.0876 (133/1511) (total),"","","","","","","","","","","","",first wave; second wave; combined total,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",22 (first wave); 97 (second wave); 119 (total),33.3 (first wave); 44.9 (second wave); 42.2 (total),"","","","",nr (first wave); nr (second wave); 0.445 (53/119) (total),nr (first wave); 0.0876 (133/1511) (second wave); 0.0876 (133/1511) (total),"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",no
68083,Y 2022,Characterizing cancer and COVID-19 outcomes using electronic health records,Consensus,Peer-reviewed,PLOS One,"Optum® de-identified COVID-19
Electronic Health Record (EHR)
Optum1’s longitudinal EHR repository is derived from more than 700
hospitals and 7000 clinics in the United States",2022-05,"Characterizing cancer and COVID-19
outcomes using electronic health records","Kim, YK ",Prospective,Cohort ,Yes,not specified,USA,N/A,N/A,2020-06-01,2020-12-31,"271,639","Our primary objective was to determine the effect of cancer on the outcomes of COVID-19,
specifically hospitalization, intensive care unit (ICU) admission, ventilator use, and all-cause
deaths occurring within 30 days of COVID-19 infection, by comparing these outcomes
between COVID-19 patients with and without a cancer diagnosis. ","The secondary objective
was to identify factors associated with mortality in COVID-19 patients with recent cancer
treatment. Potential predictors included chemotherapy and radiation therapy within 3 months
before the COVID-19, age, sex (not included for breast, endometrial, and prostate cancers),
race/ethnicity, insurance type, regions, and comorbidity conditions such as chronic conditions
identified and known risk factors ",Severity; Hospitalisation; ICU admission; Mortality,no,All types of cancer; Cancer diagnosed within one year before COVID diagnosis; Active treatment not stated.,"Yes
253,179 pts Non cancer: 18,460 cancer with 10,246 patients with a diagnosis of cancer within 1 year",Matched; No matching ratio; Not reported.,"",median,66,IQR,57-76,47.3,10426,median,46,IQR,32-60,42.7,253179,Not mentioned,"","","","","","","","","","","","","","","","","",3648,35.0,42542,16.8,"","","","",5183,49.7,49725,19.6,"","","","",1986,19.0,15599,6.2,"","","","",2338,22.4,18270,7.2,"","","","",2675,25.7,18145,7.2,"","","","",4402,42.2,62429,24.7,"","","","","","","","","","","","","","","","","","","","",Peripheral Vascular Disease: 2574,Peripheral Vascular Disease: 24.7,Peripheral Vascular Disease: 14708,Peripheral Vascular Disease: 5.8,"","","","","","","","","","","","",Ventilator use,Admitted to ICU is given as an outcome,30-day mortality; all-cause,Ventilator use,univariate; multivariate,Age; Sex; Comorbidities,"",887,mRR,1.85,1.58–2.17,<0.001,NR,0.019 (4854/253179),mRR,1.35,1.12–1.63,0.002,NR,0.025 (6449/253179),mRR,1.21,0.89–1.63,0.22,NR,0.011 (2855/253179),"",mRR,1.31,1.19-1.44,<0.001,NR,0.099 (25092/253179),"",2143,mRR,1.08,0.88–1.32,0.47,NR,0.019 (4854/253179),mRR,0.92,0.74–1.13,"0.409 
",NR,0.025 (6449/253179),mRR,1.06,0.78–1.45,0.70,NR,0.011 (2855/253179),"",mRR,"0.99  
",0.90–1.09,0.876 ,NR,0.099 (25092/253179),"","","","","","","","","","","","","","","","","","","","","","","","","","","","",794,mRR,0.91,0.69–1.19,"0.50 
",NR,0.019 (4854/253179),mRR,0.81,0.61–1.07,0.14,NR,0.025 (6449/253179),mRR,0.90,0.61–1.35,0.62,NR,0.011 (2855/253179),"",mRR,1.05  ,0.93–1.20,0.42,NR,0.099 (25092/253179),"",207 (liver); 121 (pancreas),mRR (liver); mRR (pancreas),2.46 (liver); 1.94 (pancreas),1.80–3.36 (liver); 1.19–3.16 (pancreas),<0.001 (liver); 0.008 (pancreas),NR (liver); NR (pancreas),0.019 (4854/253179) (liver); 0.019 (4854/253179) (pancreas),mRR (liver); mRR (pancreas),0.96 (liver);0.72 (pancreas),0.62–1.49 (liver); 0.35–1.46 (pancreas),"0.85 (liver); 0.363 (pancreas)
",NR (liver); NR (pancreas),0.025 (6449/253179) (liver); 0.025 (6449 /253179) (pancreas),mRR (liver); mRR (pancreas),1.14 (liver); 0.84 (pancreas),0.63–2.05 (liver); 0.33–2.12 (pancreas),0.67 (liver); 0.71 (pancreas),NR (liver); NR (pancreas),0.011 (2855/253179) (liver); 0.011 (2855/253179) (pancreas),"",mRR (liver); mRR (pancreas),1.23 (liver); 0.98 (pancreas),1.00–1.51 (liver); 0.71–1.35 (pancreas),0.05 (liver); 0.91  (pancreas),NR (liver); NR (pancreas),0.099 (25092/253179) (liver); 0.099 (25092/253179) (pancreas),"",474,mRR,1.15,0.86–1.53,0.34,NR,0.019 (4854/253179),mRR,0.80,0.57–1.13,0.202,NR,0.025 (6449/253179),mRR,0.79,0.49–1.30,0.36,NR,0.011 (2855/253179),"",mRR,1.06  ,0.91–1.22,0.46,NR,0.099 (25092/253179),"","1781
",mRR,0.82,0.70–0.96,0.015,NR,0.019 (4854/253179),mRR,0.81,0.68–0.96,0.017,NR,0.025 (6449/253179),mRR,0.78,0.60–1.01,0.055,NR,0.011 (2855/253179),"",mRR,0.95,"0.88–1.02
",0.177,NR,0.099 (25092/253179),"",291,mRR,1.62,0.96–2.74,0.07,NR,0.019 (4854/253179),mRR,1.58,1.03–2.41,0.04,NR,0.025 (6449/253179),mRR,1.53,0.81–2.90,0.19,NR,0.011 (2855/253179),"",mRR,"1.15 
",0.90–1.46,0.27,NR,0.099 (25092/253179),"","","","","","","","","","","","","","","","","","","","","","","","","","","","",476,mRR,0.83,0.46–1.51,"0.55 
",NR,0.019 (4854/253179),mRR,0.58,0.30–1.11,"0.10 
",NR,0.025 (6449/253179),mRR,0.38 ,0.12–1.19,0.10,NR,0.011 (2855/253179),"",mRR,0.76   ,0.59–0.9,0.035,NR,0.099 (25092/253179),"",409,mRR,0.96,0.67–1.38,0.82,NR,0.019 (4854/253179),mRR,0.89,0.57–1.38,0.61,NR,0.025 (6449/253179),mRR,0.58,0.27–1.27,0.177,NR,0.011 (2855/253179),"",mRR,"0.86 
",0.69–1.06,0.163,NR,0.099 (25092/253179),"","","","","","","","","","","","","","","","","","","","","","","","","","","","",8952,mRR,"1.12 
",1.04–1.22,0.004,NR,0.019 (4854/253179),mRR,0.97,0.89–1.06,0.52,NR,0.025 (6449/253179),mRR,0.95,0.84–1.08,0.453,NR,0.011 (2855/253179),"",mRR,1.05,1.00–1.09,0.03,NR,0.099 (25092/253179),"",2224,mRR,1.48 , 1.30–1.68,<0.001 ,NR,0.019 (4854/253179),mRR,1.27,1.10–1.46,0.001,NR,0.025 (6449/253179),mRR,1.41,1.16–1.72,0.001,NR,0.011 (2855/253179),"",mRR,1.31 ,1.22–1.40, <0.001 ,NR,0.099 (25092/253179),"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",10426,mRR,1.17,1.08-1.25,<0.001,0.075 (781/10426),0.019 (4854/253179),mRR,1.02,0.95-1.11,0.54,0.065 (674/10426),0.025 (6449/253179),mRR,1.05,0.93-1.17,0.45,0.032 (332/10426),0.011 (2855/253179),"",mRR,1.10,1.06-1.14,<0.001,0.24 (2476/10426),0.099 (25092/253179),"","","","","","","","","","","","","","","","","","","","","","","","","","","","","",1580,mRR,2.09,1.82–2.39,<0.001,NR,0.019 (4854/253179),mRR,1.33,1.13–1.56,0.001,NR,0.025 (6449/253179),mRR,1.32,1.04-1.68,0.021,NR,0.011 (2855/253179),"",mRR,"1.26  
",1.16–1.37,<0.001 ,0.24 (2476/10426),0.099 (25092/253179),"","","","","","","","","","","","","","","","","","","","","","","","","","","","","",NR,NR,uRR; mRR,1.31; 1.37 ,"1.08-1.60; 1.12–1.69
",0.006; 0.003,NR; NR,0.019 (4854/253179); 0.019 (4854/253179),"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",NR,NR,uRR; mRR,"1.89; 1.83 
",1.44-2.49; 1.37–2.46,<0.001; <0.001,NR; NR,0.019 (4854/253179); 0.019 (4854/253179),"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",no
67898,H 2022,Outcomes of Patients With Active Cancer and COVID-19 in the Intensive-Care Unit: A Multicenter Ambispective Study,Consensus,Peer-reviewed,Frontiers in Oncology ,"",2022-03,"
Outcomes of Patients With Active
Cancer and COVID-19 in the
Intensive-Care Unit: A Multicenter
Ambispective Study",Plais H,Prospective,Cohort,Yes,inpatient,France,17 French ICUs,17 French ICUs,2020-03-12,2021-03-08,409,Mortality at day 60 after ICU admission ,"",Mortality,no,"All types cancer; Treatment (including chemotherapy, targeted therapy, immunotherapy, radiotherapy, or surgery) administered within 6 months, or active surveillance within 6 months of ICU admission, or haematological cancer that is not in complete remission; Active treatment not stated. ",Adult patients admitted to participating ICUs without active canceras per above definition. Same cohort/hospitals/country. ,"Matched; 1:3; age, antimicrobial treatment, BMI, chronic respiratory disease, congestive heart failure, hospitalisation within the last 3 months, diabetes, HIV, immunosuppressive therapy, PaO2 at baseline, SAPS II and SOFA scores, sex, organ transplant","",Mean,69,NR,65-73,68.6,105,Mean,67,NR,59-75,69.4,315,Not mentioned,"","","","","","","","","","","","","","","","","",24,22.9,107,34,"","","","",10,9.5,29,9.2,"","","","","","","","","","","","",1,1,8,2.5,"","","","",12,11.4,32,10.2,"","","","",8,7.6,12,3.8,"","","","",26,24.8,17,5.4,"","","","","","","","","","","","",3 (HIV); 1 (solid organ transplantation),2.9 (HIV); 1 (solid organ transplantation),6 (HIV); 11 (solid organ transplantation),1.9 (HIV); 3.5 (solid organ transplantation),"","","","","","","","","","","","","","",60-day mortality after ICU admission; All-cause,"",univariate; multivariate,"Age; Other: Cancer type, norepinephrine use, antimicrobial treatment, treatment with hydroxychloroquine and azithromycin, age at admission, period of admittance based on definition 1st and 2nd waves of SARS-Cov-2 in France","",12,"","","","","","","","","","","","","","","","","","","","","","","","","","",6,"","","","","","","","","","","","","","","","","","","","","","","","","","",8,"","","","","","","","","","","","","","","","","","",Includes hepatobiliary cancers,"","","","","","","",10,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",Grouped with upper GI ,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2,"","","","","","","","","","","","","","","","","","","","","","","","","","",2,"","","","","","","","","","","","","","","","","","","","","","","","","","",1,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",54,uOR; mOR,1.88; 2.344,0.82-4.27; 0.87-6.31,0.13; 0.0262,NR; NR,0.274 (86/315); 0.274 (86/315),"","","","","","","","","","","","","","","","","","","","",51,uOR; mOR,3.19; 4.144,1.38-7.37; 1.24-13.83,0.0065; 0.0262,NR; NR,0.274 (86/315); 0.274 (86/315),"","","","","","","","","","","","","","","","","","","","",Endocrine: 2 ,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",105,uOR,2.3,1.24-4.28,0.0082,0.562 (59/105),0.274 (86/315),"","","","","","","","","","","","","","","","","","","","","",31,"","","","","","","","","","","","","","","","","","","","","","","","","","",23,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",420,100,uOR,2.3,1.24-4.28,0.0082,0.562 (59/105),0.274 (86/315),"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",yes
67363,E 2021,Endothelial activation and stress index (Easix) as an early predictor for mortality and overall survival in hematological and non-hematological patients with covid-19: Multicenter cohort study,Consensus,Peer-reviewed,Journal of Clinical Medicine,"",2021-09,Endothelial Activation and Stress Index (EASIX) as an Early Predictor for Mortality and Overall Survival in Hematological and Non-Hematological Patients with COVID-19: Multicenter Cohort Study,Kalicinska E.,Retrospective,Cohort,Yes,inpatient,Poland,"","Department and Clinic of Hematology, Blood Neoplasms and Bone
Marrow Transplantation of Wroclaw Medical University
Department of Internal Medicine,
Pneumology and Allergology of Wroclaw Medical University
Experimental Hematooncology Department of Medical University in Lublin
Department of Infectious Diseases
and Hepatology of Wroclaw Medical University
Department of Hematology of Collegium
Medicum in Bydgoszcz
Department of Hematology and Bone Marrow Transplantation SSM Nicolaus Copernicus in Torun
Department of Hematology, Transplantation and
Internal Medicine, Medical University of Warsaw",2020-03,2021-03,523,Overall survival time (time from COVID-19 diagnosis to death or last contact),"In-hospital mortality
COVID-19 severity 
Time of hospitalisation (duration)",Severity; Hospitalisation; Mortality,no,"Patients with haematological cancers were selected; these were further divided into 5 groups: (1) acute leukemia/MDS EB-2, (2) chronic lymphocytic leukemia/indolent
lymphoma, (3) aggressive lymphoma, (4) multiple myeloma and (5) other",Ratio of cancer:control is 125:398. Patients with SARS-CoV-2 infection without hematological cancer.,No matching.,"",Median,62,IQR,48-70,64,125,Median,66,IQR,56-77,51,398,Not mentioned,"","","","","","","","","",60,48,181,46,"","","",0.622,25,20,60,15,"","","",0.194,"CAD: 11
CHF: 50
Supraventricular arrhythmia: 14","CAD: 9
CHF: 13
Supraventricular arrhythmia: 11","CAD: 98
CHF: 7
Supraventricular arrhythmia: 36","CAD: 25
CHF: 6
Supraventricular arrhythmia: 9","","","","CAD: <0.001
CHF: 0.029
Supraventricular arrhythmia: 0.459","","","","","","","","","","","","","","","","",17,14,19,5,"","","",0.001,4,3,21,5,"","","",0.343,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","Severity is not clearly defined, although there are definitions for asymptomatic, mild, moderate, severe, and critical diseases.","Critical disease is defined
as respiratory failure, septic shock and/or multiple organ dysfunction [12].","Mortality was defined as in-hospital mortality
Follow-up period was 6 months","Asymptomatic COVID-19 infection is defined as a positive SARS-CoV-2 test without symptoms consistent with COVID-19.
Mild illness is defined as the presence of any signs and/or symptoms of COVID-19 but without shortness of breath, dyspnea or abnormal chest imaging. 
Moderate illness is defined as evidence of lower respiratory disease during clinical assessment or imaging and oxygen saturation of (SpO2) >94% in room
air. 
Severe illness is defined as saturation below 94% in room air, a ratio of arterial
partial pressure of oxygen to fraction of inspired oxygen (PaO2/FiO2) <300 mmHg, respiratory frequency >30 breaths/min or lung infiltrates >50%. 
Critical disease is defined as respiratory failure, septic shock and/or multiple organ dysfunction. ",multivariate,Other: Not specified,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",125,RR,"","",<0.001,46/125,90/398,"","","","","","",RR,"","",Asymptomatic: 0.006; Mild: 0.001; Moderate: 0.062; Severe: 0.003; Critical: 0.089,Asymptomatic: 13/125; Mild: 23/125; Moderate: 23/125; Severe: 43/125; Critical: 23/125,Asymptomatic: 15/398; Mild: 30/398; Moderate: 106/398; Severe: 197/398; Critical: 49/398,"Time of hospitalisation in days, median (IQR):
Cancer: 11 (1-20)
Non-cancer: 19 (9-16)
p: 0.094","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",no
67144,N 2021,Clinical Course of Cancer Patients With COVID-19: A Retrospective Cohort Study,Consensus,Peer-reviewed,JNCI Cancer Spectrum,"We used anonymous data from the Mount Sinai Health System
(MSHS) COVID-19 registry, which includes all patients with an
encounter at a MSHS facility who were diagnosed with, under
investigation, or screened for COVID-19",2020-11,"Clinical Course of Cancer Patients With COVID-19: A Retrospective
Cohort Study",Alpert N,Retrospective,Cohort ,Yes,inpatient and outpatient (no breakdown),USA ,New York ,Mount Sinai Hospital ,2020/03/01 ,2020/05/27,5556,"sepsis, venous thromboembolism, acute kidney injury, intensive care unit admission, all-cause mortality.","",Severity; ICU admission; Mortality,no,"All Types Cancer; newly diagnosed cancer or on active treatment 

","matched for gender, age, comorbidity ","Matched;
ratio cancer:non cancer 421:5135; age, gender, comorbidity ","",Mean,69.2,SE,0.7,59.4,421,Mean ,63.8,SE,0.2,56.6,5135,Not mentioned,"","","","","","","","","",223,53,1677,32.7,cOR,2.32,1.9-2.84,"",139,33,1138,22.2,cOR,1.73,1.4-2.14,"",177,42,1300,25.3,cOR,2.14,1.75-2.62,"","","","","","","","","",26,6.2,107,2.1,cOR,3.09,1.99-4.81,"",70,16.6,566,11,cOR,1.61,1.23-2.11,"",64,15.2,427,8.3,cOR,1.98,1.49-2.63,"","","","","","","","","","","","","","","","","",43,10.2,388,7.6,cOR,1.39,1.00-1.94,"","Chronic lung disease = COPD + Asthma

CVD = HF + AF + coronary artery disease 

Others = Obesity",Others = Obesity,Others = Obesity,Others = Obesity,"",Others = Obesity,Others = Obesity ,"Chronic lung disease = COPD + Asthma

CVD = HF + AF + coronary artery disease 

Others = Obesity

I calculated crude OR and CI and have left p-values for James as discussed ","sepsis defined as more than 1 of the following; temperature greater than 100.4 degrees F; heart rate greater than 90 beats per minute; respiratory rate greater than 20 breaths per
minute; white blood cell count less than 4000 or greater than 12 000 cells/lL","ICU defined as intensive care unit, no other info given ",all cause,"sepsis defined as more than 1 of the following; temperature greater than 100.4 degrees F; heart rate greater than 90 beats per minute; respiratory rate greater than 20 breaths per
minute; white blood cell count less than 4000 or greater than 12 000 cells/lL",multivariate; Other: Crude,Age; Sex; Comorbidities,"",19,"","","","","","","","","","","","","","","","","","","","","","","","","","",46,"","","","","","","","","","","","","","","","","","","","","","","","","","",5,"","","","","","","","","","","","","","","","","","","","","","","","","","",32,"","","","","","","","","","","","","","","","","","","","","","","","","","",32,"","","","","","","","","","","","","","","","","","","","","","","","","","",13,"","","","","","","","","","","","","","","","","","","","","","","","","","",81,"","","","","","","","","","","","","","","","","","","","","","","","","","",20,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",10,"","","","","","","","","","","","","","","","","","","","","","","","","","",15,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",273,"","","","","","","","","","","","","","","","","","","","","","","","","","",96,"","","","","","","","","","","","","","","","","","","","","","","","","","",26,"","","","","","","","","","","","","","","","","","","","","","","","","","",26,"","","","","","","","","","","","","","","","","","","","","","","","","","",421,mOR,1.02 ,0.81-1.29,0.86,129/421,1272/5135,mOR,1.04,0.80-1.34,1.0,82/421,913/5135,mOR ,1.31,1.06-1.61,0.05,253/421,2821/5135,"the paper did not specify severity, but specified sepsis which I have included in the severity column 

unspecified = multiple sites ","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",421,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",5556,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",5556,"","","","","","","","","","","","","","","","","","","","","","","","","","",no
67122,M 2022,Outcomes of SARS-CoV-2 infection in cancer versus non-cancer-patients: A population-based study in northeastern Italy,Consensus,Peer-reviewed,Tumori Journal,Regional Population-Based Cancer Registries,2021-12,Outcomes of SARS-CoV-2 infection in cancer versus non-cancer-patients: A population-based study in northeastern Italy,Rugge M,Retrospective,cohort,Yes,Other: Inpatient and outpatient (with breakdown),Italy,Veneto and Friuli Venezia Giulia,"",2020-02-22,2020-07-31,21101,"Patients’ hospitalization (whatever the clinical setting, other than the intensive care unit [ICU]) and admission to an ICU",Vital status (mortality),Hospitalisation; ICU admission; Mortality,no,All Types Cancer; Diagnosed ≤12 months before testing positive for COVID-19; Active treatment not stated,The resident population of the Veneto and Friuli Venezia Giulia regions (in North-Eastern Italy) who tested positive for SARS-CoV-2 without a history of cancer,No matching; No matching ratio,"",Median,73,IQR,62-82.25,53.4,324,Median,51,IQR,36-66,40.1,20777,Not mentioned,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",No definition stated,"",multivariate; Other: Crude,Age; Sex; Comorbidities,"",23 (lung),uOR,7.19,3.15-16.42,3.987E-06,0.435 (10/23),0.097 (2008/20777),uOR,1.24,0.17-9.22,0.845,0.001 (1/23),0.035 (734/20777),"","","","","","","",uOR,9.18,3.31-25.50,2.663E-05,0.737 (14/19),0.234 (4685/20047),Lung,34,uOR,1.61,0.62-4.17,0.333,0.147 (5/34),0.097 (2008/20777),"","","","",0.000 (0/34),0.035 (734/20777),"","","","","","","",uOR,1.82,0.84-3.95,0.131,0.357 (10/28),0.234 (4685/20047),Breast,"","","","","","","","","","","","","","","","","","","","","","","","","","","",34 (colorectal),uOR,5.10,2.52-10.32,7.996E-06,0.353 (12/34),0.097 (2008/20777),uOR,4.71,1.82-12.20,0.0015,0.147 (5/34),0.035 (734/20777),"","","","","","","",uOR,3.53,1.66-7.52,0.0011,0.519 (14/27),0.234 (4685/20047),Colorectal,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","63 (prostate, urology)",uOR,3.74,2.16-6.47,3.482E-06,0.286 (18/63),0.097 (2008/20777),uOR,1.85,0.67-5.11,0.240,0.063 (4/63),0.035 (734/20777),"","","","","","","",uOR,3.17,1.90-5.29,1.293E-05,0.492 (29/59),0.234 (4685/20047),Urinary Bladder+Prostate,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",41,uOR,8.07,4.36-14.94,9.317E-11,0.463 (19/41),0.097 (2008/20777),uOR,1.40,0.34-5.81,0.659,0.049 (2/41),0.035 (734/20777),"","","","","","","",uOR,8.53,4.11-17.69,1.790E-08,0.722 (26/36),0.234 (4685/20047),"",129,uOR,4.35,3.00-6.33,7.188E-14,0.318 (41/129),0.097 (2008/20777),uOR,1.33,0.59-3.03,0.508,0.047 (6/129),0.035 (734/20777),"","","","","","","",uOR,3.92,2.65-5.81,3.303E-11,0.545 (55/101),0.234 (4685/20047),Others,"","","","","","","","","","","","","","","","","","","","","","","","","","","",324,uOR;mOR,4.48;3.013,3.535-5.681;2.290-3.949,<0.001; NR,0.324 (105/324); 0.324 (105/324),0.097 (2008/20777); 0.097 (2008/20777),uOR;mOR,1.61;1.049,0.993-2.599;0.621-1.664,0.053; NR,0.056 (18/324); 0.056 (18/324),0.035 (734/20777); 0.035 (734/20777),"","","","","","","",uOR;mOR,4.22;2.883,3.30-5.40;2.215-3.762,<0.001; NR,0.562 (198/263); 0.562 (198/263),0.234 (4685/20047); 0.234 (4685/20047),"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",yes
66861,M 2022,Evaluation of COVID-19 Mortality and Adverse Outcomes in US Patients with or Without Cancer,Consensus,Peer-reviewed,JAMA Oncology,"Optum de-identified COVID-19 electronic health record data set, which contains data from more than 700 hospitals and 7000 clinics across the US.",2022-01,Evaluation of COVID-19 Mortality and Adverse Outcomes in US Patients With or Without Cancer,Chavez-MacGregor M,Retrospective,Cohort,Yes,inpatient and outpatient (with breakdown),USA,N/A,N/A - but included >700 hospitals in the US,2020-01-01,2021-01-28,507307,"30-day Mortality, 30-day Mechanical ventilation, 30-day ICU stay, 30-day Hospitalisation","30-day Mechanical ventilation, 30-day ICU stay, 30-day Hospitalisation",Severity; Hospitalisation; ICU admission; Mortality,no,"Used the following ICD criteria from electronic health records: 
ICD-9: 140-165, 170-176, 179-209, 239 
ICD-10: C00-C26, C30-C41, C43, C45-C58, C60-C80, C7A, C7B, C81-C96, D37-D47. 

Cancer group was split into: (a) patients receiving treatment (radiotherapy or systemic therapy) <3 months before COVID diagnosis, and (b) patients not receiving recent treatment.

Both groups are included in our review given that all cancer patients had to have at least two ICD codes for cancer within 1 year before COVID diagnosis.",Controls drawn from the same data source (Optum COVID-19 electronic health record data set) - so from the same >700 hospitals and the same >7000 clinics across the US.,"Matched; 1:5; age, sex, comorbidities","",Median,"With recent cancer treatment: 66;
Without recent cancer treatment: 68",IQR,"With recent cancer treatment: 57-75;
Without recent cancer treatment: 59-77",47.9,14287,Median,48,IQR,32-61,44.5,493020,Not mentioned,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",1547 (Severe obesity (BMI ≥40)),10.8 (Severe obesity (BMI ≥40)),50115 (Severe obesity (BMI ≥40)),10.2 (Severe obesity (BMI ≥40)),uOR (Severe obesity (BMI ≥40)),1.07 (Severe obesity (BMI ≥40)),1.02-1.13 (Severe obesity (BMI ≥40)),"","","","","","","","","",no definition stated,"ICU admission within 30-days of positive COVID test. Identified from the following electronic health record codes: 0200 - General classification ICU, 0201 - Surgical ICU, 0202 - Medical ICU, 0203 - Pediatric ICU, 0204 - Psychiatric ICU, 0206 - Intermediate ICU, 0207 - Burn care, 0208 - Trauma care, 0209 - Other intensive care, 0210 - General classification cardiac care unit (CCU), 0211 - Myocardial infarction care, 0212 - Pulmonary care, 0213 - Heart transplant, 0214 - Intermediate CCU, 0219 - Other coronary care.",30 day mortality; covid-19 specific mortality,30-day Mechanical ventilation,multivariate,"Age; Sex; Comorbidities; Other: race, diagnosis period, skilled nurse facility, insurance, geographical region","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",14287,aOR (No recent treatment);aOR (recent treatment),0.93 (No recent treatment);1.74 (Recent treatment),0.84-1.02 (No recent treatment);1.54-1.96 (Recent treatment),0.12 (No recent treatment);<0.001 (Recent treatment),0.049 (No recent treatment);0.087 (Recent treatment),0.016 (7888/493020);0.016 (7888/493020),aOR (No recent treatment);aOR (recent treatment),0.98 (No recent treatment);1.69 (Recent treatment),0.91-1.06 (No recent treatment);1.54-1.87 (Recent treatment),0.61 (No recent treatment);<0.001 (Recent treatment),0.075 (749/9991) (No recent treatment);0.137 (589/4296) (Recent treatment),0.033 (16270/493020);0.033 (16270/493020),aOR (No recent treatment);aOR (recent treatment),0.61 (No recent treatment);1.00 (recent treatment),0.54-0.68 (No recent treatment);0.88-1.13 (recent treatment),<0.001 (No recent treatment);0.94 (recent treatment),"0.038 (380/9991) (No recent treatment);
0.073 (314/4296) (recent treatment)",0.022 (10846/493020);0.022 (10846/493020),No recent treatment;Recent treatment,aOR (No recent treatment);aOR (recent treatment),0.79;1.19,0.75-0.83;1.11-1.27,<0.001;<0.001,0.251 (2508/9991);0.357 (1534/4296),0.146 (71981/493020);0.016 (7888/493020),No recent treatment;recent treatment,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","Chemotherapy: 1634;
Chemo-immunotherapy: 195","Chemotherapy: 11.4; 
Chemo-immunotherapy: 1.4","","","","","","","","","","","","","","","","","","","","","","","","","","",Targeted therapy or endocrine therapy: 1068,Targeted therapy or endocrine therapy: 7.5,"","","","","","","","","","","","","","","","","","","","","","","","","","",Targeted therapy or endocrine therapy: 1068,Targeted therapy or endocrine therapy: 7.5,"","","","","","","","","","","","","","","","","","","","","","","","","","",592,4.1,"","","","","","","","","","","","","","","","","","","","","","","","","","",806,5.6,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",no
66531,C 2021,One-year mortality and consequences of COVID-19 in cancer patients: A cohort study,Consensus,Peer-reviewed,IUBMB Life,"",2021-07,One-year mortality and consequences of COVID-19 in cancer patients: A cohort study,Chai C,Prospective,cohort,Yes,inpatient,China,"Wuhan, Hubei Province","Union Hospital, Affiliated Dongfeng Hospital, The Central
Hospital of Wuhan",2020-01-01,2020-03-18,664,1-year all-cause mortality rate and sequelae,"hospital mortality rate, the length of hospital stay, and the 12-month all-cause post-discharge mortality rate",Severity; Mortality,no,All Types Cancer; Active cancer defined as patients who received treatment for cancer in the past year; Treatment for cancer within the past year,Patients without cancer from the same COVID-19 positive population,"Matched; 1:3; age, sex","",Median,65,IQR,59-70,49,166,Median,65,IQR,59-70,49,498,Not mentioned,"",8,5,14,3,"","","","",55,33,171,34,"","","","",24,15,104,21,"","","","",12,7,40,8,"","","","",4,2,18,4,"","","","",5,3,7,1,"","","","",3,2,11,2,"","","","",11,7,25,5,"","","","","","","","","","","","","","","","","","","","",Hyperlipidemia 33,20,76,15,"","","","",Hyperuricemia 16,10,42,8,"","","","",Defined according to World Health Organization (WHO) guidelines,Not given,1-year mortality; All-cause,"Fever or suspected respiratory infection, plus one of respiratory rate >30 breaths/min, severe respiratory 
distress, or SpO2 <90% on room air",Other: Crude,"","",25,uOR (lung),2.07,0.68-6.31,0.205,0.16 (4/25),0.084 (42/498),"","","","","","","","","","","","","","","","","","","","",19,uOR,1.28,0.28-5.72,0.764,0.105 (2/19),0.084 (42/498),"","","","","","","","","","","","","","","","","","","","",10,uOR (gastric),10.86,3.02-39.02,0.0003,0.500 (5/10),0.084 (42/498),"","","","","","","","","","","","","","","","","","","","",23,"uOR (colon, rectal)",3.02,1.07-8.53,0.038,0.217 (5/23),0.084 (42/498),"","","","","","","","","","","","","","","","","","","","",9,"uOR (liver, pancreas)",3.10,0.62-15.41,0.1693,0.222 (2/9),0.084 (42/498),"","","","","","","","","","","","","","","","","","","","",5,uOR,2.71,0.30-24.84,0.3867,0.200 (1/5),0.084 (42/498),"","","","","","","","","","","","","","","","","","","","",17,"uOR (prostate, bladder, penile, testicular)",1.45,0.32-6.55,0.6467,0.118 (2/17),0.084 (42/498),"","","","","","","","","","","","","","","","","","","","",16,"uOR (cervical, ovary, endometrial)",0.72,0.09-5.62,1.1958,0.063 (1/16),0.084 (42/498),"","","","","","","","","","","","","","","","","","","","",2,uOR (brain),10.86,0.67-176.73,0.095,0.500 (1/2),0.084 (42/498),"","","","","","","","","","","","","","","","","","","","",4,uOR (nasopharyngeal),10.86,1.49-79.05,0.0189,0.500 (2/4),0.084 (42/498),"","","","","","","","","","","","",nasopharyngeal,"","","","","","","",1,"","","","",1.000 (1/1),0.084 (42/498),"","","","","","","","","","","","","","","","","","","","",4,"","","","",0.000 (0/4),0.084 (42/498),"","","","","","","","","","","","","","","","","","","","",149,uOR,2.30,1.35-3.89,0.0022,0.174 (26/149),0.084 (42/498),"","","","","","","","","","","","","","","","","","","","",17,uOR,9.65,3.54-26.32,<0.001,0.471 (8/17),0.084 (42/498),"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",166,uOR,2.80,1.71-4.57,<0.0001,0.204 (34/166),0.084 (42/498),"","","","","","",uOR,2.28,"","",0.361 (60/166),0.199 (99/498,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",no
66333,B 2021,COVID-19 amongst cancer patients: An experience from Oman,Consensus,Peer-reviewed,Journal of the Pakistan Medical Association,"For Cancer: Cancer Registry of The Directorate-General of Non-Communicable Diseases, Ministry of Health, Oman.
For COVID-19: Coronavirus Registry of Oman.",2021-10,COVID-19 amongst cancer patients: an experience from Oman,Al Bahrani BJ,Prospective,Cohort,Yes,inpatient,Oman,Muscat (and linked tertiary hospitals in Oman),"Royal Hospital, Muscat and its linked tertiary hospitals.",2020-03-24,2020-10-23,522,"ICU, Mortality, Hospitalisation*","Septicaemia, intubation (only in controls), WBC, CRP, Renal impairment, Ferritin, Hypocalcaemia, Transaminase, LDH, Troponin, D Dimer, ",Severity; Hospitalisation; ICU admission; Mortality,no,"All Types Cancer; all cancer diagnosis listed since 1996; 62.3% on active treatment: chemo-, targeted, hormonal, radio- or immunotherapy",All tertiary centre inpatients with a positive covid-19 test whom are not on the cancer registry across the whole of Oman.,Matched; 6/77: 49/445; respiratory disease,"","","","","",46.8,77,"","","","","",445,Not mentioned,"","","","","","","","","",20,26,207,46.5,uOR,0.40,0.23-0.69,7.9e-4,15,19.5,204,45.8,uOR,0.29,0.16-0.52,1.5e-5,9,11.7,82,18.4,uOR,0.59,0.28-1.22,0.15,"","","","","","","","",6,7.8,36,8.1,uOR,0.96,0.39-2.36,0.93,15,19.5,407,91.5,uOR,0.02,0.01-0.04,1e-49,6,7.8,49,11.0,uOR,0.68,0.28-1.65,0.40,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",No definition stated,Actual ICU admission (not just IMV),no definition stated; covid-19 specific mortality,ventilation support,univariate,"","",6,"","","","","","","","","","","","","","","","","","","","","","","","","","",16,"","","","","","","","","","","","","","","","","","","","","","","","","","",4,"","","","","","","","","","","","","","","","","","","","","","","","","","",10,"","","","","","","","","","","","","","","","","","","","","","","","","","",9,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",4,"","","","","","","","","","","","","","","","","","","","","","","","","","",6,"","","","","","","","","","","","","","","","","","","","","","","","","","",2,"","","","","","","","","","","","","","","","","","","","","","","","","","",3,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",6,"","","","","","","","","","","","","","","","","","","","","","","","","","",70,"","","","","","","","","","","","","","","","","","","","","","","","","","",4,"","","","","","","","","","","","","","","","","","","","","","","","","","",4,"","","","","","","","","","","","","","","","","","","","","","","","","","",3,"","","","","","","","","","","","","","","","","","","","","","","","","","",77,uOR,2.89,1.70-4.93,0.0000564,0.351,0.157,uOR,0.03,0.02-0.06,5e-40,0.195,0.877,"","","","","","","","","","","","","","","",27,"","","","","","","","","","","","","","","","","","","","","","","","","","",50,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",26,33.8,"","","","","","","","","","","","","","","","","","","","","","","","","","",8,10.4,"","","","","","","","","","","","","","","","","","","","","","","","","","",14,18.2,"","","","","","","","","","","","","","","","","","","","","","","","","","",5,6.5,"","","","","","","","","","","","","","","","","","","","","","","","","","",3,3.9,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",522,100,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",no
66084,Y 2021,Clinical features and death risk factors in COVID-19 patients with cancer: a retrospective study,Consensus,Peer-reviewed,BMC Infectious Diseases,"",2021-08,Clinical features and death risk factors in COVID-19 patients with cancer: a retrospective study,Zhou Y,Retrospective,Cohort,Yes,inpatient,China,Wuhan,"Taikang Hospital
Other temporary hospitals of Wuhan",2020-02-10,2020-04-15,309,Clinical features of COVID-19 patients with cancer and identify death outcome related risk factors,"",Severity; Mortality,no,All types cancer; no definition stated,"Age, gender, and comorbidities matched
Cancer:control = 1:2","Matched; 1:2;
Age, gender, comorbidity","",median,66,IQR,24-90,54.4,56,median,66,IQR,20-95,55.8,115,Not mentioned,"","","","","","","","","",37,35.9,59,28.6,"","","",0.195,14,13.6,23,11.1,"","","",0.579,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",Heart disease: 11,Heart disease: 10.7,30 (Heart disease),14.5 (Heart disease),"","","",0.379 (Heart disease),"","","","","","","","",symptomatology,no definition stated,no definition stated; covid-19 specific mortality,"clinical criteria: Respiratory rate >30 breaths per minute, O2 saturation <93% at rest, Oxygenation index is <300mmHg",univariate,"","",17 (lung),"","","","","","","","","","","","","","","","","","","","","","","","","","",23,"","","","","","","","","","","","","","","","","","","","","","","","","","",15,"","","","","","","","","","","","","","","","","","","","","","","","","","",4 (colorectal),"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",1,"","","","","","","","","","","","","","","","","","","","","","","","","","",13 (bladder+prostate),"","","","","","","","","","","","","","","","","","","","","","","","","","",8 (ovarian+cervical+endometrial),"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",103,uOR,2.89,1.17-7.09,0.0211,0.117 (12/103),0.044 (9/206),"","","","","","",uOR,1.19,0.72-1.97,0.505,0.350 (36/103),0.311 (64/206),"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",no
65975,G 2021,Immunological alternation in COVID-19 patients with cancer and its implications on mortality,Consensus,Peer-reviewed,OncoImmunology,Health records in two branches of Tongji Hospital,2021-01-04,Immunological alternation in COVID-19 patients with cancer and its implications on mortality,"Cai, Guangyao",Retrospective,Cohort,Yes,inpatient,China,Wuhan,Tongji hospital (Optical Valley Branch and Sino-French New City Branch),2020-02-04,2020-03-31,2052,"Death 
Time from illness onset to death/discharge
Survival time: time from COVID onset to death or discharge","Severity of COVID-19 
Fever - axillary temp at least 37.3ºC ",Severity; Mortality,no,All Cancer Types; definition of active not stated; active treatment not stated,"Cancer:non-cancer = 93:1959

Patients from the same hospital ","Matched; 1:10; age, sex, symptoms, co-morbidities (propensity score 1); age, sex, symptoms, co-morbidities, immunological indices (propensity score 2)","",Median of all; Median of propensity score matching 1; median of propensity score matching 2,65; 65; 65,IQR,56-71; 56-71;58-73,47.3; 47.3; 59.2,91 (All); 93 (Propensity score matching 1);  49 (Propensity score matching 2),Median of all; Median of propensity score matching 1; median of propensity score matching 2,62; 65; 66,IQR,51-70; 56-71; 57-74,48.7; 47.8; 60.6,1959 (All); 930 (Propensity score matching 1);  490 (Propensity score matching 2),Not mentioned,"","","","","","","","","",38,40.9,774,39.5,"","","","",17,18.3,328,16.7,"","","","",12,12.9,189,9.6,"","","","","","","","","","","","","","","","","","","","",4,4.3,28,1.4,"","","","",0,0,18,0.9,"","","","","","","","","","","","","","","","","","","","",3;0,3.2;0.0,50;9,2.6;0.5,"","","","",Others: Hepatitis B;Hepatitis C,"","","","","","","",7th edition of the Diagnosis and Treatment Protocol of COVID-19,"",All cause mortality,Clinical criteria,univariate; multivariate,"Age; Sex; Comorbidities; Other: multivariate logistic regression model 1: symptoms, multivariate logistic regression model 2: symptoms, immune indices including hsCRP, PCT, ferritin, TNF-α, IL-1β, IL-2 R, IL-6, IL-8, IL-10, lymphocytes","",12,"","","","","","","","","","","","","","","","","","","","","","","","","","",13,"","","","","","","","","","","","","","","","","","","","","","","","","","",7,"","","","",0.667 (2/3),"","","","","","","","","","","","","",Oesophagus,"","","","","","","",10,"","","","","","","","","","","","","","","","","","","","","","","","","","",5,"","","","","","","","","","","","","","","","","","","","","","","","","","",4,"","","","","","","","","","","","","","","","","","","","","","","","","","",11,"","","","",0.500 (4/8),"","","","","","","","","","","","","",Bladder,"","","","","","","",6,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",1,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",9,"","","","",0.555 (5/9),"","","","","","","","","","","","","","","","","","","","","",14 thyroid,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","uOR total population;uOR propensity score 1;uOR propensity score 2;mOR  model 1 total population;mOR model 1 propensity score 1;mOR model 1 propensity score 2;mOR  model 2 total population;mOR model 2 propensity score 1;mOR model 2 propensity score 2;
uHR total population;uHR propensity score 1;uHR propensity score 2;mHR model 1 total population;mHR model 1 propensity score 1;mHR model 1 propensity score 2;mHR model 2 total population;mHR model 2 propensity score 1;mHR model 2 propensity score 2",2.708;2.907;0.862;2.640;2.468;0.867;1.931;0.716;1.115;1.995;1.648;0.786;2.023;1.965;0.972;0.778;1.442;0.513,"1.655-4.429;1.263-3.481; 0.436-1.702;1.498-4.654;1.388-4.388;0.403-1.866;
0.498-7.493;0.127-4.028;0.277-4.485;1.280-3.108;1.044-2.603;0.435-1.423;1.296-3.159;1.239-3.117;0.532-1.779;0.404-1.496;0.724-2.872;0.419-1.545
",<0.001;0.004;0.668;0.001;0.004;0.715;0.341;0.704;0.878;0.002;0.032;0.427;0.002;0.004;0.928;0.451;0.298;0.804,0.247 (23/93);0.247 (23/93);0.245 (12/49);0.247 (23/93);0.247 (23/93);0.245 (12/49);0.247 (23/93);0.247 (23/93);0.245 (12/49);0.247 (23/93);0.247 (23/93);0.245 (12/49);0.247 (23/93);0.247 (23/93);0.245 (12/49);0.247 (23/93);0.247 (23/93);0.245 (12/49),0.108 (212/1959);0.135 (126/930);0.253 (124/490);0.108 (212/1959);0.135 (126/930);0.253 (124/490);0.108 (212/1959);0.135 (126/930);0.253 (124/490);0.108 (212/1959);0.135 (126/930);0.253 (124/490);0.108 (212/1959);0.135 (126/930);0.253 (124/490); 0.108 (212/1959); 0.135 (126/930); 0.253 (123/490),"","","","","","","","","","",Moderate 0.0860 (8/93); severe 0.434 (45/93); critical 0.430 (40/93),Moderate 0.119 (233/1955); Severe 0.702 (1372/1955); critical 0.179 (350/1955),"","","","","","","","","",37 ('early'),NA as used early as reference ,"","","",0.189 (7/37),"","","","","","","","","","","",Moderate 0.135 (5/37); severe 0.514 (19/37); critical 0.351 (13/37),"",Moderate;severe;critical,"","","","","","","",18 ('late'),Using EARLY as reference uOR; HR; mOR model 1; HR,0.536; 0.629;0.975; 2.347,0.099-2.887; 0.131-3.029;0.051-18.495; 0.305-18.053,0.468; 0.563;0.987; 0.412,0.111 (2/18); NA; NA; NA,"","","","","","","","","","","",Moderate 0.0556 (1/18); severe 0.556 (10/18); critical 0.389 (7/18),"","","","","","","","",model 1 adjustment of covariates,38 ,"","","","","","","","","","","","","","","","","","","","","","","","","","","",9,9.7,uOR; uHR;mOR model 1;mHR model 1,1.400; 1.109;0.876; 0.521,0.253 - 7.759; 0.240 - 5.133;0.115 - 6.646; 0.080 - 3.402,0.700;0.894;0.898;0.496,0.222 (2/9); NA; NA; NA,0.108 (212/1959);0.135 (126/930); NA; NA,"","","","","","","","","","",Moderate 0.000 (0/9); severe 0.444 (4/9); critical 0.556 (5/9),"",Note that all these therapies are within 40 days,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2,2.2,uOR; uHR;mOR model 1;mHR model 1,4.583;3.949;22.027;25.952,0.267 - 78.548;0.498 - 31.280;0.311 - 1558.242;0.771 - 873.562,0.294;0.193;0.155;0.070,0.500 (1/2); NA; NA; NA,0.108 (212/1959);0.135 (126/930); NA; NA,"","","","","","","","","","",Moderate 0.000 (0/2); severe 0.500 (1/2); critical 0.500 (1/2),"","","","","","","","","",4,4.3,uHR,0.513,0.000 - 510.340,0.513,0.000 (0/4),0.108 (212/1959),"","","","","","","","","","",Moderate 0.000 (0/4); severe 0.500 (2/4); critical 0.500 (2/4),"","","","","","","","","",1,1.1,uHR,0.048,0.000 - 8846600,0.755,0.000 (0/1),0.108 (212/1959),"","","","","","","","","","",Moderate 0.000 (0/1); severe 0.000 (0/1); critical 1.000 (1/1),"","","","","","","","","",2,2.15,uHR,0.045,0.000-5547.994,0.603,0.000 (0/2),0.108 (212/1959),"","","","","","","","","","",Moderate 0.000 (0/2); severe 0.000 (0/2); critical 1.000 (2/2),"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",93;93;49;93;93;49;93;93;49;93;93;49;93;93;49;93;93;49,100,"uOR total population;uOR propensity score 1;uOR propensity score 2;mOR  model 1 total population;mOR model 1 propensity score 1;mOR model 1 propensity score 2;mOR  model 2 total population;mOR model 2 propensity score 1;mOR model 2 propensity score 2;
uHR total population;uHR propensity score 1;uHR propensity score 2;mHR model 1 total population;mHR model 1 propensity score 1;mHR model 1 propensity score 2;mHR model 2 total population;mHR model 2 propensity score 1;mHR model 2 propensity score 2
",2.708;2.907;0.862;2.640;2.468;0.867;1.931;0.716;1.115;1.995;1.648;0.786;2.023;1.965;0.972;0.778;1.442;0.513,"1.655-4.429;1.263-3.481; 0.436-1.702;1.498-4.654;1.388-4.388;0.403-1.866;
0.498-7.493;0.127-4.028;0.277-4.485;1.280-3.108;1.044-2.603;0.435-1.423;1.296-3.159;1.239-3.117;0.532-1.779;0.404-1.496;0.724-2.872;0.419-1.545
",<0.001;0.004;0.668;0.001;0.004;0.715;0.341;0.704;0.878;0.002;0.032;0.427;0.002;0.004;0.928;0.451;0.298;0.804,0.247 (23/93);0.247 (23/93);0.245 (12/49);0.247 (23/93);0.247 (23/93);0.245 (12/49);0.247 (23/93);0.247 (23/93);0.245 (12/49);0.247 (23/93);0.247 (23/93);0.245 (12/49);0.247 (23/93);0.247 (23/93);0.245 (12/49);0.247 (23/93);0.247 (23/93);0.245 (12/49),0.108 (212/1959);0.135 (126/930);0.253 (124/490);0.108 (212/1959);0.135 (126/930);0.253 (124/490);0.108 (212/1959);0.135 (126/930);0.253 (124/490);0.108 (212/1959);0.135 (126/930);0.253 (124/490);0.108 (212/1959);0.135 (126/930);0.253 (124/490); 0.108 (212/1959); 0.135 (126/930); 0.253 (123/490),"","","","","","","","","","",Moderate 0.0860 (8/93); severe 0.434 (45/93); critical 0.430 (40/93),Moderate 0.119 (233/1955); Severe 0.702 (1372/1955); critical 0.179 (350/1955) ,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",no
65873,Y 2021,Systemic anti-cancer therapy and metastatic cancer are independent mortality risk factors during two uk waves of the covid-19 pandemic at university college london hospital,Consensus,Peer-reviewed,Cancers,Anonymized retrospective data were collected from electronic health records of the University College London Hospitals NHS Foundation Trust across two time periods ,2021-12,Systemic Anti-Cancer Therapy and Metastatic Cancer Are Independent Mortality Risk Factors during Two UK Waves of the COVID-19  pandemic at University College London Hospital,Wong Y.N.S,Retrospective,Cohort,Yes,inpatient and outpatient (with breakdown),UK,"",University College London Hospitals NHS Foundation Trust ,2020-03-01 (Wave 1-WT); 2020-12-01 (Wave 2-Alpha),2020-06-12 (Wave1-WT); 2021-02-08 (Wave2-Alpha),320 (WT); 339 (Alpha),all-cause mortality ,"Hospitalisation, ICU admission, mortality ",Hospitalisation; ICU admission; Mortality,no,Only solid cancer included (haematological cancers excluded); diagnosed within 12 months; some patients on active treatment defined as within 60 days of COVID-19 diagnosis,Same hospitals i.e. patients presenting to University College Hospitals ,"Matched; Wave 1 58:226 Wave 2 70:226; age, sex","",Wave 1median; Wave 2 median,NR; NR,Wave 1 IQR; Wave 2 IQR,NR; NR,NR (Wave 1); NR (Wave 2),58 (Wave 1); 70 (Wave 2),Wave 1 median; Wave 2 median,70.5; 71,Wave 1 IQR; Wave 2 IQR,60 - 80; 58 - 79,67.3 (Wave 1); 54 (Wave 2),226 (Wave 1); 226 (Wave 2),Wild Type (Ancestral/Wu-1); Other: alpha B.1.1.7,"","","",71; 64,31.4; 28.3,"","","","","","",123; 106,54.4; 46.9,"","","","","","",73; 77,32.3; 34.1,"","","","","","",59; 57,26.1; 25.2,"","","","","","",37; 12,16.4; 5.3,"","","","","","",4; 5,1.8; 2.2,"","","","","","",26; 23,11.5; 10.2,"","","","","","",47; 51,20.8; 22.6,"","","","","","",13; 2,5.8; 0.9,"","","","","","","","","","","","","","","","","","","","","","",Wave 1; Wave 2,"","","","","","","",All-cause mortality,"",multivariate,Age; Sex; Comorbidities,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",58 (Wave 1); 70 (Wave 2),"","","","","",0.341 (77/226) (wave 1); 0.190 (43/226) (wave 2),"","","","",0.200 (NR/58) (Wave 1); 0.224 (NR/70) (Wave 2),0.336 (76/226) (Wave 1); 0.301 (68/226) (Wave 2),"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",40,"",mHR,1.93,0.93 - 4.00,0.08,"","","","","","","","","","","","","","","","","","","","","","total number of patients data taken from text on p.8

multivariate HR for mortality taken from table 2",15,"",mHR,1.66,0.69 - 3.96,0.25,"","","","","","","","","","","","","","","","","","","","","","",8,"",mHR,0.84,0.11 - 6.28,0.86,"","","","","","","","","","","","","","","","","","","","","","","","",mHR,2.04,0.62 - 6.74,0.24,"","","","","","","","","","","","","","","","","","","","","","",5,"",mHR,1.73,0.4 - 7.41,0.46,"","","","","","","","","","","","","","","","","","","","","","","","",mHR,0.67,0.09 - 4.98,0.69,"","","","","","","","","","","","","","","","","","","","","","","",284,49.0%,"","","","","",0.341 (77/226),"","","","",0.200 (NR/58),0.336 (76/226),"","","","","","","","","","","","",0.987 (223/226),Corresponded to 'wave 1',"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",296,51.0%,"","","","","",0.190 (43/226),"","","",1.003,0.224 (NR/70),0.301 (68/226),"","","","","","","","","","","","",0.792 (179/226),Alpha B.1.1.7 Corresponded to 'wave 2',"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",no
65844,A 2021,"Impact of active cancer on COVID-19 survival: a matched-analysis on 557 consecutive patients at an Academic Hospital in Lombardy, Italy",Consensus,Peer-reviewed,British Journal of Cancer,"Medical records at IRCCS, Rozzano, Italy",2021-05,"Impact of active cancer on COVID-19 survival: a matched-analysis on 557 consecutive patients at an Academic Hospital in Lombardy, Italy",Bertuzzi AF,Retrospective,cohort,Yes,inpatient,Italy,Lombardy,"IRCCS, Rozzano",2020-02-27,2020-05-20,557,Mortality,ICU Admission,ICU admission; Mortality,no,All Types Cancer; presence of localised or metastatic disease at covid onset; no active treatment,controls from the same hospital,"Matched; 1:4; age, comorbidities","",Mean,71,95%CI,67-74,67.4,46,Mean,65,95%CI,64-66,67.3,511,Not mentioned,"",9,19.6,41,8.0,uOR,0.28,0.12-0.65,0.002131,21,45.7,263,51.6,uOR,0.79,0.43-1.45,0.442006,12,26.1,125,24.5,uOR,1.09,0.55-2.16,0.812080,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",12 (dyslipidemia); 13 (Coronary Artery Disease),26.7 (dyslipidemia); 28.9 (Coronary Artery Disease),42 (dyslipidemia); 44 (Coronary Artery Disease),23.3 (dyslipidemia); 24.4 (Coronary Artery Disease),uOR;uOR,1.45  (dyslipidemia); 1.79 (Coronary Artery Disease),0.74-2.85; 0.92-3.49,0.279626; 0.081512,"","","","","","","","",no definition stated,no definition stated,in-hospital fatality rate; covid-19 specific mortality,no definition stated,univariate; multivariate,Age,"",9,"","","","","","","","","","","","","","","","","","","","","","","","","","",3,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",33,"","","","","","","","","","","","","","","","","","","","","","","","","","",13,"","","","","","","","","","","","","","","","","","","","","","","","","","",6 (all GU); 10 (all GI),"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",46,uHR; mHR,2.79; 2.26,1.76-4.42; 1.39-3.657,<0.001; <0.001,0.500 (23/46); 0.500 (23/46),0.202 (103/511); 0.202 (103/511),"","","","","","","","","","","","","","","","","","","","","",17,"","","","","","","","","","","","","","","","","","","","","","","","","","",29,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",13,28.3,"","","","","","","","","","","","","","","","","","","","","","","","","","",4,8.7,"","","","","","","","","","","","","","","","","","","","","","","","","","",1,2.2,"","","","","","","","","","","","","","","","","","","","","","","","","","",5,10.9,"","","","","","","","","","","","","","","","","","","","","","","","","","",4,8.7,"","","","","","","","","","","","","","","","","","","","","","","","","","",21,45.7,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",557,100,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",no
65461,M 2021,SARS-CoV-2 Viral Load Is Correlated With the Disease Severity and Mortality in Patients With Cancer,Consensus,Peer-reviewed,Frontiers In Oncology | Cancer Epidemiology and Prevention,"""Medical records books"" of King Faisal Specialist Hospital and Research Centre, Riyadh, Saudi Arabia and Park View Hospital, Chittagong, Bangladesh",2021-08,SARS-CoV-2 Viral Load Is Correlated With the Disease Severity and Mortality in Patients With Cancer,Al-Mozaini M,Retrospective,Cohort,Yes,inpatient,"Saudi Arabia, Bangladesh",Riyadh and Chittagong,"King Faisal Specialist Hospital and Research Centre, Riyadh, Saudi Arabia and Park View Hospital, Chittagong, Bangladesh",2020-06-30,2020-08-07,184,Mortality,"Mild, moderate, severe cases",Severity; Mortality,no,"All types cancer, those undergoing therapy in last 12 months with radiotherapy, surgery and chemotherapy ","""A total of 120 COVID-19-positive noncancer adult patients admitted by the same hospitals and same time period were included in this study as a control group.""",Not matched,"",Median,55,IQR,10.5,75.0,64,Median,53,IQR,9.0,62.5,120,Not mentioned,"","","","","","","","","",19,29.69,21,17.5,uOR,1.99,0.98 - 4.06,0.056,13,20.31,31,25.83,uOR,0.73,0.35 - 1.52,0.40,15,23.44,11,9.17,uOR,3.03,1.30 - 7.08,0.008,"","","","","","","","","","","","","","","","",3,4.69,9,7.5,uOR,0.61,0.16 - 2.32,0.46,2,3.12,9,7.5,uOR,0.40,0.08 - 1.90,0.23,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","Radiological results: infiltrates in >50% of lung field within 24-48h; Symptomology: breathing rate 30+ breaths/min, Oxygen saturation <93%, 1+ multiple organ failures, or requiring ICU and invasive mechanical ventilation",/,Death before study end ,"Radiological results: infiltrates in >50% of lung field within 24-48h; Clinical criteria: breathing rate 30+ breaths/min, Oxygen saturation <93%, 1+ multiple organ failures, or requiring ICU and invasive mechanical ventilation",univariate,"","",9,uOR,43.17,7.79-239.15,6.9e-10,0.778,0.0917,"","","","","","","","","","","","","","","","","","","","",16,uOR,1.76,0.35-8.99,0.49,0.125,0.0917,"","","","","","","","","","","","","","","","","","","","",4,uOR,12.33,1.55-98.17,0.0033,0.500,0.0917,"","","","","","","","","","","","","","","","","","","","",12,uOR,2.47,0.47-13.02,0.27,0.167,0.0917,"","","","","","","","","","","","","","","","","","","","",3,NA (0 value),"","","",0,0.0917,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",6,NA (0 value),"","","",0,0.0917,"","","","","","","","","","","","","","","","","","","","",5,uOR,18.50,2.73-125.41,9.4e-5,0.600,0.0917,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",6,NA (0 value),"","","",0,0.0917,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",61,uOR,4.39,1.81-10.65,5.6e-4,0.262,0.0917,"","","","","","","","","","","","","","","","","","","","",3,uOR,6.17,0.51-74.73,0.11,1,0.0917,"","","","","","","","","","","","","","","","","","","","",0,"","","","","","","","","","","","","","","","","","","","","","","","","","",0,"","","","","","","","","","","","","","","","","","","","","","","","","","",64,uOR;aOR (MV regress),3.66;2.59,1.56-8.57;1.47-5.26,0.0028;0.001,0.2969(19/64);0.2969(19/64),"0.075(9/120),0.075(9/120),",aOR (MV regress),4.22,3.17-6.26,0.001,0.2031,0.050,aOR (MV regress),2.26,1.77-4.61,0.01,0.375,"","","","","","","","","","",43,uOR,3.74,1.40-9.97,0.0057,0.233,0.0917,"","","","","","","","","","","","","","","","","","","","",21,uOR,9.25,3.08-27.77,7.49e-6,0.429,0.0917,"","","","","","","","","","","","","","","","","","","","",0,"","","","","","","","","","","","","","","","","","","","","","","","","","","",33,51.6,uOR,11.89,4.72-29.96,2.549E-07,0.545 (18/33),0.0917,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",5,7.8,NR (0 value),0,"","",0 (0/5),0.0917,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",10,15.6,NR (0 value),0,"","",0 (0/10),0.0917,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",no
64926,C 2021,Severity of COVID-19 in Cancer patients versus patients without Cancer: A Propensity Score Matching Analysis,Consensus,Peer-reviewed,Journal of Cancer,"",2021-04,Severity of COVID-19 in Cancer patients versus patients without Cancer: A Propensity Score Matching Analysis,Liu C,Retrospective,Cohort,Yes,inpatient,China,Wuhan,Wuhan Hankou Hospital,2020-01-05,2020-02-21,189,"- Clinical features of COVID in cancer vs non-cancer patients,
- Clinical outcome (mortality) of COVID in cancer vs non-cancer patients","- Comparison of clinical features in cancer patients with COVID who had mild features vs those who had severe/critical symptoms, 
- Comparison of cancer history (type of cancer, duration of cancer, cancer treatment) in cancer patients with COVID who had mild features vs those who had severe/critical symptoms",Severity; Mortality,no,Not described.,Control group drawn from the same hospital (Wuhan Hankou Hospital).,"""we performed [propensity score matching] to select matched patients without cancer accounted for age, gender, and comorbidities which were recognized as potential risk factors of COVID-19 prognosis. Patients were matched 1:4""","",NR,NR,NR,NR,31.2,16,NR,NR,NR,NR,50,64,Not mentioned,"","","","","","","","","",9,56.3,28,43.8,uOR,1.65,0.55-4.99,"",4,25,10,15.6,uOR,1.80,0.48-6.72,"",3,18.8,8,12.5,uOR,1.62,0.38-6.94,"",1,6.3,3,4.7,uOR,1.36,0.13-13.97,"",1,6.3,2,3.1,uOR,2.07,0.18-24.33,"",1,6.3,3,4.7,uOR,1.36,0.13-13.97,"",0,0.0,1,1.6,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","- Mild: non-pneumonia and mild pneumonia
- Severe: SPO2 ≤ 93%, or respiratory frequency ≥ 30/min, or dyspnea, or lung infiltrates > 50% within 24 to 48 hours, or PaO2/FiO2 ≤ 300
- Critical: multiple organ dysfunction or failure, or septic shock, or respiratory failure",N/A,"Not described.
""All patients had a definite clinical outcome (dead or discharged) by the final date of follow-up, 18 March 2020.""","- Mild: non-pneumonia and mild pneumonia
- Severe: SPO2 ≤ 93%, or respiratory frequency ≥ 30/min, or dyspnea, or lung infiltrates > 50% within 24 to 48 hours, or PaO2/FiO2 ≤ 300
- Critical: multiple organ dysfunction or failure, or septic shock, or respiratory failure",Other: Study did not calculate OR/RR/HR.,"","",2 (lung),"","","","","","","","","","","","","","","","",0.5 (1/2),0.375 (24/64),"","","","","","","","",1,"","","","","","","","","","","","","","","","",0 (0/1),0.375 (24/64),"","","","","","","","",1 (gastric),"","","","","","","","","","","","","","","","",1 (1/1),0.375 (24/64),"","","","","","","","",5 (colorectal),"","","","","","","","","","","","","","","","",0.6 (3/5),0.375 (24/64),"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2 (cervical),"","","","","","","","","","","","","","","","",0 (0/2),0.375 (24/64),"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2 (thyroid+nasopharyngeal),"","","","","","","","","","","","","","","","",0 (0/2),0.375 (24/64),"","","","","","","","",1,"","","","","","","","","","","","","","","","",0 (0/1),0.375 (24/64),"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",14,"","","","","","","","","","","","","","","","",0.357 (5/14),0.375 (24/64),"","","","","","","","",2,"","","","","","","","","","","","","","","","",0.5 (1/2),0.375 (24/64),"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",16,uOR,2.72,0.58-12.86,"",0.188 (3/16),0.0781 (5/64),"","","","","","",uOR,1,0.32-3.10,"",0.375 (6/16),0.375 (24/64),"For severe disease, I have included Combined Severe/Critical as ""severe"" as that is how it is reported in the supplemental for controls.

uORs calculated by me.","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",no
64534,C 2021,More Severe COVID-19 in Patients With Active Cancer: Results of a Multicenter Cohort Study,Consensus,Peer-reviewed,Frontiers in Oncology,institutional medical records,2021-05,More Severe COVID-19 in Patients With Active Cancer: Results of a Multicenter Cohort Study,Monari C,Retrospective,Cohort,Yes,inpatient and outpatient (with breakdown),Italy,"Campania region (13 cities: Naples, Caserta, Salerno, Benevento, Pozzuoli, Eboli and Vallo della Lucania)",N/A,2020-02-28,2020-05-31,371,COVID-19 severity (requiring mechanical ventilation and/or admission to ICU and/or in case of death).,"",Severity; ICU admission; Mortality,no,"All Types Cancer; receive treatment within the last 30 days or without indication of treatment due to a late stage of disease of without treatment options; radio-, chemo- or immuno/target-therapy or surgery

","Not age matched (table 2)
Were sex matched (table 2)
Not comorbidity matched (table 2)","Matched; 17:337;
sex, age","",Median,72.0,IQR,61-78,76.5,13,Median,58.0,IQR,46-69,61.7,208,Not mentioned,"","","","","","","","","",11,64.7,138,40.9,"","","",0.083,"","","","","","","","",11,64.7,71,21.1,"","","",<0.001,"","","","","","","","","","","","","","","","","","","","","","","","",5,29.4,47,13.9,"","","",0.17,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",no definition stated,no definition stated,no definition stated; covid-19 specific mortality,"clinical criteria, non invasive ventilation, invasive ventilation",multivariate,Age; Sex; Comorbidities; Other: Charlson Index Score indicates comorbidities,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",13,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",17,uOR,7.30,2.68-19.90,<0.001,0.529 (9/17),0.134 (45/337),"","","","","","",mOR,5.33,1.72-16.53,<0.001,0.647,0.217,mORs presented are for severity,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",no
63831,G 2021,Covid-19 intensive care admissions and mortality among swedish patients with cancer,Consensus,Peer-reviewed,Acta Oncologica,Swedish Intensive Care Registry (SIR),2021-11,Covid-19 intensive care admissions and mortality among swedish patients with cancer,Gunnar Larfors,Retrospective,case-control,Yes,inpatient,Sweden,"",Swedish Intensive Care Registry (SIR),2020-03-11,2020-06-18,54651,"to comparing cancer prevalence among covid-19 cases in intensive
care and covid-19 deaths to that in the Swedish general population, in a bit to determine the impact of cancer on severe covid-19","",ICU admission; Mortality,no,"- patients with cancer diagnosis (ICD10: C00-C97 excluding non-melanoma skin cancer C44, or D45-D47) between 2011 and 2020 were identified in the Swedish Patient Register

Patients were further sub-classified into those with a treatment code of chemotherapy within three months before covid-19 death or intensive care depending on the studied outcome, and persons with a cancer diagnosed 2016 and later, without such documented treatment. People with no recent records of chemotherapy, and no cancer diagnosis 2016 or later were considered unexposed",controls are all residents in Sweden that were alive at the study period and above 18 years old,"","","","","","","","","","","","","","",Not mentioned,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",-,"Incident cases was identified in the Public Health Agency register SmiNet. Data on covid-19 cases in intensive care were extracted from the Swedish Intensive Care Registry (SIR), covering all intensive care units in Sweden.","Deaths due to covid-19 have been followed for death records, and all patients reported dead within 30 days following covid-19 positivity (as confirmed by PCR test) have been regarded as covid-19 related deaths","",multivariate,Age; Sex,"",6537 (34+6503),aOR (lung),3.4,2.4-4.7,"",0.005 (34/6573),"","","","","","","","","","","","","","","","","","","","","",32429 (31+32398),aOR,1.0,0.1-1.4,"",0.0956 (31/32429),"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",19706 (50+19656),aOR (colorectal),1.2,0.9-1.5,"",0.00254 (50/19706),"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",45057 (96+44961),aOR (prostate),1.0,0.8-1.2,"",0.00213 (96/45057),"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",23619 (81+23538),aOR,1.9,1.5-2.4,"",0.00343 (81/23619),"","","","","","","","","","","","","","","","","","","","","",72929 (147+71782),aOR,1.3,1.1-1.5,"",0.00202 (147/72929),"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",200277 (439+199838),aOR,1.3,1.2-1.4,"",0.00219 (439/200277),"0.000577 ((4566/(7906198+4566)
= 4566/7910764)",aOR,1.1 ,0.9-1.4,"",0.000488 (98/(200809+98)),0.000265 (2174/7912213),"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",5748,"",aOR,4.0,2.6-6.1,"",0.00383 (22/5748),"",aOR ,2.5,1.1-5.5,"",0.00104 (6/5792),0.00028 (2272/8113120),"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",no
63774,M 2021,COVID-19 in cancer patients: clinical characteristics and outcome-an analysis of the LEOSS registry,Consensus,Peer-reviewed,Annals of Hematology,Lean European Open Survey on SARS-COV-2 (LEOSS) registry ,2020-11,"COVID-19 in cancer patients: clinical characteristics
and outcome—an analysis of the LEOSS registry",Rüthrich MM,Retrospective,Cohort,Yes,inpatient and outpatient (with breakdown),Germany,N/A,N/A,2020-03-16,2020-08-31,2833 ,"Death (attributed to COVID-19), clinical manifestation of COVID-19 ",Survival at day 30,Mortality,no,All types cancer; active malignancy at detection of SARS-CoV-2,Same multinational cohort (LEOSS),"Matched; sex

ratio cancer:non cancer 197:2636

","","Age ranges
",<18: 5/435; 18-25: 1/435; 26-35: 4/435; 36-45: 13/435; 46-55: 36/435; 56-65: 72/435; 66-75: 108/435; 76-85: 158/435; >85: 8/435,"","",59.5,435 (all types cancer); 197 (active malignancy at detection of SARS-CoV-2),Age ranges ,<18: 47/2636; 18-25: 60/2636; 26-35: 197/2636; 36-45: 239/2636; 46-55: 434/2636; 56-65: 527/2636; 66-75: 413/2636; 76-85: 508/2636; >85: 211/2636,"","",59.5,2636,Not mentioned,"",36/225,16,"170/1270
",14,"","","","",259/430,60,1249/2591,48,"","","","",63/429; 41/426 ,14.5; 9.5,"349/2572; 172/2563 
",13.5; 6.5,"","","","",36/424; 52/420; 81/420; 34/421,8.5; 12; 19.5; 8,156/2539; 242/2537; 343/2518; 104/2521,6; 9.5; 13.5; 4,"","","","",59/427,14,222/2560,8.5,"","","","",5/428; 6/428 ,1; 1.5,53/2558; 22/2561,2; 1,"","","","",87/428,20.5,359/2569,14,"","","","",39/430; 15/429; 27/422,9; 3.5; 6.5,149/2572; 137/2564; 110/2539,6; 5.5; 4.5,"","","","",5/429,1,49/2564,2,"","","","","","","","","","","","",69/184; 19/428; 3/429; 48/429; 15/431,24; 4.5; 0.5; 11; 3.5,419/1597; 51/2558; 20/2560; 209/2358; 55/2562,26; 2; 1; 8; 2,"","","","","these comorbidities are recorded for the total cancer cohort which consisted of 54% with active malignancy

DM = with end organ damage; without end organ damage

CVD = myocardial infarction; chronic heart failure; coronary artery disease; peripheral  vascular disease

Chronic liver disease = chronic liver disease; liver cirrhosis 

Chronic lung disease = COPD; asthma; other chronic pulmonary disease 

Immunodeficiency = organ transplantation 

Others = obesity; peptic ulcer disease; connective tissue disease; dementia; hemiplegia ","these comorbidities are recorded for the total cancer cohort which consisted of 54% with active malignancy

DM = with end organ damage; without end organ damage

CVD = myocardial infarction; chronic heart failure; coronary artery disease; peripheral  vascular disease

Chronic liver disease = chronic liver disease; liver cirrhosis 

Chronic lung disease = COPD; asthma; other chronic pulmonary disease 

Immunodeficiency = organ transplantation 

Others = obesity; peptic ulcer disease; connective tissue disease; dementia; hemiplegia","DM = with end organ damage; without end organ damage

CVD = myocardial infarction; chronic heart failure; coronary artery disease; peripheral  vascular disease

Chronic liver disease = chronic liver disease; liver cirrhosis 

Chronic lung disease = COPD; asthma; other chronic pulmonary disease 

Immunodeficiency = organ transplantation 

Others = obesity; peptic ulcer disease; connective tissue disease; dementia; hemiplegia","these comorbidities are recorded for the total cancer cohort which consisted of 54% with active malignancy

DM = with end organ damage; without end organ damage

CVD = myocardial infarction; chronic heart failure; coronary artery disease; peripheral  vascular disease

Chronic liver disease = chronic liver disease; liver cirrhosis 

Chronic lung disease = COPD; asthma; other chronic pulmonary disease 

Immunodeficiency = organ transplantation 

Others = obesity; peptic ulcer disease; connective tissue disease; dementia; hemiplegia","","","","",NA,NA,30 day mortality; covid-19 specific mortality,NA,Other: Crude,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",197,cOR,2.22,1.59 - 3.10,0.0000044,52/197,367/2636,"","","","","","","","","","","","","I calculated crude OR, CI and p-value for mortality attributed to covid-19 in *active* cancer patients vs. non-cancer patients ","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",36/418,8.5,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",96/418,22.0,"","","","","","","","","","","","","","","","","","","","","","","","","","",25/418,5.5,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",39/418,9.0,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",no
62340,L 2020,SARS-CoV-2 Viral Load Predicts Mortality in Patients with and without Cancer Who Are Hospitalized with COVID-19,Consensus,Peer-reviewed,Cancer Cell,"EHRs from NewYork-Presbyterian Hospital (NYP), Weill Cornell Medical Center, NYP Lower Manhattan Hospital, and NYP Queens",2020-11,SARS-CoV-2 Viral Load Predicts Mortality in Patients with and without Cancer Who Are Hospitalized with COVID-19,Westblade LF,Retrospective,Cohort,Yes,inpatient,USA,New York,"New York-Presbyterian Hospital (NYP), Weill Cornell Medical Center, NYP Lower Manhattan Hospital, and NYP Queens",2020-03-15,2020-05-14,3014,"Intubation, Need for vasopressors, mortality","",ICU admission; Mortality,no,"1. Any cancer type 
2. Under active surveillance at time of admission for COVID-19 OR
3. Active cancer-directed therapy within 6 months (either 2 or 3)",Inpatients at the same hospitals diagnosed during the same time period,No matching,"",Median,72,IQR,66-80,53,100,Median,65,IQR,53-77,57.8,2914,Not mentioned,"",31,31,573,19.7,uOR,1.84,1.19 - 2.83,0.0054,48,48,1232,42.3,uOR,1.26,0.85 - 1.88,0.26,33,33,935,32.1,uOR,1.04,0.68 - 1.59,0.85,39,39,602,20.7,uOR,2.46,1.63 - 3.71,1e-5,"","","","","","","","",2,2,26,0.9,uOR,2.27,0.53 - 9.69,0.26,8,8,270,9.3,uOR,0.85,0.41 - 1.77,0.67,21,21,450,15.4,uOR,1.46,0.89 - 2.38,0.13,0,0,28,1.0,NA (0 value),"","","",3,3,101,3.47,uOR,0.86,0.27 - 2.76,0.80,"","","","","","","","","","","","","","","","",not defined,intubation,In-hospital mortality,not defined,univariate,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","",13,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",60,cOR,1.2940,0.7402-2.2620,0.3658,0.300 (18/60),0.249 (725/2914),"","","","","","","","","","","","","","","","","","","","",40,cOR,1.2940,0.6546-2.5579,0.4585,0.300 (12/40),0.249 (725/2914),"","","","","","","","","","","","","","","","","","","","",64,"","","","","","","","","","","","","","","","","","",only includes patients with Ct value <30,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",100,cOR,1.2940,0.8368-2.0009,0.2465,0.300 (30/100),0.249 (725/2914),cOR,0.7688,0.4406-1.3416,0.3547,0.15 (15/100),0.187 (544/2914),"","","","","","",includes patients with Ct value >30,ICU admission defined as those requiring intubation,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",100,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",100,100,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",no
62182,C 2020,Cancer History and Systemic Anti-Cancer Therapy Independently Predict COVID-19 Mortality: A UK Tertiary Hospital Experience,Consensus,Peer-reviewed,Frontiers in Oncology,Electronic health records of the University College London Hospitals NHS Foundation Trust.,2020-11,Cancer History and Systemic Anti-Cancer Therapy Independently Predict COVID-19 Mortality: A UK Tertiary Hospital Experience,Sng C. C. T.,Retrospective,Cohort,Yes,inpatient,UK,London,University College London Hospitals NHS Foundation Trust,2020-03-01,2020-05-31,320,All-cause mortality.,"",Mortality,no,All types solid cancer;  active cancer = cancer diagnosis or anti-cancer treatment within the last 12 months or radiological or biochemical evidence of active or recurrent cancer.,Patients with no evidence of cancer in their EHR recruited from the same hospital.,"Matched; 94:226; age, sex. ","",median,71,iqr,62-80,66,94,median,70.5,iqr,60-80,67,226,Not mentioned,"",7,7,13,6,uOR,1.32,0.51-3.42,0.568403,37,39,123,54,uOR,0.54,0.33-0.89,0.014103,24,26,73,32,uOR,0.72,0.42-1.23,0.230143,18,19,59,26,uOR,0.67,0.37-1.21,0.184800,12,13,37,16,uOR,0.75,0.37-1.51,0.414594,3,3,4,2,uOR,1.83,0.40-8.34,0.428448,12,13,26,12,uOR,1.13,0.54 - 2.34,0.750680,14,15,47,21,uOR,0.67,0.35-1.28,0.220784,4,4,13,6,uOR,0.73,0.23-2.29,0.586580,"","","","","","","","","","","","","","","","",immunosuppressed = ongoing corticosteroid use; comorbidities compare control cohort to 98 patients with a history of cancer (of whom 58 had active cancer),"","","","","","","","","",3 month mortality; all-cause.,"",multivariate,Age; Comorbidities; Other: Ethnicity.,"",15,aHR,0.70,0.28-1.79,0.46,0.333 (5/15),"","","","","","","","","","","","","","","","","","","","","",8,aHR,1.56,0.55-4.38,0.40,0.500 (4/8),"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",24,aHR,1.65,0.85-3.19,0.14,0.542 (13/24),"","","","","","","","","","","","","","","","","","","","","",9,aHR,0.60,0.19-1.96,0.40,0.333 (3/9),"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",58,aHR,1.64,1.03-2.6,0.04,0.448 (26/58),"","","","","","","","","","","","","","","","","","","","","total = active cancer only, subtypes include active and non-active","",58,"","","","",0.448 (26/58),0.341 (77/226),"","","","","","","","","","","","","","","","","","","","",19,uHR,1.13,0.54-2.37,0.75,0.474 (9/19),0.341 (77/226),"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",15,25.9,mHR,2.04,0.84-4.9,0.11,0.467 (7/15),0.341 (77/226),"","","","","","","","","","","","","","","","","","","","",8,13.8,mHR,1.94,0.74-5.1,0.18,0.625 (5/8),0.341 (77/226),"","","","","","","","","","","","","","","","","","","","",2,3.45,mHR,3.44,0.44-27.2,0.24,0.500 (1/2),0.341 (77/226),"","","","","","","","","","","","","","","","","","","","",5,8.62,mHR,1.94,0.45-8.4,0.38,0.400 (2/5),0.341 (77/226),"","","","","","","","","","","","","","","","","","","","",4,6.90,mHR,1.70,0.39-7.3,0.48,0.500 (2/4),0.341 (77/226),"","","","","","","","","","","","","","","","","","","","",3,5.17,mHR,1.40,0.18-10.8,0.75,0.333 (1/3),0.341 (77/226),"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",320,100,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",no
62120,G 2020,COVID-19 severity and outcomes in patients with cancer: A matched cohort study,Consensus,Peer-reviewed,Journal of Clinical Oncology,Hospital records for Weill Cornell Medicine and Lower Manhattan Hospital,2020-09,"COVID-19 Severity and Outcomes in Patients With
Cancer: A Matched Cohort Study",Brar G.,Retrospective,Cohort,Yes,inpatient,USA,New York City,2 New York-Presbyterian hospitals: Weill Cornell Medicine and Lower Manhattan Hospital,2020-03-03,2020-05-15,585,"Composite incident outcome of:
1) ICU admission
2) Intubation
3) Death","",Severity; ICU admission; Mortality,no,All types of cancer; definition of active not stated; active treatment not stated,Patients at the same two hospitals with no cancer diagnostic code,"Matched; 1:4; age, gender, comorbidities ","",Median,72.5,IQR,64.2-79.9,54.7%,117,Median,71.2,IQR,62.1-79.6,54.7%,468,Not mentioned,"",39,33.4,129,27.7,uOR,1.31,0.22-0.85,0.22,62,53.0,269,57.5,uOR,0.83,0.21-0.56,0.38,38,32.5,136,29.1,uOR,1.17,0.22-0.76,0.47,"","","","","","","","","","","","","","","","",3,"",2,0.4,uOR,6.13,0.92-1.01,0.02,3,2.6,23,4.9,uOR,0.51,0.15-0.62,0.27,"","","","","","","","",0,0,3,0.6,uOR,n/a,n/a,n/a,"","","","","","","","",22; 13; 9; 6,18.8; 11.1; 7.7; 5.1,78; 32; 33;29,16.7; 6.8; 7.1; 6.2,uOR; uOR; uOR; uOR,1.16; 1.70; 1.10; 0.82,0.27-0.69; 0.35-0.86; 0.39-0.51; 0.33-0.46,0.58; 0.12; 0.81; 0.66,CAD; HF; COPD; Asthma,"","","","","","","",No definition stated,"",No definition stated,"Intensive care unit, intubation, or death",multivariate,Age; Sex; Comorbidities,"",1,"","","","","","","","","","","","","","","","","","","","","","","","","","",15,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",22,"","","","","","","","","","","","","","","","","","","","","","","","","","",6,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",75,"","","","","","","","","","","","","","","","","","","","","","","","","","",42,"","","","","","","","","","","","","","","","","","","","","","","","","","",19,"","","","","","","","","","","","","","","","","","","","","","","","","",Combined lower + upper GI,"","","","","","","","","","","","","","","","","","","","","","","","","","","",117,uHR; mHR,0.74; 0.98,0.53-1.03; 0.58-1.67,>.05; 0.894,29/117; 0.248,100/468; 0.214,"","","","","","",mHR,0.80,0.57-1.13,>.05,"","","","","","","","","","","",22,"","","","","","","","","","","","","","","","","","","","","","","","","","",26,"","","","","","","","","","","","","","","","","","","","","","","","","","",27,"","","","","","","","","","","","","","","","","","","","","","","","","","","",52,44.4,"","","","","","","","","","","","","","","","","","","","","","","","","","",32,27.4,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",14,12.0,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",21,18.0,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",585,100,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",no
61946,M 2020,Outcomes of covid-19 patients under cytotoxic cancer chemotherapy in brazil,Consensus,Peer-reviewed,Cancers,SIVEP,2020-11/24,"Outcomes of COVID-19 Patients under Cytotoxic
Cancer Chemotherapy in Brazil","Duarte, Mateus Bringel Oliveira ",Retrospective,Cohort ,Yes,inpatient,Brazil,Brazilian Southeast region ,"",2020-01-01,2020-09-28,non-matched:38899;pair matched: 927,"Mortality, severity ","",Severity; Mortality,no,"Haematological Cancer, GI Cancer, Head and Neck Cancer, Lung Cancer, Breast Cancer, Gynaecological Cancer, Prostate Cancer, CNS Cancer, Sarcomas; active treatment only 


data pulled from addition supplementary resources (available here: https://www.mdpi.com/2072-6694/12/12/3490/s1)

",non active cancer patients from same multinational cohort ,"matched; 1:1; age, sex, race, Brazilian region, type of presentation, comorbidities ","",age ranges,"non-pair matched: <50 (121); 50-64 (172); 65-79 (1220); >80 (16) 

pair matched: <50 (49); 50-64 (99); 65-79 (89); >80 (9) ","","",non-pair matched: 43.2%;pair matched: 49.6% ,431 (non-matched); 246 (matched),age ranges,"non-pair matched: <50 (10192); 50-64 (11730); 65-79 (11379); >80 (5167) 

pair matched: <50 (166); 50-64 (274); 65-79 (216); >80 (25) ","","",non-pair matched: 57.5%;pair matched: 45.2% ,250 (non-matched); 246 (matched) ,Not mentioned,"","","","","","","","","","","","","","","","","",non-pair matched:66; pair matched: 38,non-pair matched: 15.3; pair matched:15.5,non-pair matched:11333; pair matched:103,non-pair matched: 49; pair matched: 15.1,"","","","",non-pair matched:83; pair matched: 60,non-pair matched:  19.3;pair matched: 24.4,non-pair matched: 15866; pair matched: 145,non-pair matched: 41.2; pair matched: 21.3,"","","","","","","","","","","","","","","","","","","","",non-pair matched:23; pair matched:15 ,non-pair matched: 5.3%;pair matched:  6.1%,non-pair matched: 2630; pair matched: 38,non-pair matched: 6.8%; pair matched: 5.6%,"","","","",non-pair matched:17; pair matched:11,non-pair matched: 3.9%; pair matched: 4.5%,non-pair matched: 2152; pair matched: 28 ,non-pair matched: 5.6%; pair matched: 4.1%,"","","","","","","","","","","","","","","","","","","","","neurological disease:
non-pair matched:5; pair matched:5 ","neurological disease:
non-pair matched: 1.1%; pair matched: 2.0%",neurological disease: non-pair matched: 2026;  pair matched:13,neurological disease: non-pair matched: 5.3%;  pair matched:1.9%,"","","","","","","","","","","","",NA,"",no definition stated,invasive ventilation ,univariate; Other: crude,"","",30,"","","","","","","","","","","","","","","","","","","","","","","","","","",66,"","","","","","","","","","","","","","","","","","","","","","","","","","",39,"","","","","","","","","","","","","","","","","","","","","","","","","","",64,"","","","","","","","","","","","","","","","","","","","","","","","","","",18,"","","","","","","","","","","","","","","","","","","","","","","","","","",0,"","","","","","","","","","","","","","","","","","","","","","","","","","",10,"","","","","","","","","","","","","","","","","","","","","","","","","","",42,"","","","","","","","","","","","","","","","","","","","","","","","","","",8,"","","","","","","","","","","","","","","","","","","","","","","","","","",11,"","","","","","","","","","","","","","","","","","","","","","","","","","",5,"","","","","","","","","","","","","","","","","","","","","","","","","","",10,"","","","","","","","","","","","","","","","","","","","","","","","","","",320,"","","","","","","","","","","","","","","","","","","","","","","","","","",111,"","","","","","","","","","","","","","","","","","","","","","","","","","",17,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",431,"","","","",non-matched: 265/431; pair-matched: 162/ 246,non-matched: 14255/38468; pair-matched: 217/ 681,"","","","","","","","","","",non-matched: 97/431; pair-matched: 59/ 246,non-matched: 9848/38468;  pair-matched:158/ 681,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",non-matched: 431; pair-matched:: 246 ,"","","","",non-matched: 265/431;  pair-matched: 162/ 246,non-matched: 14255/38468; pair-matched: 217/ 681,"","","","","","","","","","",non-matched:  97/431; pair-matched: 59/ 246,non-matched: 9848/38468; pair-matched: 158/ 681,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","
non-matched: 38899;pair matched: 927
",100,"","","","",non-matched: 265/431; pair-matched: 162/ 246,non-matched: 14255/38468; pair-matched: 217/ 681,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",non-matched: 97/431; pair-matched: 59/ 246,non-matched: 9848/38468; pair-matched: 158/ 681,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",no
61922,V 2020,Case fatality rate of cancer patients with COVID-19 in a New York Hospital system,Consensus,Peer-reviewed,American Association for Cancer Research,medical records,2020-05,Case Fatality Rate of Cancer Patients with COVID-19 in a New York Hospital System,Mehta V,Retrospective,Cohort,Yes,inpatient,USA,New York City,Montefiore Health System,2020-03-18,2020-04-08,1308,Case fatality in COVID-19 patients with cancer vs. patients without cancer,"",Severity; ICU admission; Mortality,no,All Types Cancer; history of malignancy; part of sample in active treatment,Age and sex matched 5:1 ratio,"Matched; 1:5;
Age, sex","",Median,69,Range,10-92,58,218,"","","","","",1090,Not mentioned; Other,"","","","","","","","","",147,67.4,"","","","","","",80,36.7,"","","","","","",43,19.7,"","","","","","","","","","","","","","","","","","","","","","",54,24.8,"","","","","","",62,28.4,"","","","","","","","","","","","","","","","","","","","","","","33 (congestive heart failure, CHF)",15.1,"","","","","","","","","","","","","","",no definition stated,no definition stated,no definition stated; covid-19 specific mortality,need for ventilator support,multivariate,Age; Sex,"",11 (lung),aOR,7.58,2.28-25.15,0.001,0.545 (6/11),0.137 (149/1090),"","","","","","","","","","","","","","","","","","","","",28,aOR,1.05,0.36-3.08,0.933,0.143 (4/28),0.137 (149/1090),"","","","","","","","","","","","","","","","","","","","",8,aOR,3.79,0.90-16.02,0.071,0.375 (3/8),0.137 (149/1090),"","","","","","","","","","","","","","","","","","","","",21 (colorectal),aOR,3.89,1.58-9.54,0.003,0.381 (8/21),0.137 (149/1090),"","","","","","","","","","","","","","","","","","","","",7,aOR,2.53,0.49-13.14,0.277,0.286 (2/7),0.137 (149/1090),"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",13,aOR,3.95,1.27-12.23,0.018,0.385 (5/13),0.137 (149/1090),"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",8,aOR,0.90,0.11-7.39,1.066,0.125 (1/8),0.137 (149/1090),"","","","","","","","","","","","","","","","","","","","",3,aOR,3.16,0.28-35.04,0.358,0.333 (1/3),0.137 (149/1090),"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",164,aOR,2.11,1.42-3.12,0.0002,0.250 (41/164),0.137 (149/1090),"","","","","","","","","","","","","","","","","","","","",54,aOR,3.71,2.08-6.63,1.165E-05,0.370 (20/54),0.137 (149/1090),"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",218,aOR,2.45,1.74-3.46,4.527E-7,0.280 (61/218),0.137 (149/1090),"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",42,19.3,uOR,1.49,0.69-3.27,0.334,0.190 (8/42),0.137 (149/1090),"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",49,22.5,uOR,1.83,0.91-3.66,0.089,0.224 (11/49),0.137 (149/1090),"","","","","","","","","","","","","","","","","","","","",5,2.3,uOR,1.58,0.18-14.22,0.700,0.2000 (1/5),0.137 (149/1090),"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",yes
61478,B 2020,Characteristics and Outcomes of 35 Breast Cancer Patients Infected With COVID-19,Consensus,Peer-reviewed,Frontiers in Oncology,"Our study was performed in five designated tertiary hospitals for the treatment of COVID-19 in Wuhan, China.",2020-10,Characteristics and Outcomes of 35 Breast Cancer Patients Infected With COVID-19,Zhang B,Retrospective,Cohort,Yes,inpatient,China,Wuhan,"Our study was performed in five designated tertiary hospitals for the treatment of COVID-19 in Wuhan, China.",2020-01-17,2020-05-18,171,"Disease severity, mortality ","",Severity; ICU admission; Mortality,no,All types cancer; No definition of active cancer; Active treatment not stated,"Comparison group drawn from same five tertiary hospitals as cancer groups.

Our study was performed in five designated tertiary hospitals for the treatment of COVID-19 in Wuhan, China. Thirty-five breast cancer
patients with COVID-19, 81 other types of cancer patients with COVID-19, and 55 COVID-19 patients without cancer were recruited between January 17, 2020 and May 18, 2020",No matching,"",median; median,56 (breast cancer); 58 (other cancers),IQR; IQR,45 - 62 (breast cancers);  49 - 62 (other cancers),0 (breast cancers); 46.9 (other cancers),116,median,57,IQR,49 - 64,41.8,55,Not mentioned,"","","","","","","","","",24,20.7,17,30.9,cOR,0.58,0.28 - 1.21,1.177,16,13.8,10,18.2,cOR,0.72,0.30 - 1.71,1.354,9,7.8,7,12.7,cOR,0.58,0.20 - 1.64,1.346,"","","","","","","","","","","","","","","","","","","","","","","","",6,5.2,0,0,cOR,undefined,undefined,undefined,"","","","","","","","","","","","","","","","",6 (common pulmonary infections); 9 (anaemia),5.2 (common pulmonary infections); 7.8 (anaemia),0 (common pulmonary infections); 0 (anaemia),0 (common pulmonary infections); 0 (anaemia),cOR,undefined,undefined,undefined,"","","","","","","","",No definition stated,"",No definition stated,No definition stated,"univariate; Other: Univariate reported for breast cancer patients, Crude calculated for all cancer patients","","",12 (lung); 2 (nasopharynx),"","","","","","","","","","","","","","","","","","","","","","","","","","",35,"","","","",0 (0/35),0 (0/55),"","","","",0 (0/35),0 (0/55),"","","","",0.314 (1135),0.200 (11/55),"","","","","","","","",6 (gastric); 1 (oesophageal),"","","","","","","","","","","","","","","","","","","","","","","","","","",6 (colon); 3 (rectum),"","","","","","","","","","","","","","","","","","","","","","","","","","",5 (pancreas); 4 (liver),"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",3 (bladder),"","","","","","","","","","","","","","","","","","","","","","","","","","",7 (cervical); 3 (ovarian),"","","","","","","","","","","","","","","","","","","","","","","","","","",1 (meningioma),"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",1 (osteosarcoma),"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",6 (leukaemia); 6 (myeloma); 4 (lymphoma); 2 (myelodysplastic syndrome),"","","","","","","","","","","","","","","","","","","","","","","","","","",7 (thyroid); 1 (liposarcoma),"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",116,"","","","",0.069 (8/116),0 (0/55),"","","","",0.069 (8/116),0 (0/55),cOR,4.59,2.16 - 9.77,0.0001,0.534 (62/116),0.200 (11/55),"non-cancer data taken from table 5 and cancer data summed across both cohorts from table 6. I calculated crude OR, CI and p-value using this data","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",no
61253,K 2020,Covid-19 in patients with hematological and solid cancers at a Comprehensive Cancer Center in Germany,Consensus,Peer-reviewed,Cancer Medicine,EHRs from University Hospital Freiburg,2020-08,Covid-19 in patients with hematological and solid cancers at a Comprehensive Cancer Center in Germany,Shoumariyeh K,Retrospective,cohort,Yes,inpatient,Germany,Freiburg,University Hospital of Freiburg,2020-02-27,2020-04-10,78,Treatment,Mortality ,Severity; ICU admission; Mortality,no,All types of cancer; no definition of active cancer; 36% in active treatment,controls at the same hospital,Matched; 1:1; age,"",Median,73,range,54-95,56.4,39,Median,76,range,45-96,64.1,39,Not mentioned,"",6,15.4,9,23.1,"","","",0.4998,"","","","","","","","",5,12.8,9,23.1,"","","",0.3768,30,76.9,34,87.2,"","","",0.3768,"","","","","","","","",1,2.6,3,7.7,"","","",0.6151,5,12.8,15,38.5,"","","",0.0183,3,7.7,11,28.2,"","","",0.0362,"","","","","","","","","","","","","","","","",3 (Rheumatological),7.7 (Rheumatological),3,7.7 (Rheumatological),"","","",1.000,"","","","","","","","",No definition stated,No definition stated ,No definition stated; covid-19 specific mortality,Mechanical Ventilation,univariate,"","",5,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",3 (all GI),"","","","","","","","","","","","","","","","","","",all GI,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",16 (uro-gynec),"","","","","","","","","","","","","","","","","","",uro-gynec,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",5,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",29,uOR,0.47,0.15-1.42,1.218,6/29,14/39,uOR,0.80,0.29-2.24,1.250,9/29,14/39,uOR,0.97,0.33-2.83,1.039,8/29,11/39,"","","","","","","","",7,uOR,0.45,0.08-2.40,1.346,2/10,14/39,uOR,4.17,0.93-18.72,0.063,7/10,14/39,uOR,1.09,0.24-5.00,0.919,3/10,11/39,LYMPHOMA/MYELOMA,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",3,"","","","","","","","","","","","","","","","","","",LEUKEMIA/PHN,"","","","","","","",39,uOR,0.46,0.17-1.27,1.135,8/39,14/39,uOR,1.24,0.50-3.10,0.658,16/39,14/39,uOR,1.00,0.37-2.68,1.000,11/39,11/39,"","","","","","","","","",29,"","","","","","","","","","","","","","","","","","","","","","","","","","",10,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",78,100,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",no
59743,N 2020,Outcomes of the 2019 novel coronavirus in patients with or without a history of cancer: A multi-centre North London experience,Consensus,Peer-reviewed,Therapeutic Advances in Medical Oncology,5 North London hospitals.,2020-09,"Outcomes of the 2019 novel coronavirus in 
patients with or without a history of cancer: 
a multi-centre North London experience","Joharatnam-Hogan, N",Retrospective,Cohort,Yes,inpatient,UK,London,Not specified - 5 North London hospitals.,2020-03-01,2020-04-30,120,COVID-19 mortality and severe disease.,"",Severity; Mortality,no,Not specified,Matched control group recruited from same five hospitals,"Comparator group matched for age (74), gender (67% male) and number of comorbidities (median 2).

Cancer : control = 30 : 90","",Median,74,IQR,70-78,67,30,Median,74,IQR,66-81,67,90,Not mentioned,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","Composite of ITU admission, invasive ventilation or death.","","","Composite of ITU admission, invasive ventilation or death.",univariate; Other: UV but intrinsically matched cohorts,"","",5,"","","","","","","","","","","","","","","","","","","","","","","","","","",4,"","","","","","","","","","","","","","","","","","","","","","","","","","",1,"","","","","","","","","","","","","","","","","","","","","","","","","","",5,"","","","","","","","","","","","","","","","","","","","","","","","","","",3,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",8,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",1,"","","","","","","","","","","","","","","","","","","","","","","","","","",1,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",29,"","","","","","","","","","","","","","","","","","","","","","","","","","",1,"","","","","","","","","","","","","","","","","","","","","","","","","","",1,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",30,uOR,1.05,0.4-2.5,0.9,0.367,0.356,"","","","","","",uOR,0.87,0.4-2.0,0.7,0.367,0.400,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",14,"","","","","",6/30,32/90,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",7,"","","","","",4/30,32/90,"","","","","","","","","","","","","","","","","","","","",1,"","","","","","","","","","","","","","","","","","","","","","","","","","","",2,"","","","","",1/30,32/90,"","","","","","","","","","","","","","","","","","","","",1,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",120,100,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",no
